Characterisation of a putative agr system in Clostridium botulinum and Clostridium sporogenes by Cooksley, Clare Marie
Cooksley, Clare Marie (2008) Characterisation of a 
putative agr system in Clostridium botulinum and 
Clostridium sporogenes. PhD thesis, University of 
Nottingham. 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/11463/1/490055.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
· Copyright and all moral rights to the version of the paper presented here belong to 
the individual author(s) and/or other copyright owners.
· To the extent reasonable and practicable the material made available in Nottingham 
ePrints has been checked for eligibility before being made available.
· Copies of full items can be used for personal research or study, educational, or not-
for-profit purposes without prior permission or charge provided that the authors, title 
and full bibliographic details are credited, a hyperlink and/or URL is given for the 
original metadata page and the content is not changed in any way.
· Quotations or similar reproductions must be sufficiently acknowledged.
Please see our full end user licence at: 
http://eprints.nottingham.ac.uk/end_user_agreement.pdf 
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
Characterisation of a Putative agr System in 
Clostridium botulinum and Clostridium 
sporogenes 
Clare Marie Cooksley, B. Sc. 
GEORGE GREEN LIBRARY OF,, 
SCIENCE AND ENGINEERIN 
Thesis submitted to the University of Nottingham for the degree of 
Doctor of Philosophy, September 2007 
Declaration 
Unless otherwise acknowledged, the work presented in this thesis is my own. No part 
has been submitted for another degree in the University of Nottingham or any other 
institute of learning. 
c-C. Q c 4-L. -I 
Clare Cooksley 
September 2007 
Table of Contents 
List of Figures 
.................................................................................... 
vii 
List of Tables 
....................................................................................... 
x 
Abbreviations 
..................................................................................... 
xii 
Abstract 
............................................................................................ 
xv 
Acknowledgments 
............................................................................... 
xvi 
1.0 Introduction 
.................................................................................... 
1 
1.1 Introduction to clostridia 
........................................................... 
1.2 Clostridium botulinum 
............................................................... 
1.2.1 Discovery and occurrence 
................................................ 
1 
1.2.2 Toxin types 
.................................................................. 
2 
1.2.3 Botulinum. neurotoxin structure 
.......................................... 
3 
1.2.4 Mechanism of toxin action 
.............................................. 
5 
1.2.5 Types of botulism and epidemiology 
.................................... 
6 
LZ5.1 Foodborne botulism 
........................................... 
6 
LZ5.2 Wound botulism 
................................................ 
8 
LZ5.3 Infant botulism 
................................................. 
8 
1.2.6 Treatment 
................................................................... 
9 
1.2.7 Theraneutics 
............................................................... 
10 
1.2.8 Bioterrorism 
................................................................ 
10 
1.2.9 Regulation of botulinum neurotoxin expression 
in C botulinum 
............................................................ 
11 
1.3 Clostridium sporogenes 
............................................................ 
12 
1.4 Sporulation in clostridia 
.......................................................... 
13 
1.5 Quorum sensing 
.................................................................... 
14 
1.5.1 The principle of quorum sensing 
...................................... 
14 
1.5.2 Quorum sensing in Gram-positive bacteria 
........................... 
16 
1.5.3 Inactivation of die agr system 
.......................................... 
22 
1.5.4 Quorum sensing in clostridia 
............................................ 
22 
1.5.5 Evidence for agr in clostridia 
.......................................... 
23 
1.6 Mutational studies in clostridia 
.................................................. 
24 
1.7 Project aims 
.......................................................................... 
28 
2.0 Materials and Methods 
..................................................................... 
29 
2.1 Media 
............................................................................................................ 
29 
2.1.1 Luria-Bertani medium 
.................................................. .................. 
29 
2.1.2 TYG medium 
.................................................................................. 
29 
2.1.3 Brain Heart Infusion (BHI) agar 
........................................... 
29 
2.1.4 Spizizen's Minimal Salts Medium (SMM) 
.................. ................. 
29 
2.1.5 B. subtilis Competence Medium 
.................................. ................. 
30 
2.1.6 B. subtilis Transformation Medium 
............................. ................. 
30 
2.1.7 5X Minimal salts 
......................................................... 
30 
2.1.8 B. subtilis Minimal growth mediwn 
..................... ............... 
30 
2.1.9 B. subtilis Starvation medium 
........................................... 
31 
2.2 Supplements 
......................................................................... 
31 
2.3 Growth Conditions 
................................................................. 
31 
2.4 Bacterial strains 
..................................................................... 
33 
2.5 Plasmids 
.............................................................................. 
34 
2.6 Oligonucleotide primers 
........................................................... 
38 
2.6.1 Primers used in Chapter 3 
................................................ 
38 
2.6.2 Primers used in Chapter 4 
................................................ 
40 
2.6.3 Primers used in Chapter 5 
................................................ 
43 
2.7 Preparation and manipulation of DNA 
........................................ 
46 
2.7.1 Preparation of plasmid DNA 
............................................ 
46 
2.7.2 Preparation of chromosomal DNA (E. coli and 
C sporogenes) 
............................................................ ....... 
46 
2.7.3 Preparation of chromosomal DNA (C. bolulinum) 
.................. 
46 
2.7.4 Restriction enzyme digests 
....................................... ....... 
47 
2.7.5 Bbint-ending of DNA 
............................................ ...... 
47 
2.7.6 De-phosphorylation of linearised, DNA fragments 
................... 
47 
2.7.7 Analysis of DNA by agarose get electrophoresis 
............. ........ 
48 
2.7.8 Purification of DNA fragments 
.................................. ....... 
48 
2.7.9 Polymerase Chain Reaction 
...................................... ....... 
48 
ii 
2.7.10 DNA ligation 
............................................................ 
49 
2.7.11 TOPO TA cloning methods 
........................................... . 
49 
2.7.12 Preparation of electrocompetent E. coli cells 
....................... . 
49 
2.7.13 Electroporation 
......................................................... . 
50 
2.7.14 Transformation of DNA into Bacillus subtilis 
(method 1) 
....................................................................... . 
50 
2.7.15 Transformation of naturally competent B. subtilis 
cells with DNA (method 2) 
.................................................... 
50 
2.7.16 Blue/white colony selection 
........................................... 
51 
2.7.17 Conjugation of E. coli CA434 (HB 10 1) with 
C. sporogenes 10696 (filter mating method) 
................................ 
51 
2.7.18 Conjugation of E. coli CA434 (HB 10 1) with 
C sporogenes 10696 or C botulinum Hall A (spot method) 
............. 
51 
2.7.19 DNA sequencing 
........................................................ 
52 
2.7.20 Southern hybridisation 
................................................. 
52 
2.8 RNA analysis 
....................................................................... 
. 
53 
2.8.1 Preparation of total RNA from C sporogenes (method 1) 
......... 
54 
Z8. LI Removal of contaminating genomic DNA 
from total RNA 
......................................................... 
54 
Z 8. L2 DNase treated RNA sample clean up 
..................... 
55 
2.8.2 Preparation of total RNA from C sporogenes 
(method 2) 
....................................................................... 
. 
55 
Z8.2.1 RNase inhibitorlMase treatment 
........................ 
56 
2. &Z2 Sample clean up 
............................................... 
56 
2.8.3 Quantification of RNA and DNA 
...................................... . 
56 
2.8.4 One-step Reverse Transcriptase (RT)-PCR 
.......................... . 
57 
2.8.5 Real Time Quantitative PCR 
........................................... . 
57 
Z8.5.1 Primers 
...................... 
57 
. .................................. 
2.8.5.2 RNA extraction 
............................................... 
57 
Z8.5.3 Rt.., erse transcription 
........................................ 
58 
Z8.5.4 Real time PCR 
............... ................................. 
58 
Z 8.5.5 Standard curve generation 
.................................. 
59 
Z8.5.6 Data analysis 
...... 
2.8.6 Northem hybridisation 
................. ................................. 
59 
iii 
2.9 Estimation of segregational stability of plasmids in 
Bacillus subtilis and Clostridium spp 
................................................ 
61 
2.10 Induction of gene replacement using integrative vector 
in Clostridium sporogenes 
.............................................................. 
62 
2.11 Induction of target gene knockout using the ClosTron 
System 
..................................................................................... 
63 
2.11.1 Using plasmid pMTL007 
............................................... 
63 
2.11.2 Using plasmid pMTLO07CE-2 
........................................ 
63 
2.12 Measurement of spore formation in Clostridium species 
.................. 
64 
3.0 Identification and Characterisation of Clostridial agr Systems 
.................... 
65 
3.1 Introduction 
......................................................................... 
65 
3.2 Results 
................................................................................. 
68 
3.2.1 Sequencing of the agr regions of C sporogenes 
..................... 
68 
3.2.2 Comparison of agr region gene products amongst 
clostridia. and other Gram-positive bacteria 
.................................. 
69 
3.111 AgrD alignments 
.............................................. 
69 
3. ZZ2 AgrB alignments 
.............................................. 
75 
3. ZZ3 Differences between the two intraspecies 
AgrD and AgrB proteins in C. botulinum and 
C. sporogenes 
.......................................................... 
76 
3. Z2.4 Analysis of regionsflanking agrB 
and agrD in clostridia 
................................................ 
76 
3.2.3 BLAST searches on agr and flanking regions 
....................... . 
78 
3.2.4 Expression analysis of agr genes in C sporogenes 
................. . 
80 
3. Z4.1 Reverse Transcriptase PCR analysis to 
investigate linkage of agr gene expression in 
C. sporogenes 
.......................................................... 
80 
iv 
3. Z4.2 Real Time RT-PCR to analyse expression 
of agrDl and agrD2 in C. sporogenes 
............................. 
83 
3.3 Discussion 
............................................................................ 
86 
3.3.1 Sequencing of the agr regions of C sporogenes 
..................... 
86 
3.3.2 Comparison of AgrD and AgrB amongst clostridia 
and other Gram-positive bacteria 
............................................. 
86 
3.3.3 Analysis of regions flanking agrB and agrD in clostridia 
.......... 
89 
3.3.4 Expression analysis of agr genes in C. sporogenes 
.................. 
93 
4.0 Gene Modulation Techniques in Clostridium sporogenes 
........................ *.. 
98 
4.1 Introduction 
......................................................................... 
98 
4.2 Unstable plasmids as a tool for gene knockout in clostridia 
............... 
98 
4.2.1 Results 
.................................................................... 
101 
4. Z1.1 Plasmid segregational stability in 
Bacillus subtilis 
...................................................... 
105 
4. ZI. 2 Plasmid segregational stability in 
Clostridium sporogenes 
............................................. 
105 
4. ZL3 Construction and insertion of a pyrF 
knockout cassettefor use with integrative vector 
pMTL51121, acI 
....................................................... 
107 
4.2.2 Discussion 
............................................................... 
114 
4.3 Gene modulation in C. sporogenes using antisense RNA 
technology 
............................................................................... . 
117 
4.3.1 Antisense target gene selection for this study 
....................... 
119 
4.3.2 Results 
.................................................................... 
121 
4.3. ZI Construction of antisense 'mutants ...................... 121 
4.3.2.2 Effect of antisense production on sporulation 
......... 
124 
4.3.3 Discussion 
............................................................... 
127 
5.0 Gene inactivation in C. botulinum and C. sporogenes using the 
ClosTron System 
............................................................................... 
131 
V 
5.1 Introduction 
........................................................................ 
131 
5.1.1 Adaptation of the group H intron for use in 
Clostridium spp 
................................................................ 
135 
5.1.2 Generation of multiple gene knockout mutants using 
the ClosTron System 
.......................................................... 
137 
5.2 Results 
.............................................................................. 
143 
5.2.1 Generation of single knockout mutants 
.............................. 
143 
5.2.2 Screening of putative single knockout mutants 
..................... 
146 
5.2.3 Generation of putative double knockout mutants 
................... 
153 
5. Z3.1 Step I- Generation of agrDI mutant 
.................... 
153 
S. Z3.2 Step 2- Construction ofplasmid 
expressing FIp recombinase 
........................................ 
156 
5. Z3.3 Step 3- Excision of removable RAM 
................... 
157 
5.2.4 Characterisation of clostridial mutants generated 
using the ClosTron system 
................................................... 
158 
5.3 Discussion 
........................................................................... 
162 
5.3.1 Future work 
.............................................................. 
170 
6.0 General Discussion 
........................................................................ 
174 
6.1 Introduction 
........................................................................ 
174 
6.2 A functional agr system in C botulinum and C sporogenes 
.............. 
174 
6.3 Gene modulation techniques for determining agr gene function 
........ 
176 
6.4 Construction of targeted knockout mutants for determining 
function of the agr genes 
............................................................. 
178 
6.5 Summary and future work 
...................................................... 
179 
Bibliography 
..................................................................................... 
182 
Appe. ioix 1 
....................................................................................... 
198 
Appendix 2 
....................................................................................... 
201 
Appendix 3 
....................................................................................... 
219 
Appendix 4 
....................................................................................... 
220 
Appendix 5 
....................................................................................... 
222 
vi 
List of Figures 
Chapter 1.0 
Figure 1.1 Arrangement of neurotoxin genes in different C botulinum 
types 
................................................................................. 
Figure 1.2 Diagram of the agr quorum sensing system from S. aureus 
............... 
18 
Figure 1.3 Structures of the AIPs from the four S. aureus agr groups 
................ 
21 
Figure 1.4 Schematic representation of single crossover recombination 
.............. 
26 
Figure 1.5 Schematic representation of double crossover recombination 
............ 
27 
Chapter 3.0 
Figure 3.1 agr gene regions in four species of clostridia 
................................ 
67 
Figure 3.2 Phylogenetic tree of AgrD proteins of various Gram-positive 
bacteria 
........................................................................... 
71 
Figure 3.3 AgrD protein alignment of various Gram-positive bacteria 
............... 
72 
Figure 3.4 AgrD protein aligmnents 
....................................................... 
73 
Figure 3.5 Phylogenetic tree of AgrB proteins of various Gram-positive 
bacteria 
............................................................................ 
75 
Figure 3.6 Protein alignment of regions immediately upstream of 
AgrB in C botulinum, C sporogenes, C perfringens 
and C acetobutylicum 
.......................................................... 
77 
Figure 3.7 Protein aligmnent of regions upstream of AgrB in C perfringens 
and C botulinum 
................................................................. 
78 
Figure 3.8 Reverse transcriptase PCR to show linkage of agr gene 
expression in C sporogenes 
....... ............................................ 
81 
Figure 3.9 Real Time RT-PCR to assess agrD expression in C sporogenes 
......... 
85 
vii 
Chapter 4.0 
Figure 4.1 
Figure 4.2 
Figure 4.3 
Figure 4.4 
Figure 4.5 
Figure 4.6 
Figure 4.7 
Figure 4.8 
Figure 4.9 
Replication in rolling circle plasmids 
......................................... 
99 
Strategy used to generate integrative vector pMTL51121acI 
............ 
102 
Representation of the chromosomal arrangements which 
may arise from two possible single crossover events 
..................... 
109 
Plasmid map and screening results on SO DNA 
......................... 
Ill 
Proposed mechanisms of action of antisense RNA 
........................ 
118 
Schematic representation of the agr regions in the 
C. sporogenes 10696 genome 
................................................ 
119 
Schematic representation of the sporulation phosphorylation 
cascade in B. subtilis 
........................................................... 
120 
Plasmid map of inducible antisense delivery vector pMTL9361 
........ 
121 
Confirmation of antisense RNA expression in agrBI and agrB2 
'mutants ......................................................................... 123 
Figure 4.10 Confirtnation of antisense, RNA expression in 336 and 340 
'mutants ......................................................................... 123 
Figure4.11 Sporulation in C sporogenes agrB 'mutants' in the presence 
and absence of IPTG 
........................................................... 
125 
Figure4.12 Sporulation in C sporogenes 336 and 340 kinase 'mutants' in the 
Chapter 5.0 
presence and absence of IPTG 
................................................ 
126 
Figure 5.1 Secondary structure and recognition sites of the L lactis ItrB 
group II intron, 
.................................................................. 
133 
Figure 5.2 Plasmid map of the pMTL007 ClosTron vector 
........................... 
136 
Figure 5.3 Plasmid map of pMTLO07C-E2 
............................................. 
138 
Figure 5.4A SOEing PCR carried out on L. lactis ItrB group Il intron 
................ 
139 
Figure 5.4B Ligation of retargeted vector into pMTL007 plasmid 
..................... 
140 
Figure 5.4C Expression of intron RNA and retrohoming of RNP 
..................... 
141 
viii 
Figure 5AD Splicing of the ErmRAM in ClosTron mutants 
............................ 
142 
Figure 5.5 Schematic representation of the agr regions in the C botulinum 
ATCC 3502 genome 
........................................................... 
143 
Figure 5.6 Products obtained from the re-targeting SOEing PCR carried out 
on the L lactis group 11 intron 
................................................ 
145 
Figure 5.7 Schematic representation of PCR screens carried out on 
putative integrants 
.............................................................. 
148 
Figure 5.8 PCR screen 1 on four C. botulinum and two C. sporogenes 
mutants 
........................................................................... 
149 
Figure 5.9A Southýrn blot to demonstrate the presence of a single intron 
insertion in four C botulinum mutants 
...................................... 
151 
Figure 5.9B Southern blot to demonstrate the presence of a single intron 
insertion in two C. Sporogenes mutants 
..................................... 
152 
Figure 5.10A PCR screen I on C. botulinum agrDl mutant generated using 
pMTLO07C-E2 
................................................................. 
155 
Figure 5.10B PCR screen 2 on C botulinum agrDl mutant generated using 
pMTLO07C-E2 
................................................................. 
155 
Figure 5.10C PCR screen 3 on C. botulinum agrDl mutant generated using 
pMTLO07C-E2 
................................................................. 
156 
Figure 5.11 Plasmid map of vector pMTL5402F-FLP 
.................................. 
157 
Figure 5.12 Growth of six clostridial mutants compared to wild type 
................ 
159 
Figure 5.13 Sporulation in four C botulinum mutants 
.................................. 
160 
Figure 5.14 Sporulation in two C sporogenes mutants 
................................. 
161 
Figure 5.15 Functional domains of the C. botulinum kinase proteins 0336 
and 0340 
........................................................................ 
167 
Figure 5.16 Schematic diagram depicting the insertion site of the group 
II intron in the C botulinum agrD mutants, along with 
the possible transcriptional fusions which may occur 
..................... 
168 
ix 
List of Tables 
Chapter 3.0 
Table 3.1 Percentage protein identity between gene products in the agr regions 
of C sporogenes and C botulinum 
........................................... 
69 
Table 3.2 Protein identity between the two AgrD and two AgrB 
proteins of C botulinum and C sporogenes 
................................. 
76 
Table 3.3 BLAST search results for Agr flanking regions in four 
clostridial species 
............................................................... 
79 
Chapter 4.0 
Table 4.1 Segregational stability of integrative vector pMT51121acl in 
B. subtilis 168, expressed as percentage plasmid loss 
..................... 
105 
Table 4.2 Segregational stability of integrative vector pMTL51121acl 
in C sporogenes cured strain, expressed as percentage 
plasmid loss 
..................................................................... 
106 
Table 4.3 Segregational stability of integrative vector pMTL51121acl 
containing pyrF knockout cassette in C sporogenes cured 
strain, expressed as percentage plasmid loss 
............................... 
108 
Table 4.4 Segregational stability of integrative vector pMTL51121acl 
containing pyrF knockout cassette in C. sporogenes SC3, 
expressed as percentage plasmid loss 
....................................... 
133 
Table 4.5 Nomenclature of eight antisense 'mutants' created in 
sporogenes 
.................................................................. 
122 
Chapter 5.0 
Table 5.1 Target sites and primers utilised for gene knockout of four 
genes in C botulinum ATCC 3502 and two genes in 
C sporogenes 10696 
......................................................... 
144 
Table 5.2 Results from conjugation and integration experiments for 
knockout of genes in C botulinum and C sporogenes 
.................. 
146 
Table 5.3 Primers used in three different PCR screens of C. botulinum 
and C sporogenes putative knockout mutants 
............................ 
147 
Table 5.4 Results from conjugation and integration experiments for the 
knockout of agrDl in C botulinum using plasmid 
pMTLO07C-E2 
................................................................ 
154 
xi 
List of Abbreviations 
ABC ATP binding cassette 
Agr Accessory gene regulator 
AHL Acyl homoserine lactone 
AM Autoinducer I 
AI-2 Autoinducer 2 
AIP Autoinducing peptide 
AQ Absolute quantification 
ATCC American Type Culture Collection 
BHI Brain Heart Infusion 
BLAST Basic local alignment search tool 
bp Base pairs 
cDNA Complementary DNA 
cfU Colony-forming units 
Cm. Chloramphenicol 
CT Threshold cycle 
DEPC Diethyl pyrocarbonate 
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
DNTP Deoxyribonucleoside, 5'- triphosphate 
dso, Double stranded (+) origin 
EBS Exon binding site 
EDTA Ethylene diamine tetraacetic acid 
Erm. Erythromycin 
FRT Flp recombinase target 
9 Gram 
9 Gravity 
h Hour 
HA Haemagglutinin 
HPA Health Protection Agency 
IBS Intron binding site 
IEP Intron encoded protein 
IPTG Isopropyl P-D-thiogalactopyranoside 
xii 
Kb Kilobase 
k Da Kilo Dalton 
Kg Kilogram 
I Litre 
LB Luria-Bertani 
M Molar 
mg Milligram 
Ml Millilitre 
mm Millimolar 
mm Millimeter 
mRNA Messenger ribonucleic acid 
NCBI National Centre for Biotechnology Information 
nM Nanomolar 
NTNH Non toxic non haemagglutinin 
OD Optical density 
ORF Open reading frame 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PNPG p-nitrophenyl cc-D-glucopyranoside 
QS Quorum sensing 
RAM Retrotransposition Activated selectable Marker 
RBS Ribosome binding site 
RC Rolling circle 
RCA Reinforced Clostridial Agar 
RIP RNAIII inhibiting peptide 
RNA Ribonucleic acid 
RNase Ribonuclease 
RNP Ribonuclear protein 
Rpm Revolutions per minute 
RQ Relative quantification 
rRNA Ribosomal ribonucleic acid 
RT-PCR Reverse transcriptase polymerase chain reaction 
SIDS Sudden infant death syndrome 
xiii 
SNARE Soluble NSF (N-ethyl maleimide sensitive fusion protein) 
Attachment protein Receptor 
sso Single stranded (-) origin 
TAE Tris-acetate-EDTA buffer 
TeTx Tetanus toxin 
TSS Toxic shock syndrome 
TYG Tryptone, yeast extract, sodium thioglycolate medium 
ýX Microfarads 
P9 Microgram 
PI Microlitre 
PM Micromolar 
UV Ultraviolet 
V Volts 
VAMP Vesicle associated membrane protein 
v/v Volume to volume 
W/v Weight to volume 
X-Gal 5-bromo-4-chloro-3-indolyl-o-D-galactoside 
x1v 
Abstract 
Botulinum. neurotoxin induces a potentially fatal paralytic condition in humans and 
various animal species collectively known as 'botulism'. It consequently poses a major 
problem to the food industry, due to the ability of its spores to survive in cooked foods. 
The incidence of wound botulism has also suffered a recent increase in the UK. The 
genome sequence of the C botulinum Group I strain ATCC 3502 has recently been 
determined. In silico analysis has revealed the presence of two distinct loci capable of 
encoding proteins with homology to AgrB and AgrD of the Staphylococcus aureus agr 
quorum sensing system. The functional characterisation of these genes has been carried 
out in order to determine whether they play a role in quorum sensing. To simplify 
laboratory procedures, C. sporogenes, the non-toxic counterpart of C. botulinum, was 
initially focused on. The agr regions in C. sporogenes were sequenced and their 
proteins compared with those of C. botulinum and other Gram-positive bacteria. 
Regions of conservation were observed amongst the clostridia and, to a lesser extent, 
between clostridia and staphylococci. 
Transcriptional linkage assays showed some of the genes of the C sporogenes agr 
regions to be co-expressed, and Real-Time RT-PCR demonstrated the maximal 
expression of these genes during late exponential growth. 
Modulation of the expression of the identified agr genes is a prerequisite to 
determining their function. Due to an initial lack of an effective gene knockout tool, 
antisense RNA expression was used for this purpose in C sporogenes, and showed that 
down regulation of the agrB genes affects sporulation. The development of an 
integrative vector system for gene inactivation in C sporogenes was also attempted. 
Knockout mutants in C botulinum and C sporogenes were later constructed using the 
newly-developed ClosTron system. These mutants were used to demonstrate that 
AgrDl, AgrD2 and an orphan sensor kinase protein all play a role in the control of 
sporulation in C. botulinum and C. sporogenes. 
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Chapter 1.0 
Introduction 
Chapter 1- Introduction 
1.1 Introduction to clostridia 
Clostridium is one of the largest prokaryotic genera, containing over 130 species of 
Gram-positive, anaerobic, spore forming bacilli (Andreesen et aL, 1989; MacFaddin, 
2000). The pathogenic clostridia cause disease by the release of potent toxins. In fact, 
tetanus and botulinum. neurotoxins, produced by Clostridium tetani and Clostridium 
botulinum respectively, are two of the most harmful natural compounds known (Durre, 
2001). Tetanus toxin acts on inhibitory motor nerve endings in the central nervous 
system, causing spastic muscle paralysis. Botulinurn toxin affects the peripheral nervous 
system at the endings of stimulatory motor neurones by preventing the calcium- 
dependent release of acetylcholine, and causes the flaccid paralysis of botulism (Durre, 
2001). 
Clostridium perfringens produces a number of toxins associated with gas gangrene and 
clostridial myonecrosis, while Clostridium difficile causes pseudomembranous colitis 
and antibiotic-associated diarrhoea, via the release of Toxins A and B (Durre, 2001). 
Other, non-pathogenic, strains of clostridia also exist including Clostridium butyricum, 
which has been approved as a probiotic against enterohaemorrhagic Escherichia coli in 
Japan. Others include Clostridium acetobutylicum and Clostridium sporogenes, which 
have been used in turnour therapy research. C acetobutylicum has also been used in 
industrial solvent production (Durre, 2001). 
1.2 Clostridium botulinum 
1.2.1 Discovgy and occurrence 
C botulinum was first isolated in 1895 by van Ermengem and was originally narned 
Bacillus botulinus (Bell & Kyriakides, 2000). It was later placed into the genus 
Clostridium by Bengtson in 1924 (Hatheway, 1993). The name botulism is derived from 
the Latin 'botulus' which means 'sausage'. Botulism was, for a long time, associated 
with the consumption of contaminated sausages and the commonly-used name for the 
disease was 'sausage poisoning' (Bell & Kyriakides, 2000). 
C botulinum occurs naturally in soil and lake sediments, and its spores are also found 
on plants growing in soil contaminated with faeces. It can be spread from plant to plant 
by bees that accumulate spores along with pollen, and honey is consequently frequently 
contaminated with C botulinum spores (Salyers & Whitt, 2002). It is thought that C 
botulinum spores are probably wide-spread in all parts of the world. 
1.2.2 Toxin types 
The C botulinum neurotoxins are made up of seven structurally related proteins 
- 
serotypes A-G (Quinn & Minton, 2001). These toxin types differ in complex size, 
level of activation, substrate cleavage sites, receptor binding affinity, degree of muscle 
weakening and duration of action (Blocker et aL, 2003). The strains of C botulinum can 
be placed into four physiological groups as follows: 
Group I- Proteolytic strains producing toxin types A, B or F. 
Group II 
- 
Non-proteolytic strains producing toxin types B, E or F. 
Group III 
- 
Non-proteolytic strains producing toxin types C or D. 
Group IV 
- 
Proteolytic strains producing toxin type G. 
(Hatheway, 1993) 
In addition to these four groups, strains of Clostridium butyricum (producing toxin type 
E) and Clostridium barati (producing toxin type F) have also been isolated from cases 
of infant botulism (Aureli et aL, 1986; Hall et aL, 1985). 
The only groups documented as -iusing disease in humans are groups I and II, with the 
most common toxin types being A, B and E (also F but less frequently) (Quinn & 
Minton, 2001). All organisms isolated from cases of wound botulism have been 
members of group I (Hatheway, 1993). Group III strains tend to cause disease in birds 
and animals and group IV strains are not thought to cause disease at all (Quinn & 
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Minton, 2001). Occasionally, strains of C bolulinum may exist which produce a 
mixture of two different toxin types. These have been reported by Gimenez and 
Ciccarelli (1970), who isolated a strain producing types A and F; Pourneyrol et al. 
(1983), with a strain producing types A and B; and Hatheway and McCroskey (1989), 
with a strain producing types B and F. However, in strains containing two different 
toxin genes, the second gene can often be silent, due to the presence of nucleotide 
deletions or insertions which result in frameshift mutations. These strains therefore only 
produce one toxin type (Quinn & Minton, 2001). 
1.2.3 Botulinum neurotoxin structure 
Botulinurn toxins form heterocomplexes with other non-toxic proteins (Quinn & 
Minton, 2001). This complex allows the toxin to remain stable, particularly under the 
acidic conditions encountered in the gastrointestinal tract (Hatheway, 1993). The 
neurotoxin is always found in association with a non-toxic, non-haemagglutinating 
protein (NTNH), which is of an equivalent size to the toxin. Other proteins with 
haemagglutinating activity may also be present, depending on the toxin serotype (Quinn 
& Minton, 2001). The botulinurn neurotoxins are released as progenitor toxins, in 
complex with these non-toxic counterparts. 
The mature 150 kDa botulinum toxin is originally synthesised and released from the 
bacteria as a single, inactive protein via cell lysis. Proteolytic clipping is required to 
form the active toxin, and may be carried out by a protease produced by the clostridia, 
or by a gastric protease (Salyers & Whitt, 2002). Dekleva and Dasgupta (1990) isolated 
a 62 kDa amidase from C botulinum type A Hall strain, which had the capacity to 
process the single chain neurotoxin, resulting in the di-chain active form. The recent 
completion of the C botulinum genome sequence has revealed a 62 kDa clostripain 
protein which may also be implicated in the proteolytic cleavage of the neurotoxin 
(Sebaihia et al., 2007). This proteolysis results in a covalently linked hetero-dimeric 
polypeptide, held together by a disulphide bond (Quinn & Minton, 2001). 
Hence the final modified, active toxin consists of a heavy chain and a light chain. The 
heavy chain is 100 kDa and is involved in the binding of the toxin to target cells 
(mediated by the carboxy terminal domain) and formation of channels in the neuronal, 
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membrane to allow the light chain to enter the cell (mediated by the amino ten-ninal 
domain). The 50 kDa light chain is the catalytic domain, exhibiting metalloprotease 
activity (Salyers & Whitt, 2002). 
As far as the genetic organisation of the toxin genes is concerned, the gene encoding the 
NTNH protein immediately precedes the gene for the toxin. In clostridia that possess 
haernagglutinin activity, the encoding gene precedes the NTNH gene and evidence so 
far suggests that the haemagglutinin proteins are always encoded by the opposite DNA 
strand to the NTNH and neurotoxin genes (Quinn & Minton, 2001). The HA 
components are encoded by a tricistronic operon, while the NTNH and neurotoxin 
genes are transcribed alone, or form bicistronic operons (Marvaud et al., 1998a). Figure 
1.1 illustrates the arrangement of the neurotoxin and associated genes in the different C 
botulinum types. 
Types A and B 
Types C and D 
1.3 kb 
Type F and infant type A 
0.3 kb 
Type E and C butyricum 
Type G 
cntR 
*-MEEýM> C telani 
P47 
Figure 1.1 
- 
Arrangement of neurotoxin genes in different C. bolulinum types. 
CNT, clostridial neurotoxin gene; NTNH, non-toxic, non-haemagglutinating protein 
gene; cntR, transcriptional regulator (botR); P47, an ORF encoding a 47 kDa protein 
with unknown function; X, and X,, genes of unk-nown function; numbers indicate 
haernagglutinating protein genes. Adapted from Quinn & Minton (2001). 
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In some clostridia, the toxin genes are not carried on their chromosomes but may be 
carried on a lysogenic bacteriophage, which can integrate the gene into the bacterial 
chromosome. Only a bacterium infected with that phage is able to produce toxin, which 
is the case in C botullnum types C and D (Salyers & Whitt, 2002). The loss of such 
phages renders the bacteria unable to produce toxin (Hatheway, 1993). The genes for 
types A, B, E and F toxins are not phage-encoded and are located on the bacterial 
chromosome. In contrast, Zhou et aL (1995) demonstrated that the genes for the toxin 
complex of C botulinum type G are located on a large plasmid. 
1.2.4 Mechanism of toxin action 
Once the stable botulinurn progenitor toxins have passed through the acidic 
environment of the stomach, they dissociate in the alkaline conditions of the intestines. 
The botulinum. toxin is transcytosed from the mucosal side of the intestinal epithelium 
and passes into the bloodstream (Foran et aL, 2003). The binding domain of the toxin 
heavy chain is then able to bind to the membrane of the cholinergic motor nerve 
terminals via a group of sialic acid-containing glycolipids called gangliosides (Foran et 
al., 2003). Once bound to its receptors, the toxin enters the cell by receptor-mediated 
endocytosis into vesicles in the nerve cell. Acidification of these vesicles causes the 
translocating domain of the toxin heavy chain to change conformation. This enables it 
to form ionic channels in the lipid bilayer, allowing the toxin to enter the cytoplasm 
(Simpson, 2004). 
Neurotransmitters are released from secretory vesicles at the nerve synapse by a process 
that depends on fusion of the vesicle to the membrane of the nerve cell. This fusion is 
dependent on a conserved set of membrane proteins, which form a complex and are 
known as SNARE proteins (Soluble NSF [N-ethyl maleimide sensitive fusion protein] 
Attachment protein REceptor) proteins (Fasshauer et al., 1998; Sutton et al., 1998). 
These SNARE proteins are divided into groups and are essential components involved 
in vesicle fusion and secretory events in secretory cells. The SNARE proteins located in 
the nerve terminals are: 
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1. Vesicle Associated Membrane Protein (VAMP), also known as synaptobrevin 
2. Syntaxin 
3. SNAP-25 (a 25 kDa synaptosomal protein) 
(Quinn & Minton, 2001) 
The botulinum neurotoxins act on the cholinergic synapses of the peripheral nervous 
system by inhibiting the secretion of neurotransmitters. This inhibition occurs via the 
zinc-dependent hydrolysis of one or more of the SNARE proteins. Disabling any of 
these proteins prevents fusion of the vesicles to the nerve cell membrane and subsequent 
release of neurotransmitter. Mechanistically, the botulinum neurotoxins are able to bind 
to these SNARE proteins via a ten-residue consensus sequence of amino acids, of which 
all the SNARE proteins contain multiple copies (Herreros et al., 1999). The blockage of 
the nerve synapses results in the characteristic flaccid paralysis observed in all forms of 
botulism. 
1.2.5 Types of botulism and Midemiolo 
C botulinum causes three naturally occurring types of disease: wound botulism, 
foodborne botulism and infant botulism. However, a fourth type, inhalational botulism, 
can also occur as a consequence of a man-made aerosolised version of the toxin 
(Coleman and Yergler, 2002). The only known case of this occurred in Germany in 
1962 (Amon et at, 2001). 
Botulism occurs after the toxin is absorbed into the circulation from a wound or a 
mucosal surface like the gut (Coleman & Yergler, 2002). Botulism is not an infection, it 
is in fact an intoxication; C. botulinum is unable to colonise the gut of healthy adults 
due to competition fi-orn the commensal flora. The three main types of botulism are 
outlined below. 
LZ5.1 Foodborne botulism 
This form of the disease has historically been the most commonly occurring type in the 
UK and, consequently, C botulinum has been the principal target of the food processing 
industry for almost a century. This form of the disease occurs following the 
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consumption of food that contains toxin produced by the bacterium. Contamination of 
food by C. botulinum is not uncommon, but simple ingestion does not usually cause the 
disease. Any bacteria germinating from spores cannot compete with the commensal 
flora of the gut and are therefore unable to grow to a high enough concentration to cause 
disease. Disease occurs when spores germinate in foods, producing toxin, which is 
subsequently ingested (Salyers & Whitt, 2002). The bacterium does not grow easily in 
foods but is most common in home-canned foods that have been heated, cooled and 
stored for long periods at room temperature. It is also an emerging issue with the 
increasing popularity of minimally heated, chilled foods, or 'ready-meals' (Peck, 2006). 
Growth and neurotoxin production can occur at 10-12*C in proteolytic C botulinum 
(Peck & Stringer, 2005), but worryingly, growth has been reported for non-proteolytic 
C botulinum at temperatures as low as YC (Graham et al., 1997). This is well below 
the required 81C, which applies to storage of chilled foods in England and Wales (Peck, 
2006). The estimated lethal dose of a type A toxin for a human of 70 kg is 
approximately 70 ýtg orally and 0.7-0.9 pg if inhaled (Amon et al., 2001). 
Initial neurological symptoms include nausea, diarrhoea, headache, dizziness, slurred 
speech and a dry mouth. If symptoms become more severe, the muscle paralysis can 
affect the muscles of the respiratory and cardiac systems, and death can subsequently 
occur if left untreated (Bell & Kyriakides, 2000). The symptoms of foodborne botulism 
appear approximately 12 to 36 hours after exposure to the toxin (McLauchlin et al., 
2006). 
Although the occurrence of foodborne botulism is relatively rare (only 62 cases were 
reported between 1922 and 2006 (McLauchlin et al., 2006)), the severity of its 
symptoms and prolonged treatment required by patients means that the cost to health 
services is extremely high. Setlow and Johnson (1997) predicted that in the USA, each 
case of botulism could cost approximately $30 million. It is therefore imperative that 
steps are taken to prevent the growth and toxin formation of C botulinum in foods. 
Recently, due to the treatment of foodbome botulism with equine antitoxin and 
supportive therapy, the fatality rate has fallen to 5-10% of cases (Peck, 2006). The 
introduction of effective control measures has also aided the reduction in the incidence 
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of foodbome botulism, with most cases now seemingly associated with home-prepared 
foods where the recommended precautions have not been adhered to. 
LZ5.2 Wound botulism 
It is possible for C botulinum to colonise a deep wound, as its environment may be 
sufficiently anaerobic to allow growth. Tissue destruction in the wound results in the 
blood supply to the area being substantially reduced. Any remaining oxygen is depleted 
by the body cells, leaving an anaerobic environment for the bacterium. The toxin 
produced then passes into the blood stream and causes disease, with similar symptoms 
to foodborne botulism. Previously, this type of botulism has been relatively rare in the 
UK, but there has been a recent increase in its incidence, which is largely due to its 
occurrence in intravenous drug users. C botulinum wound infections had not been 
reported in the UK and Republic of Ireland until 2000 (Akbulut et al., 2005). However, 
between the beginning of 2000 and the end of 2002 there were thirty-three clinically 
diagnosed cases of wound botulism in the UK and Ireland. The incidence is now rising 
rapidly with a further 15 cases in 2003,40 in 2004 and at least 30 in 2005. All of these 
patients had injected heroin (Brett et al., 2004; Akbulut et al., 2005; McLauchlin et al., 
2006). Cases of wound botulism have also been previously reported when deep wounds 
have been heavily contaminated with soil containing C. botulinum (Salyers & Whitt, 
2002). 
LZ5.3 Infant botulism 
Infant botulism is relatively uncommon world-wide, but is the most common type of 
botulism in the USA (Quinn & Minton, 2001; Cox & Hinkle, 2002). In fact, since 1976, 
when the first two cases were diagnosed (Dodds, 1993), over 1000 cases have been 
reported world-wide, and over 90% of these were in the USA (Dodds, 1993; Cox & 
Hinkle, 2002). This form of the disease affects otherwise healthy children, who are 
usually less than one year old. At this age, the child's intestines are vulnerable to 
colonisation by C. botulinum because their commensal flora is not yet fully developed 
(Dodds, 1993). The most common cause of infant botulism seems to be spores in the 
general environment. These are ingested and can germinate in the anaerobic 
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environment of the gut, resulting in colonisation. and toxin production (McMaster et aL, 
2000). The only food so far suspected of causing infant botulism is honey, which can 
carry large numbers of bacterial spores (Dodds, 1993). In fact, honey has been 
implicated in a number of cases of infant botulism (Sonnabend et aL, 1985; Cox & 
Hinkle, 2002) and it is now recommended that parents do not feed honey to children 
below one year of age (Cox & Hinkle, 2002). A study by Cherington (1998) showed 
that up to 25% of honey products were found to contain spores. 
Infant botulism has also been implicated in Sudden Infant Death Syndrome (SIDS), a 
suggestion which was first made by Midura and Amon (1976). However, recent 
research has produced conflicting reports (Sonnabend et aL, 1985; Byard et aL, 1992). 
1.2.6 Treatment 
Once the toxin has bound to, and entered a neurone, any treatment is futile. Nerve 
regeneration may occur if a patient survives, but survivors often suffer irreversible 
neurological damage (Salyers & Whitt, 2002). The only treatment that can be given is 
supportive care during the paralysis, which may include mechanical ventilation in 
severe cases (Foran et al., 2003). However, if administered promptly, antitoxin is able 
to neutralise any free toxin which has not yet bound to the nerve endings (McLauchlin 
et al., 2006). This usually consists of polyvalent anti-toxin, as the specific toxin type 
may not be known (Bell & Kyriakides, 2000). However, as these antitoxins are only 
effective if administered promptly, and may cause allergic reactions (Breidenbach & 
Brunger, 2005), the development of curative treatments is crucial. Foran et al. (2003) 
reviewed some of the developing new treatments for botulism, which include the use of 
protease inhibitors and the genetic transfer of toxin-protease-resistant SNARES. 
Interestingly, the recent research of Satoh and colleagues suggests that the thearubigin 
fraction from black tea is highly efficient at blocking botulinum. neurotoxin action in 
vitro (Satoh et al., 2001; Satoh et al., 2002; Satoh, 2005). 
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1.2.7 Therapeutics 
Although, in its naturally occurring concentrations, botulinum neurotoxin is potentially 
lethal, the therapeutic use of neurotoxin type A was approved by the Food and Drug 
Administration in the USA in 1989 (Barnes, 2003). Highly diluted toxin is able to 
relieve muscle spasm within three days and has consequently been used to treat 
numerous spastic muscle conditions (Durre, 2001). These include spasms affecting 
vision (blepharospasm and strabismus); cerebral palsy (Durre, 2001); 
pharyngoesophageal spasm (Chao et al., 2004); overactive bladder (Cruz, 2004); 
hemifacial spasm (Laskawi et al., 1994); spasticity after stroke (Childers et al., 2004); 
migraine (Blumenfeld et al., 2004); excessive sweating (Naumann & Jost, 2004); 
whiplash injuries (Juan, 2004) and some of the symptoms of Parkinson's disease and 
Raynaud's syndrome (Cordivari et al., 2004; Sycha et al., 2004). 
1.2.8 Bioterrorism 
The extreme potency of the C botulinum neurotoxins has rendered them a potential 
bioterrorist's weapon. They are among the most dangerous candidates for use in 
bioterrorism, along with anthrax and smallpox (Durre, 2001). The C botulinum 
neurotoxin has been classed as a category A agent by the Centres for Disease Control in 
Atlanta, USA. These substances are the most serious threats and are 'easily 
disseminated, often transmissible from person to person, likely to cause high mortality, 
panic and disruption and would require some form of special intervention by the 
relevant public health authority (Lamb, 2001). 
Botulinurn neurotoxin could potentially be used in an aerosol, or to contaminate food 
supplies, and Ig could be sufficient to kill one million people (Lamb, 2001). It was first 
developed as a biological weapon over sixty years ago and was released as an aerosol 
by the Aum Shinrikyo cult in Japan in the 1990s. However, no cases of botulism 
resulting from this release were reported (Whitby et aL, 2002). Iraq has also admitted to 
producing 19,000 litres; of botulinum toxin and loading approximately half of this into 
missiles and bombs (Amon et aL, 2001). It is also claimed that, incredibly, the amount 
of toxin which has still not been accounted for in Iraq is three times the amount required 
to kill every human being on earth (Amon et aL, 2001). 
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Some comfort can, however, be taken from the fact that the distribution of the toxin via 
aerosol from a biological weapon would not be easy, and the production and 
distribution of large enough quantities would be difficult (Durre, 2001). The toxin can 
also be easily inactivated by standard water-cleaning procedures so it would be difficult 
to produce high enough concentrations to be effective. Botulism cannot be spread from 
person to person and is treatable, as described above, to a certain extent (Lamb, 2001). 
The fact that, generally, the mortality rate is less than 10% would also make it a less 
appealing agent to bioterrorists (Whitby et aL, 2002). 
1.2.9 Regulation of botulinum neurotoxin expression in C botylinum 
Various factors have been implicated in the regulation of botulinum neurotoxin gene 
expression. These include two-component systems allowing the bacteria to sense 
changes in the population density of the external environment (known as Quorum 
Sensing, and discussed later), and the availability of exogenous carbon and nitrogen 
sources (Patterson-Curtis & Johnson, 1989). 
C botulinum types A, B, C, D, F and G possess a regulatory gene botR which is thought 
to regulate toxin expression. The BotR protein is approximately 21 kDa and shows 
characteristics of a DNA binding protein (Marvaud et al., 1998b). In types C and D the 
botR gene is located upstream of both the HA and NTNH genes. In types A, B, F and G, 
the botR gene is found between the HA and NTNH genes (Marvaud et al., 1998a) [see 
Figure 1.1]. Marvaud et al. (1998b) demonstrated that over-expression of the BotR/A 
protein in C. botulinum type A induced a higher level of production of botulinurn 
neurotoxin A and associated non-toxic proteins, showing that BotR is indeed a positive 
regulator of toxin expression. They also used antisense mRNA to inhibit expression of 
the botRIA gene, which decreased the toxicity of the culture supernatant. A similar 
regulator, Tetl; ý is found in C. tetani. Marvaud et al. (1998a) showed that BotR/A was 
also able to regulate the tetanus toxin (TeN7) gene in C letani. This was due to their 
high sequence homology, with TetR showing overall identity of 50-65% with BotR/C 
and BotR/F (Marvaud et al., 1998a). 
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More recent research has shown that BotR and TetR regulate toxin production by 
functioning as alternative sigma factors. The BotR/A-core enzyme complex recognises 
two separate promoters; one driving transcription of the neurotoxin and NTNH genes 
and one driving transcription of the HA genes (Raffestin et al., 2005). It has also been 
suggested that these regulators belong to the same family of alternative sigma factors in 
which C difficile TcdR and C peýfiringens UviA are found (Raffestin et al., 2005; 
Gamier & Cole, 1988; Mani & Dupuy, 2001; Mani et al., 2002). These sigma factors 
differ so much in their structure and function from major sigma factors identified in 
other prokaryotes that they have been assigned to their own group (group 5 of the cr 70 
family) (Dupuy & Matamouros, 2006). 
1.3 Clostridium sporogenes 
C sporogenes is biochemically and morphologically similar to group I strains of C 
botulinum, with up to 100% rRNA and 70-100% DNA homologies (McKinney et aL, '* 
1993). As it does not produce a neurotoxin, it is an ideal candidate to study in place of 
C botulinum. Results can be extrapolated to C botulinum, but the hazards posed by 
working with the toxigenic species are avoided. Indeed it is routinely used by the food 
industry as a non-hazardous C botulinum model. 
McKinney et al. (1993) produced probes that were able to distinguish between C 
botulinum and C sporogenes using selective hybridisation. DNA sequences present in 
C botulinum group I but absent in C sporogenes could then be detected. The probes 
were not sequences of the toxin genes, indicating that there are additional differences, 
besides the absence of the toxin in C sporogenes. 
Although thought to be relatively non-pathogenic, C sporogenes has occasionally been 
associated with various diseases including cerebrocortical necrosis, osteornylitis and 
antibiotic-associated haemorrhagic diarrhoea. The virulence factor associated with 
haemorrhagic diarrhoea is the haemorrhagic toxin, which shows collagenase activity 
(Hara-Kudo et al., 1996). 
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1.4 Sporulation in clostridia 
One of the most notable characteristics of the clostridia is their ability to form 
endospores. These dormant cells are generally formed under conditions unfavourable 
for growth and are highly resistant to harsh treatments like heat, freezing, chemicals, 
radiation and desiccation (Brown, 2000). In other spore-forming bacteria like Bacillus 
species, spores are generally produced in response to a lack of nutrients. However, in 
clostridia, carbon and energy sources are required in order for sporulation to take place, 
and other factors which may affect the cells' decision to sporulate include pH, 
temperature and exposure to oxygen (Durre, 2001). 
The ability of C botulinum spores to persist in cooked foods is a major factor 
responsible for cases of foodborne botulism. Indeed, spores of non-proteolytic strains of 
C botulinum are able to survive the pasteurisation process and also to germinate even at 
refrigeration temperatures (Webb et al., 2007; Graham et al., 1997). As a result, a 
minimum standard heat treatment of 121.1'C for 3 minutes has been recommended as 
the treatment required in canned foods for a 'botulinum cook' (Peck, 2006; Stumbo et 
al., 1975). Clearly this is not always adhered to during home-preparation of foods, 
which is when cases of foodborne botulism are usually observed. 
Spore formation is a crucial survival mechanism utilised by the clostridia, which 
enables them to persist in an aerobic atmosphere until more favourable, anaerobic, 
conditions are found. It may also therefore be considered as a virulence factor, as, in the 
pathogenic clostridia, the formation of spores generally contributes to the survival of the 
organism in the environment and the subsequent development of disease. Indeed, once 
conditions become more favourable, spores are able to germinate back into vegetative 
cells, and subsequently cause disease by the production of toxins. In fact, it has been 
shown that some species of clostridia, require sporulation to take place in order for 
toxins to be produced. For example, the C peýfiringens enterotoxin is only synthesised 
in sporulating cells (Durre & Hollergschwandner, 2004). Any ingested bacteri" 
sporulate in the intestines, with the concomitant production of enterotoxin. This toxin is 
responsible for causing histological damage to the intestinal epithelium, resulting in 
severe diarrhoea (McClane & Rood, 2001). C. perfringens-related food poisoning is 
currently the third most common foodbome disease in the USA (Li & McClane, 2006). 
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C difficile is a major contributory organism in hospital acquired infections due to the 
resistance of its spores to many chemical treatments. Most commonly-used detergents, 
as well as ethanol, are inactive against its spores, which are consequently able to persist 
in the hospital environment. Spores are easily transmitted between patients, and also 
between healthcare workers and patients. Furthermore, is has been shown that C 
difficile spores are able to survive in the environment for five months (Kim et al., 198 1). 
Because of this persistence, cases of C difficile-related diarrhoea are increasing rapidly, 
with 51,690 UK cases being reported in 2005 alone (HPA report, 2006). The estimated 
cost of C. difficile-associated infections in the USA is $ 1.1 billion per year (McFarland 
et al., 2007). 
Clostridial spore formation is therefore an important virulence factor which, coupled 
with toxin production, allows these organisms to successfully persist in an aerobic 
environment and cause serious diseases. It is therefore vital to investigate the processes 
which control sporulation in order to better understand the control of clostridial 
virulence. Effective control measures may then be implemented in an effort to prevent 
or reduce spore formation. 
1.5 Quorum sensing 
1.5.1 The trincinle of auorum sensin 
Quorum sensing is a mechanism of cell to cell communication among bacteria (Lerat & 
Moran, 2004). It is utilised by bacterial populations as a means of co-ordinately 
responding to external stimuli in a cell density-dependent manner. This occurs via 
signalling molecules known as autoinducers, and results in the regulation of specific 
genes. These signal molecules are released so that bacteria can detect the density of a 
population in a particular environment. The molecules are released during growth and 
accumulate in the environment. Once the concentration of the signal molecule reaches a 
threshold, or quorum, this triggers a response in the bacterial population (Winzer et al., 
2003). This usually involves a cascade of events which ultimately leads to changes in 
gene regulation (Winzer et al., 2003). Genes regulated by quorum sensing include those 
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involved in virulence factor production (Winzer et al., 2003), cell migration, formation 
of biofilms (Lerat & Moran, 2004), sporulation (Hilgers, & Ludwig, 2001) and 
production of toxins (Kleerebezern & Quadri, 2001). It may be favourable for individual 
bacterial cells to suppress the expression of certain genes when the population density 
falls below a threshold. By waiting until the population size has increased, the 
concentration of virulence factor produced, and hence its effect, is much greater 
(Winzer et al., 2003). 
Quorum sensing was first described in the Gram-negative bacterium Vibrio fischer! 
(Nealson et al., 1970). This bacterium lives on marine eukaryotes and produces light for 
its hosts. Light emission only occurs when the bacterial cell density reaches a threshold, 
and the luciferase operon is transcribed. The autoinducer is an acylated homoserine 
lactone (AHL) (Lerat & Moran, 2004). AHLs accumulate, and once a threshold is 
reached, activate a transcriptional regulator of the LuxR family (Winzer et al., 2003). 
Quorum sensing systems have subsequently been discovered in many bacterial species. 
Vibrio harveyi is another marine bacterium whose luminescence is regulated by quorum 
sensing. However, this organism has two quorum sensing systems (Bassler et aL, 1993). 
One is similar to that of Vibriofischeri and uses the AHL signal molecule. The second 
system relies on the accumulation of a molecule called autoinducer 2 (Al-2), which is 
believed to be a furanosyl borate diester (Chen et aL, 2002). AI-2 is generated via the 
LuxS enzyme (Schauder et aL, 2001) and binds to a periplasmic protein LuxP, which 
then interacts with a membrane-bound histidine protein kinase, LuxQ. Following a 
series of dephosphorylation reactions, LuxO can no longer activate transcription of the 
repressor gene, and the lux operon is consequently transcribed (Winzer et aL, 2003). 
A variety of Gram-positive and Gram-negative bacteria possess luxS homologues, 
similar to those found in V harveyi (Winzer et aL, 2003). In fact, it has been claimed 
that BLAST searches have shown evidence of luxS homologues in the genomes of 
'most bacteria] species for which complete sequence data are available' (Hilgers & 
Ludwig, 2001). In addition, Xavier and Bassler (2003) found that the luxS gene exists in 
35 of the 89 currently available complete bacterial genomes by database analysis. PCR, 
along with AI-2 activity assays, have allowed the identification of luxS in a number of 
species for which no genome sequences are available (Xavier & Bassler, 2003). 
15 
In some cases, signalling molecules can be recognised by different bacterial species. 
This is known as interspecies cross-talk and can either promote or inhibit gene 
expression (Sturme et al., 2002). As luxS has been found in many different bacteria, it 
has recently been proposed that A1-2 could serve as a 'universal signal' for interspecies; 
cross-talk (Xavier & Bassler, 2003). However, this is yet to be proved in species other 
than Vibrio. 
Despite the proposed role of LuxS in quorum sensing, some researchers have recently 
questioned this theory and postulated that it is in fact a metabolic side product, produced 
during the activated methyl cycle (a recycling pathway involved in the metabolism of 
methionine) (Winzer et al., 2002; Winzer et al., 2003). Indeed, Doherty et al. (2006) 
demonstrated that the inactivation of luxS in S. aureus had no effect on virulence- 
associated traits. It is possible that the phenotypic changes observed in some bacteria 
following inactivation of luxS, may be due to the absence of the AI-2 signal molecule, 
but they could also be attributed to the disruption of the activated methyl cycle (Winzer 
et al., 2003). The true role of this protein is yet to be elucidated. 
Because quorum sensing controls the regulation of so many processes, including the 
production of virulence factors, it has been the focus of attention as a therapeutic target 
in the search for alternatives to conventional antibiotic therapy, which is becoming 
increasingly redundant due to the emergence of resistance. Areas attracting particular 
interest are the recent increase in Methicillin-Resistant Staphylococcus aureus (MRSA) 
(Abraham, 2006) and the problem of biofilm formation in Pseudomonas aeruginosa 
infections in cystic fibrosis patients (Lyczak et al., 2000). 
1.5.2 Q]qorum sensing in Gram-positive bacteria 
Quorum sensing in Gram-positive bacteria occurs via a range of different signals but all 
systems involve a two-component regulatory signal transduction system, consisting of a 
membrane-bound receptor histidine protein kinase, and an intracellular response 
regulator (Sturme et al., 2002). When this response regulator is phosphorylated by the 
receptor kinase, transcription of target genes is activated or repressed. Transcription of 
genes involved in the production of the autoinducing peptides is also activated (Sturme 
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et al., 2002). Most Gram-positive bacteria use signalling molecules that are created 
from large precursors and post-translationally modified (Fuqua & Greenberg, 1998). 
They are then exported using ATP binding cassette (ABC) export systems (Klein et al., 
1992; van der Meer et al., 1993). Some bind to sensor kinases in the cell membrane, 
which transduce the signal across the membrane. Others bind to intracellular receptors 
after being transported into the cell by oligopeptide permeases. 
The paradigm for Gram-positive quorum sensing is the staphylococcal agr (accessory 
gene regulator) system. This is the only known quorum sensing system in the 
staphylococci (Kies et al., 2003) and was first identified in S. aureus. In late exponential 
to stationary phase, this system inhibits the expression of a number of surface proteins, 
for example fibronectin binding proteins A and B, and increases the expression of many 
secreted virulence factors (Yarwood & Schlievert, 2003). The system is able to switch 
on in the later parts of the growth phase by sensing the cell density of its surroundings 
(Otto et al., 1998). The virulence factors controlled by agr include cc, P and 8 cytotoxins 
(haernolysins), serine protease, DNase, fibrinolysin, enterotoxins; A-D, toxic shock 
syndrome (TSS) toxin I (Otto et al., 1998), and leucocidins (Lina et al., 1998). Other 
proteins whose production is regulated by agr in staphylococci include staphopain, 
lipase, phospholipase C, nuclease, hyaluronidase, coagulase, protein A (Novick, 2003), 
arginase, peptidase and chitinase B (Dunman et al., 2001). In addition, agr is also 
involved in the invasion and apoptosis of epithelial cells (Yarwood & Schlievert, 2003). 
The agr locus is approximately 3.5 Kb and is made up of two transcripts 
- 
RNAII and 
RNAIII, which are generated from the P2 and P3 promoters, respectively. The P2 
operon codes for four proteins generating the agr sensing mechanism 
- 
Agr A, B, C and 
D (Novick et al., 1995). The P3 operon codes for RNAIII, which is the effector 
molecule of the two-component system, and controls the expression of target genes. It 
also encodes staphylococcal 8 toxin (Janzon et al., 1989; Novick et al., 1995). The roles 
of the components of the agr system are outlined below and illustrated in Figure 1.2. 
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Figure 1.2 
- 
Diagram of the agr quorum sensing system from S. aureus, taken from 
Chan et al. (2004). The AgrD propeptide is modified and secreted from the cell by 
AgrB and possibly another peptidase. This results in the formation of the mature AIP, 
which binds to the AgrC sensor kinase. Subsequent phosphorylation of AgrC activates 
the AgrA response regulator which promotes transcription of the agrBDCA operon. It 
also increases transcription of RNAIII, the effector molecule of the system. 
AgrC is the transmembrane sensor kinase of a two-component system, whose N 
terminal interacts with a signal molecule. Activation of AgrC then occurs via a 
phosphorylation event. It was originally proposed that the C tenninal was 
autophosphorylated at a histidine residue when stimulated by the signal molecule (Ji et 
al., 1995; Novick et al., 1995). However, subsequent investigations have found that 
AgrC is partially phosphorylated in the absence of any AIP. It has been suggested that 
the cytoplasmic domain of AgrC is dimeric, containing a four-helix bundle, and that 
autophosphorylation would occur as a trans process (Novick, 2003). 
AgrA is the response regulator, which is required for the activation of the P2 and P3 
promoters and is phosphorylated by AgrC. It binds with high affinity to the RNAIII-agr 
intergenic region, with this binding being localised to a pair of direct repeats in the P2 
and P3 promoter regions (Koenig et al., 2004). 
AgrD is a propeptide, which is synthesised within the cell, processed and then secreted. 
AgrD requires modification by AgrB for production of the mature Autoinducing Peptide 
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(Ji et al., 1995; Zhang et al., 2002). The AgrD protein is processed at both the N and C 
terminal ends. A cyclisation reaction occurs, where a thioester linkage is formed 
between a conserved cysteine residue and the C terminal carboxyl group, in order to 
form the mature thiolactone AIP (Novick, 2003; Lyon and Novick, 2004). 
AgrB is a transmembrane protein essential for the generation and secretion of the 
autoinducing peptide (AIP). In S. aureus the peptide export system is not an ABC 
transporter, and it has been suggested that this function may be carried out by AgrB 
(Sturme et al., 2002). It is also required for the proteolytic modification of AgrD 
(Yarwood & Schlievert, 2003; Zhang et al., 2002). This modification of AgrD results in 
the production and secretion of the AIP. 
AIP, the autoinducing peptide of the two-component system, is a cyclic thiolactone of 
seven to nine amino acids, and is crucial for agr activity (Zhang et al., 2002). The agr 
genes are constitutively expressed at low cell densities, but when the AIP level reaches 
a threshold, the agr response is activated (Ji et al., 1995). Signalling by AgrA and AgrC 
results in an increase in the transcription of RNAII and RNAIII in a positive feedback 
manner (Yarwood & Schlievert, 2003). 
RNAIII has two functions. It encodes the 8 haemolysin toxin via the h1d gene, but is 
also responsible for the increase in transcription of extracellular virulence factors, such 
as toxins, and the decrease in transcription of cell surface proteins (Yarwood & 
Schlievert, 2003). It has recently been demonstrated that RNAIII exerts these effects by 
its 3' domain acting as an antisense RNA, and repressing translation of mRNAs 
encoding virulence factors acting early in the infection process (Boisset et aL, 2007). In 
addition, the increase in transcription of secreted virulence factors observed in the later 
stages of infection was shown to occur by the antisense down-regulation of Rot 
(repressor of toxins) mRNA by RNAIII. Since Rot has been identified as an antagonist 
to the agr response, this de-repression permits the translation of many of the secreted 
virulence factors associated with the later stages of infection. It has also been 
demonstrated that the 3' domain of RNAIII by itself is able to promote the synthesis of 
several exoproteases and exotoxins, (Boisset et aL, 2007). 
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Signal molecules produced by the agr system in S. aureus have been shown to stimulate 
agr activation in cells of their own population, but to inhibit expression of the agr 
system in cells of a different population (Kies et al., 2003). This is largely due to the 
fact that variations in specific regions of agrB, agrD and agrC have resulted in the 
allocation of four agr specificity groups in S. aureus (Novick, 2003). The groups were 
determined by assessing the ability of their AIP molecules to inhibit the agr response in 
other groups (Ji et al., 1997). These AEP groups show extremely high specificity, and 
just a single amino acid change can transform the AIP to a different group (Novick, 
2003). Cross inhibition occurs across these four AIP groups, but the AIPs from groups I 
and IV are able to activate each other's agr system due to their strong similarity (Chan 
et al., 2004). The structures of the AIPs from the four S. aureus agr groups are 
illustrated in Figure 1.3. 
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Figure 1.3 
- 
Structures of the AlPs from the four S. aureus agr groups. Letters refer to 
amino acid residues. Exocyclic tail residues are shown in grey; endocyclic residues are 
shown in white. Taken from Lyon et al. (2002). 
The production of RNAIII is affected by a second regulatory system 
- 
the 
staphylococcal accessory regulator sar (Blevins et al., 2002). Indeed, Blevins et al. 
(2002), Bayer et al. (1996) and Dunman el al. (200 1) demonstrated that mutating sarA 
resulted in a decrease in the production of RNAIII. Binding of SarA to the P2 and P3 
promoters promotes transcription of RNAII and RNAIII, indirectly affecting virulence 
factor regulation. The sar locus also operates independently of agr, regulating other 
virulence factors directly (Dum-nan et al., 200 1). 
 (i) aVINN 
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1.5.3 Inactivation of the a-or svstem 
Mutation of the agr system has been shown to have a number of effects. The expression 
of exotoxins such as cc, 0 and 8 toxins, serine protease, DNase, fibrinolysin, enterotoxin 
B and TSS toxin 1 has been shown to decrease, hence reducing virulence. An increase 
was also seen in the expression of many surface proteins (Recsei et al., 1986). 
Mutation of agr has also been shown to inhibit proteolytic, lipolytic and haemolytic 
activity in S. aureus (Blevins et al., 2002). Kies et al. (2003) demonstrated that 
production of the antibiotic epidermin in a S. epidennidis agr mutant was strongly 
reduced compared to the wild type, showing that the agr system plays an important role 
in epidermin biosynthesis. 
The agr system therefore has potential for targeting in an attempt to attenuate virulence 
in staphylococci. However, there is an alternative argument that inactivating the agr 
system may, in fact, contribute to the conversion of an acute infection to a chronic one 
(Kong el aL, 2006). Some studies have shown that inhibiting the agr system enables 
staphylococci to form biofilms more readily. Vuong et aL (2004) demonstrated this in S. 
epidermidis and suggested that this may present problems when using medical implant 
devices. 
1.5.4 Quorum sensing in clostridia 
Several clostridia, including C botulinum, have been found to possess LUXS 
homologues. The C botulinum IuxS gene shows 50.3% sequence identity with that of V 
harveyi, but limited literature is available on its mechanism of control of cellular 
functions. To date, there is only one documented report on the function of C. botulinum 
IuxS (Zhao et aL, 2006). This group demonstrated that AI-2 was present in C botulinum 
culture supernatant and that this supernatant promoted the germination and outgrowth of 
spores. However, there is no evidence to suggest that this promotion was directly due to 
the effect of AI-2. 
LuxS has also been investigated in other clostridial species and indeed, Ohtani et al. 
(2002b) showed that the IuxS gene is involved in the regulation of toxin production in 
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C perfringens via quorum sensing. This group also demonstrated that luxS mutants 
produced much less a, r, and 0 toxins than the wild type, and that these mutants could 
be complemented with wild type culture supernatant to restore toxin production. 
The study of quorum sensing in C difficile is also gathering momentum, due to the 
emerging incidence of C difficile-associated disease (CDAD) in hospitals. Carter et al. 
(2005) demonstrated that AI-2 is also produced by this clostridial species. In the region 
upstream of luxS, genes encoding a putative two component signal transduction system 
were identified, and the system was found to be involved in the regulation of AI-2 
production. However, they suggested that AI-2 was not involved in the control of toxin 
production, as down-regulation of the luxS gene using antisense RNA did not cause a 
reduction in toxin production. 
Lee & Song (2005) also carried out a similar study into luxS and quorum sensing in C 
difficile, and demonstrated an up-regulation of toxin A mRNA production in response to 
exposure to AI-2-containing C difficile supernatant. However, they could not 
demonstrate a concomitant increase in the level of the toxin. Their data do suggest, 
however, that luxS plays some role in the regulation of toxin production in C difficile. 
1.5.5 Evidence for azr in clostridia 
Sequence aligriments show that agr homologues occur in a number of bacteria besides 
staphylococci. In particular, they have been found in various clostridial species. They 
also occur in Listeria monocytogenes (Autret et al., 2003), Lactobacillus plantarum 
(Diep et al., 1994) and Enterococcusfaecalis (Nakayama et aL, 2001). 
Recent completion of the sequencing of the C botulinum genorne at the Sanger 
Institute, Cambridge, has revealed that it contains two agrB and two agrD homologues. 
However, there are currently no data available on the function of these agr genes, or 
whether they are involved in the control of virulence factor production. The 
investigation into the role of these genes could provide vital information on gene 
regulation in C botulinum. 
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1.6 Mutational studies in clostridia 
Historically, clostridia have been extremely difficult to manipulate genetically, which 
has hampered progress on the investigation of gene regulation in this genus. Currently, 
the only methods of transferring plasmid vectors into clostridia are by electroporation or 
conjugation from E. coli donors. However, electroporation is hampered in some strains 
of clostridia, for example Clostridium acetobutylicum, which possess a restriction 
system that cuts DNA originating from E. coli, or other GC rich DNA (Tummala et al., 
2001). 
Typically, the study of gene function in prokaryotes is achieved by the mutation of the 
gene of interest, followed by phenotypic analysis. In many bacteria this is often 
achieved by a process known as allelic exchange mutagenesis, which relies on 
homologous recombination between similar sequences in the chromosome and in a 
plasmid vector. A non-functional copy of the target gene, often containing an antibiotic 
resistance marker, is introduced into a suicide plasmid, which is unable to replicate in 
the target host. Once this plasmid is introduced to the host, homologous recombination 
occurs between the host target gene and the inactive copy on the plasmid. This 
recombination may result in the inactivation of the chromosomal target gene, and will 
confer antibiotic resistance to the mutated cell. 
Two different types of bacterial mutants can be created using allelic exchange 
mutagenesis; double crossover and single crossover mutants. Single crossover mutants 
arise from a single recombination event between the chromosomal target gene and a 
non-functional copy of the target gene, which is truncated at both the 5' and 3' termini. 
Figure 1.4 illustrates that, as well as a mutant version of the target gene, the plasmid 
used for its delivery is also integrated into the chromosome. This event results in the 
presence of two mutated copies of the gene on the chromosome; one truncated at the 5' 
end and one truncated at the 3' end (Carter, 2004). However, mutants obtained by this 
process exhibit instability due to the presence of large repeated flanking regions, and are 
able to revert to the wild type genotype (Carter, 2004). 
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The more favourable form of allelic exchange mutagenesis relies on the occurrence of 
two recombination events, resulting in a double crossover mutant. The target gene in 
this case is disrupted, usually by an antibiotic resistance cassette, and the vector 
sequence is excised from the chromosome during a second recombination event (Figure 
1.5). This second event, which occurs between homologous regions in the chromosome, 
may result in the excision of both the vector and mutated target gene (resulting in 
reversion to the wild type genotype) or the removal of the vector sequence only 
(resulting in a target gene disrupted by the antibiotic resistance cassette) (Carter, 2004). 
Although this form of mutagenesis has routinely been used in many species of 
eubacteria, it has been largely unsuccessful in the clostridia. In fact, until recently, there 
were no effective gene knockout techniques available for general use in clostridia. Over 
the past 15-20 years members of the clostridial scientific community have attempted 
various methods of gene inactivation; most of them unsuccessful or unreliable. Even 
though mutants have occasionally been created in clostridial species such as C 
perfiingens (Ohtani et al., 2002a; Huang et al., 2004) and C difflcle (Teichert et al., 
2006; O'Connor, et al., 2006), knockout mutants in C botulinum are yet to be obtained. 
In fact, even now, genetic manipulation in C botulinum is in its infancy compared with 
that of C perfiringens and C acetobutylicum (Bradshaw et aL, 1998). 
For many years, the clostridial scientific community has been in dire need of a highly 
efficient clostridial universal knockout system, in order to rapidly advance the 
molecular genetic study of this genus. 
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Figure 1.4 
- 
Schematic representation of single crossover recombination (adapted from 
Carter, 2004 and Pennington, 2006). A non-functional copy of the target gene, truncated 
at the 5' and 3' termini, is introduced to the host on a plasmid. The whole plasmid is 
integrated into the chromosome by a single crossover recombination event, resulting in 
the presence of two truncated copies of the gene in the chromosome. 
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- 
Schematic representation of double crossover recombination (adapted 
from Carter, 2004). A copy of the target gene interrupted by an antibiotic resistance 
cassette is introduced into the host on a plasmid and a single crossover event occurs as 
shown in Figure 1.4. However, a second recombination event occurs, resulting in either: 
I- the removal of the vector sequence only, leaving the target gene disrupted by the 
antibiotic resistance cassette; or 2- the excision of both the vector and mutated target 
gene and reversion to the wild type genome. 
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1.7 Project aims 
C hotulinum poses a major problem to the food industry due to its ability to produce 
spores which are able to survive in cooked foods. Smith et al. (2004) proposed that 
quorum sensing is likely to occur in both pathogenic and spoilage bacteria existing in 
foods. It is therefore clear that a better understanding of the quorum sensing pathways 
involved in the control of spoilage and virulence factors must be gained. This will aid 
the development of measures which can be taken to ensure the safety of food, and the 
prevention of serious diseases such as botulism. Once potential targets are identified, 
this may pave the way for the use of Generally RqCognised As Safe (GRAS) quorum 
sensing inhibitors which can be used in food processing in an attempt to render foods 
safer (Smith et al., 2004). 
The main aim of this study was to investigate the role of the agr system in gene 
regulation in C. botulinum. At the initiation of the project, facilities for handling C. 
botulinum were not available at the University of Nottingham. Experiments were 
therefore initially carried out using the closely-related organism C sporogenes. It is 
currently unknown whether the agr genes in these two clostridial species are functional, 
and if so, which target genes they control. The various clostridial agr regions were first 
compared to investigate their conservation and possible evolutionary history. The 
expression profile of the agr genes was also investigated to give information on whether 
the system was likely to be functional and at what time during the growth cycle it was 
maximally effective. 
In order to determine which cellular processes the agr system is involved in, an 
effective mutational tool was required. Three techniques were attempted in order to 
produce mutants in C sporogenes and C botulinum, which could be used to assess the 
functional role of the agr systems. The primary phenotype under investigation was 
sporulation. 
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Chapter 2.0 
Materials and Methods 
Chapter 2- Materials and Methods 
2.1 Media 
All media were sterilised by autoclaving at 121*C and 15 psi for 20 minutes unless 
otherwise stated. 
2.1.1 Luria-Bertani medium 
Luria-Bertani (LB) broth contained 10 g of Tryptone (Difco Laboratories), 5g of Yeast 
Extract (Difco Laboratories) and 5g sodium chloride (Sigma Ltd) in II of distilled 
water. LB agar was prepared by the addition of 1% (w/v) no. I Bacteriological agar 
(Oxoid). 
2.1.2 TYG medium 
TYG medium contained 30 g of Tryptone (Difco Laboratories), 20 g of Yeast Extract 
(Difco Laboratories) and Ig of sodium thioglycollate (Sigma) in II of distilled water. 
Sterile glucose was added to a final concentration of 0.5% (w/v) after autoclaving if 
necessary. TYG agar was prepared by the addition of 1% (w/v) no. I Bacteriological 
agar (Oxoid). 
2.1.3 Brain Heart Infusion (BHI) agar 
BHI agar contained 47 g BHI powder (Oxoid) in II distilled water. 
2.1.4 Spizizen's Minimal Salts Medium (SMM) 
SMM was prepared according to Anagnostopoulos & Spizizen (1961) and contained 14 
g anhydrous dibasic potassium phosphate, 6g anhydrous monobasic potassium 
phosphate, Ig sodium citrate and 0.2 g magnesium sulphate (heptahydrate) in II 
distilled water. The pH was adjusted to 7.0 and the medium filter sterilised. 
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2.1.5 B. subtilis Competence Medium 
Competence medium was prepared according to Anagnostopoulos & Spizizen (1961) 
and contained 10 ml SMM (see 2.1.4), 0.5 ml 10% glucose solution, 5 ýtl 0.1 M calcium 
chloride solution, 0.1 ml 250 mM magnesium sulphate solution, 0.1 ml 50 nM 
manganese chloride solution, 0.2 ml 10% casamino acids and 0.25 ml 10 mM 
tryptophan. The individual components were filter sterilised prior to use. 
2.1.6 B. subtilis Transformation Medium 
Transformation medium was prepared according to Anagnostopoulos & Spizizen (196 1) 
and contained I ml SMM (see 2.1.4), 50 ýLl 10% (w/v) glucose solution, 20 ýd 250 mM 
magnesium sulphate solution, I pI 10% (w/v) casamino acids and 25 PI 10 mM 
tryptophan. The individual components were filter sterilised prior to use. 
2.1.7 5X Minimal salts 
5X minimal salts was prepared as described by Bron (1990) and consisted of 10 g 
ammonium sulphate, 74 g anhydrous dibasic potassium phosphate, 27 g anhydrous 
monobasic potassium phosphate, 9.5 g trisodiurn citrate and Ig magnesium sulphate 
heptahydrate. The solution was made up to II with distilled water and the pH adjusted 
to 7.0. 
2.1.8 B. subtilis Minimal Szowth medium 
Minimal growth medium was prepared as described by Bron (1990) and consisted of 10 
ml 5X minimal salts, 500 ýd 50% (w/v) glucose, 500 pI 2% (w/v) casamino acids, 100 
pI 10 mg/mI L-tryptophan and 50 pI 2.2 mg/mI ferric ammonium citrate. The solution 
was made up to 50 ml with distilled water and filter sterilised prior to use. 
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2.1.9 B. subtilis Starvation medium 
Starvation medium was prepared as described by Bron (1990) and consisted of 10 ml 5 
X minimal salts and 500 pI 50% (w/v) glucose. The solution was made up to 50 ml with 
distilled water and filter sterilised prior to use. 
2.2 Supplements 
Media supplements were prepared and stored according to the manufacturer's 
instructions. Antibiotics were used at the following working concentrations: 
Ampicillin 100 AgIml 
Erythromycin 500 ýtglml (E. coli), 10 ýLg/ml (C sporogenes and Bacillus), 
20 gg/ml (C botulinum) 
Cycloserine 250 pg/ml 
Chloramphenicol 25 pg/ml 
Thiamphenicol 15 gg/ml (C. sporogenes), 20 pg/ml (C. botulinum) 
5-bromo-4-chloro-3 indolyl-p-D-galactoside (X-Gal) was used at 80 pg/ml. 
2.3 Growth Conditions 
All E coli cultures were grown aerobically on LB medium and Bacillus on BHI or LB. 
Both were incubated at 37*C. Liquid cultures of E coli were grown in LB broth with 
agitation at 200 rpm. E coli and Bacillus strains were frozen at 
-80*C as bead stocks 
(PRO-LAB Diagnostics). 
C sporogenes was grown in an anaerobic cabinet (MK3 Anaerobic Work Station, Don 
Whitley Scientific Ltd) containing an atmosphere of 80% nitrogen, 10% hydrogen and 
10% carbon dioxide. TYG medium containing cycloserine was used unless otherwise 
stated. 
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C botulinum was grown in a MG 1000 Anaerobic Work Station (Don Whitley Scientific 
Ltd) on TYG medimn containing cycloserine. 
Clostridial strains were maintained in cooked meat broths (Oxoid) and stored at room 
temperature. Spore deficient strains were kept in glycerol stocks at 
-80"C. 
Growth of liquid cultures was monitored by measuring optical density at 600 run (A6oo) 
using a Pharmacia LKB Novaspec Il. 
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2.4 Bacterial strains 
Strain Genotype/Description Reference/Source 
Clostridium sporogenes Wild type strain N. P. Minton, University of 
I 
NCIMB 10696 Nottingham, UK 
Clostridium hotulinum Wild type strain - ' M. W. Peck, Institute of 
ATCC 3502 Food Research, Norwich, 
UK 
Clostridium sporogenes pIM13 
-based plasmid Pennington, 2006 
cured strain 10696-1 introduced into C 
sporogenes 10696 wild 
type, which was 
subsequently cured of 
plasmid 
Clostridium sporogenes Group II intron inserted This study 
0336 mutant into CSP0336 gene 
Clostridium sporogenes Group II intron inserted This study 
0340 mutant into CSP0340 gene 
Clostridium botulinum Group II intron inserted This study 
agrD1 mutant into agrD1 gene 
Clostridium botulinum Group II intron inserted This study 
agrD2 mutant into agrD2 gene 
Clostridium botulinum Group II intron. inserted This study 
0336 mutant into CB00336 gene 
Clostridium botulinum Group Il intron inserted This study 
0340 mutant into CB00340 gene 
Bacillus subtilis Cu2l89 A. Roberts, University 
College, London, UK 
Escherichia coli TOP 10 F- mcrA A(mrr-hsdRMS- Invitrogen Ltd 
mcrBC) ý801acZM15 
AlacX74 deoR recA I 
araD139 A(ara-leu)7697 
galUgalKrpsL (StrR) 
endAl nupG 
Escherichia coli CA434 thi-I hsdS20 (r-B, m-B) M. Young, UCW, 
(HB101) supE44 recAB ara-14 Aberystwyth, UK 
leuB5proA2 lacYl galK 
I rpsL20 (strR) xyl-5 mt1-1 I 
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2.5 Plasmids 
Plasmid Genotype/Description Reference/Source 
pCR2.1-TOPO E. coli PCR clonin vector, RI 
Invitrogen 
ColE 1, Amp Kan 
pMTL5112 Clostridial shuttle Pennington, 2006 
expression vector, ColEl, 
R 
plM 13, Erm 
pMTL2lEPl01acIfacoriT Inducible clostridial Carter, 2004 
vector, promoterless 
pAMO I replicon with 
upstrewnfac, ptb:: IacI 
fusion, Erm R 
pMTL23 E. coli cloning vector, Chambers et al., 1988 
ColEl, AmPR 
_ pMTL51121acI Clostridial shuttle This study 
expression vector with 
repL under inducible 
control, ColE I, pIM13, 
Erm 
pCR2.1:: catPABsrGI PCR amplified C. Pennington, 2006 
perfiringens catP 
(AgellPvuII fragment) 
from pJIR418 with internal 
BsrGI site deleted, ColE I, 
Amp R, KanR 
pCR2.1:: CspopyrF PCR amplified C Pennington, 2006 
sporogenes yý fragment, R ColEl, Amp Kan 
pMTL5l121acI-.. pyrF1catP Clostridial shuttle This study 
expression vector with 
repL under inducible 
control and pyrF knockout 
cassette inserted ColE 1, 
plM 13, ErMR 
pMTL9361 Inducible clostridial Carter, 2004 
expression vector, pCD6 
replicon,, ýptb: JacI, Pf., 
lacZ, Erm R 
pMTL9361:: CsagrBIASI Inducible clostrilial This study 
expression vector 
containing C. sporogenes 
agrB1 small antisense 
NotIlKpnl fragment 
pMTL9361:: CsagrBIAS2 Inducible clostridial This study 
expression vector 
containing C. sporogenes 
agrB1 large antisense 
NotllKpnl fragment 
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Plasmid Genotype[Description Reference/Source 
pMTL9361:: CsagrB2ASI Inducible clostridial This study 
expression vector 
containing C sporogenes 
agrB2 small antisense 
NotllKpnI fragment 
pMTL9361:: CsagrB2AS2 Inducible clostridial This study 
expression vector 
containing C sporogenes 
agrB2 large antisense 
NotVKpnl fragment 
pMTL9361:: Cs336ASI Inducible clostridial This study 
expression vector 
containing C sporogenes 
0336 small antisense 
Not nI fragment 
pMTL9361:: Cs336AS2 Inducible clostridial This study 
expression vector 
containing C. sporogenes 
0336 large antisense 
NotIlKpA fragment 
pMTL9361:: Cs340ASI Inducible clostridial This study 
expression vector 
containing C. sporogenes 
0340 small antisense 
NotIlKpnl fragment 
pMTL9361:: Cs340AS2 Inducible clostridial This study 
expression vector 
containing C sporogenes 
0340 large antisense 
NotIlKpnl fragment 
pMTL007 Inducible clostridial Heap et al., 2007 
expression vector for 
expression of ClosTron, 
containing Enn RAM, 
ColE 1, pC13102, CMR 
pMTLO07C-E2 Constitutive clostridial J. T. Heap, University of 
expression vector for Nottingham 
expression of ClosTron 
containing Enn RAM, 
flanked by FRT sites, 
ColE I, pCB102, Cm R 
pCP20 Vector expressing Flp S. Pommier, University of 
recombinase from Nottingham 
Saccharom ces cerevistae, R ý CM 
, 
Amp II 
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Plasmid Genotype/Description Reference/Source 
pMTL5402F Inducible clostridial Heap et al., 2007 
expression vector, ColEl, 
pCB102, Cm R 
pMTL5402F-FLP Inducible clostridial This study 
expression vector for 
expression of Flp, ColEl, 
pCB 102, Cm R 
pMTLO07:: CboagrDI-23a Inducible clostridial This study 
expression vector for 
expression of ClosTron 
containing intron 
retargeted to C. botulinum 
agrD1 
pMTLO07:: CboagrD2-47a Inducible clostridial This study 
expression vector for 
expression of ClosTron 
containing intron 
retargeted to C botulinum 
agrD2 
pMTLO07:: CboO336- Inducible clostridial This study 
1203s expression vector for 
expression of ClosTron 
containing intron 
retargeted to C. botulinum 
0336 
pMTLO07:: CboO340-690s Inducible clostridial This study 
expression vector for 
expression of ClosTron 
containing intron 
retargeted to C. botulinum 
0340 
pMTLO07C-E2:: Cboagr Constitutive clostridial This study 
DI-23a expression vector for 
expression of ClosTron 
containing intron 
retargeted to C. hotulinum 
a, grDI 
pMTLO07C-E2:: CspO336- Constitutive clostridial This study 
1207s expression vector for 
expression of ClosTron 
containing intron 
retargeted to C sporogenes 
0336 
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Plasmid Genotype/Description Reference/Source 
pMTLO07C-E2:: CspO340- Constitutive clostridial This study 
711s expression vector for 
expression of ClosTron 
containing intron 
retargeted to C. sporogenes 
10340 
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2.7 Preparation and manipulation of DNA 
2.7.1 PMaration of plasmid DNA 
Plasmid DNA was prepared using the Qiagen QlAprep Miniprep, kit (Qiagen Ltd. UK) 
following the manufacturer's instructions. An additional step was included for Gram- 
positive bacteria; 20 mg/mI lysozyme (Sigma) was added to buffer PI before 
resuspending the bacterial pellet. The lysate was incubated at 37*C for 5 minutes and 
then the Qiagen protocol continued as normal. 
2.7.2 Prgparation of chromosomal DNA (E. coli and C Moroggenes) 
Chromosomal DNA was prepared using the Qiagen DNeasy Tissue kit (Qiagen Ltd. 
UK) following the manufacturer's instructions. An additional step was added after the 
3 0-minute incubation at 3 7*C in lysis buffer. 4 pl 100 mg/ml RNase was added and the 
samples incubated at room temperature for 2 minutes. 
2.7.3 Prqparation of chromosomal DNA (C botulinum) 
Cells from 1-9 ml overnight C botulinum culture were harvested by centrifugation at 
5000 Xg for 10 minutes, and resuspended in 180 ýd enzymatic lysis buffer (20 mM 
Tris-Cl, pH 8,2 mM sodium EDTA, 1.2% Triton X-100,20 mg/mI lysozyme). The 
suspension was incubated at 37'C for 30 minutes. A 25 PI aliquot of proteinase K (600 
mAU/ml) from the Qiagen DNeasy Tissue Kit was added, followed by 200 pl Buffer 
AL from the same kit. The cell suspensions were incubated at 73"C for 30 minutes, an 
equal volume of phenol: chlorofonn: isoamylalcohol (25: 24: 1 
- 
Sigma) added and the 
lysate mixed by flicking the tube. The lysate was incubated for 15 minutes at room 
temperature, mixing the contents every 5 minutes to inactivate botulinum toxin. Tubes 
were centrifuged for I minute at 16,000 Xg and the top aqueous phase transferred to a 
new tube. The efficacy of phenol destruction of spores was tested by plating 100 PI of 
the aqueous phase onto a TYG plate and incubating overnight. The aqueous phase was 
stored at 
-20*C overnight. 
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After overnight incubation, if no growth was visible on the TYG plate, the protocol was 
completed. 4 pl RNaseA (100 mg/ml) was added to the aqueous phase, vortexed and 
incubated at room temperature for 2 minutes. An equal volume of chloroform was 
added and centrifuged for 3 minutes at 16,000 X g. The aqueous phase was removed to 
a new tube. A 1/10 volume of 3M sodium acetate, pH 5.2 was added to the solution of 
DNA and mixed by vortexing briefly. A total of 2.5 volumes of ice cold 100% ethanol 
was added, mixed by vortexing and placed at 
-80"C for I hour. Tubes were then 
centrifuged for 5 minutes at 16,000 Xg and the supernatant discarded. AI ml aliquot 
of room temperature 70% ethanol was added, the tube mixed by inversion and 
centrifuged as before. The supernatant was discarded and the pellet air-dried before 
resuspending in TE buffer (10 mM Tris-Cl, I mM EDTA, pH 8). 
2.7.4 Restriction enzMe digest 
Restriction enzymes were supplied by New England Biolabs Inc. and were used 
according to the manufacturer's instructions. Digest reactions contained 0.5-1 ýtg DNA, 
I VI restriction enzyme and IX reaction buffer made up to a final volume of 20 PI with 
sterile distilled water. Reactions were incubated at 37C for 3 hours until digestion was 
complete (except for SmaI, which was incubated at 25"C). 
2.7.5 Blunt-ending of DNA 
Blunt-ending of DNA was carried out using T4 DNA polymerase or Klenow 
polymerase (New England Biolabs Inc). Both enzymes were used at 1150 dilution in the 
supplied buffer, along with I ýtl 100 mM dNTPs. The reactions were incubated at 12*C 
(T4 DNA polymerase) or 25*C (Klenow) for 15 minutes. 
2.7.6 De-phosphoMLIation of linearised DNA fragments 
Where necessary, linearised DNA fragments were de-phosphorylated using alkaline 
phosphatase (New England Biolabs Inc. ). The enzyme was used at 1150 dilution in the 
supplied buffer and reactions were incubated at 370C for I hour. 
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2.7.7 Analyýis of DNA by agarose gel electrophoresis 
Agarose gels were made up using 1% (w/v) agarose (VWR International Ltd) in Ix 
TAE buffer (40 mM Tris, I mM EDTA and 0.1% (v/v) glacial acetic acid). Ethidiurn 
bromide was added to a concentration of 10 ýtg/ml. Gels were run at 80-100 V in IX 
TAE buffer. Before loading, 5 ýd sample was added to I pl 6X loading buffer (40% 
(w/v) sucrose, 0.25% (w/v) bromophenol blue). DNA was visualised on a UV 
transillumintor and aI Kb DNA ladder (New England Biolabs Inc) used at 0.5 pglpl. 
2.7.8 Purification of DNA fragments 
PCR fragments were purified from agarose gel by extracting with a scalpel and using a 
Qiagen QIAquick Gel Extraction kit according to the manufacturer's instructions. PCR 
products were purified using the Qiagen QIAquick PCR Purification kit according to 
the manufacturer's instructions. 
2.7.9 Polymerase Chain Reaction 
Oligonucleotide primers were synthesised by Sigma-Genosys UK or Operon UK. 
Epicentre (Wisconsin, USA) PCR reagents were used and each reaction contained: 0.5 
ýd (1.25 units) FailSafe PCR enzyme mix (containing a proof-reading Taq DNA 
polymerase); 12.5 jil Failsafe PCR 2X buffer E; I ýd of each oligonucleotide primer (10 
gM stock), I gl DNA template (100 ng) and distilled water to give a final reaction 
volume of 25 pl. Reactions were carried out in a Biometra T3000 thermocycler. 
The following program was used: initial heating to 94C for 4 minutes, then 30 cycles 
of the following: denaturation at 94'C for I minute, annealing at an appropriate 
temperature for I minute, and elongation at 72"C for an appropriate time. The final step 
in the reaction was a hold at 72C for 7 minutes. The annealing temperature used was 
dependent on the melting temperatures of the primers used, and was set at 2-PC below 
the melting temperature. The elongation time was dependent on the length of the 
template (I minute per kilobase). 
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2.7.10 DNA ligation 
Digested, purified vectors and inserts were ligated together at insert: vector ratios of 3: 1 
and 5: 1. A control ligation without insert was also set up to assess any re-ligation of the 
vector. Ligation reactions were set up using I jil T4 DNA ligase and IX ligation buffer 
(New England Biolabs Inc. ) and made up to 10 ýtl with sterile distilled water. Reactions 
were incubated at room temperature for I hour or overnight at 4'C. 
2.7.11 TOPO TA cloning methods 
The TOPO TA cloning kit (Invitrogen Life Technologies) was used, according to the 
manufacturer's instructions, to clone PCR fragments into the pCR2.1-TOPO vector. 
TOPO vectors are provided linearised with topoisomerase covalently bound to the 3' 
phosphate on each strand. This creates ddT overhangs, which are directly compatible 
with the deoxyadenosine overhangs of the 3' end of the PCR products (added by Taq 
polymerase). Ligation reactions were carried out as follows: 4 PI PCR product, I til 1: 4 
salt solution and 1 pI pCR2.1-TOPO vector containing topoisomerase were mixed 
gently and incubated at room temperature for 30 minutes. 
2.7.12 PLeRaration of electrocomRetent E. coli cells 
A 100 ml volume of LB broth was inoculated with I ml overnight broth culture of E. 
coli ToplO or CA434 and incubated shaking at 37 *C until an A6W of 0.5 
- 
0.8 was 
reached. Cultures were placed on ice for 15 minutes. Cells were harvested by 
centrifugation at 5000 Xg for 15 minutes at 4'C, and then washed in 100 ml ice cold 
sterile distilled water. This wash step was repeated but the cells were resuspended in 2 
ml 10% glycerol. The cells were harvested again and the final pellet resuspended in 300 
ýtl 10% glycerol and stored at 
-80"C in 40 ýtl aliquots. 
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2.7.13 Electroporation 
To remove salt prior to electroporation, ligation reactions were dialysed against distilled 
water for 30 minutes. Dialysis discs with 0.025 gm pores (Millipore, UK) were used. A 
5 pl aliquot of dialysed ligation mix was added to 40 gl electrocompetent cells and the 
mixture transferred to an electroporation cuvette with a2 mm. gap (Biorad). 
Electroporation was carried out using a Gene Pulser (Biorad) set to 200 C2,2.5 kV and 
25 gFD. After electroporation, 500 gI LB medium was added to the cells, which were 
then recovered by incubating shaking at 37"C for I hour, before being plated onto LB 
agar plates containing appropriate selection. 
2.7.14 Transformation of DNA into Bacillus subtilis (method 1) 
DNA was transformed into Bacillus subtilis as described by Anagnostopoulos & 
Spizizen (1961). A heavy inoculum of fresh overnight growth was added to 20 ml 
competence medium and incubated at 37"C with agitation until an AWO of 3 was 
achieved. The cells were diluted ten-fold in transformation medium and I ml aliquots 
added to I pg plasmid DNA. Cells were incubated at 37*C for a further 90 minutes. 
Aliquots were then spread onto LB agar plates containing the appropriate selection. 
2.7.15 Transformation of naturally comnetent B. subtilis cells with DNA (method 2 
The transformation protocol was adapted from Bron (1990). 10 ml minimal growth 
medium was inoculated with a single colony of B. subtilis and incubated overnight at 
37'C with agitation. A 1.4 ml aliquot of an overnight culture was used to inoculate 10 
ml pre-warmed fresh minimal growth medium and the culture grown at 37"C with 
agitation for 3 hours. An II ml aliquot of pre-warmed starvation medium was added to 
the culture and growth continued at 37'C for 2 hours until competence was achieved. A 
300 pl volume of competent cells was transferred to a sterile tube and I pg plasmid, 
DNA in 10 pl TE buffer added. The cells were incubated at 37"C with agitation for 45 
minutes. Pre-warmed LB broth (700 pl) was added and the cells incubated for a further 
45-60 minutes. Cells were then plated out onto LB agar with appropriate selection in 10, 
100 and 200 pl aliquots and incubated overnight at 37"C. 
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2.7.16 Blue/white colony selection 
Blue/white selection was used when cloning fragments into the pCR2.1-TOPO vector. 
The successful insertion of a PCR product into this vector results in the disruption of the 
IacZ gene. X-Gal was added to the LB Amp plates, at a final concentration of 80pg/ml, 
to screen for P-galactosidase production. Any colonies producing this enzyme would 
cleave the X-Gal, resulting in the production of a blue coloration. This indicated that 
there was no insert present in these colonies. White colonies lacked P-galactosidase 
activity, indicating that the insert was usually present. 
2.7.17 Conjugation of E. coli CA434 (HB 101) with C. sporoggenes 10696 (filter mating 
method) 
Recipient and donor cells were harvested from 10 ml overnight broth cultures. The 
clostridial recipient cells were resuspended in I ml TYG broth and this same I ml 
suspension used to resuspend the E coU donor cells. Nitrocellulose filters with 0.45 pm 
pores were placed onto TYG + 0.5% glucose plates and 200 pl mixed cell suspension 
spread onto the filters. Plates were incubated anaerobically overnight. Filters were 
placed in I ml TYG in 20 ml universals and vortexed for I minute to dislodge the cells. 
A 100 pl aliquot of resuspended cells was spread onto TYG plates without glucose, 
_ 
containing appropriate selection for the vector, and cycloserine, and incubated 
anaerobically overnight. 
2.7.18 Conjugation of E. coli CA434 (HBIOI) with C. 
- 
Moroggenes 10696 or C. 
botulinum Hall A (snot method) 
The 'spotting' method was carried out as described by Purdy et aL (2002). Donor and 
recipient cells were grown overnight in 5 ml broths (E. coli donor CA434 in LB, aerobic 
with agitation; clostridial recipient in TYG, anaerobic without agitation). AI ml aliquot 
of donor strain was taken and the cells harvested by centrifuging at 5000 Xg for I 
minute. The pellet was resuspended in I ml sterile PBS and the cells harvested as 
before. The pellet was transferred to the anaerobic work station and resuspended in 200 
pl clostridial recipient strain. The whole 200 pl cell suspension was spotted, in 10 ýd 
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aliquots, onto non-selective TYG plates containing 0.5% glucose and incubated for 4-6 
hours at 37T in anaerobic conditions. The cells were harvested by flooding the plate 
with I ml sterile PBS and dislodging the cells with a plastic spreader. The resulting 
slurry was removed and spread onto selective plates, followed by incubation at 37"C 
overnight in anaerobic conditions. 
2.7.19 DNA spAuencing 
Sequencing of DNA was carried out at the DNA Sequencing Laboratory, School of 
Biomedical Sciences, Queen's Medical Centre, Nottingham, using a3 100 Genetic 
Analyser (Applied Biosystems), or by GeneService (UK). Sequence analysis was 
carried out using the Lasergene DNAstar computer package or the Invitrogen Vector 
NTI package. 
The National Centre for Biotechnology Information (NCBI) website was used to search 
sequence databases (http: //www. ncbi. nlm. nih. gov/blasto. 
2.7.20 Southem hvbridisation 
DNA was quantified according to 2.8.3 and diluted so that equal concentrations were 
loaded in each gel lane. Each DNA sample (1-3 pg) was digested overnight with 
appropriate restriction enzymes according to 2.7.4. Samples were run on a 0.8% agarose 
gel as described in 2.7.7. The blotting apparatus was then set up as follows. The gel tray 
used to cast the gel in was turned upside down in a tray containing 0.4 M sodium 
hydroxide. A layer of filter paper (Whatman) was placed on top to form a wick, and the 
gel placed on top of the paper. A piece of N+ nylon membrane (Roche) was placed on 
top of the gel, followed by five pieces of blotting paper (Sigma), all of which had been 
soaked in 0.4 M sodium hydroxide. A weight was placed on the top to maximise 
blotting efficiency and the apparatus incubated at room temperature overnight. 
Following transfer, the membrane was removed, wrapped in cling film and exposed to 
UV light for 2 minutes on each side to crosslink the DNA. The membrane was then 
rinsed in 2X SSC (300 mM sodium chloride, 30 mM sodium citrate, pH 7). Blots were 
incubated in 10 ml DIG Easy Hyb (Roche) in hybridisation cylinders for I hour at 420C 
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using a Techne Hybridiser HB- I D. The Easy Hyb was discarded and replaced with 10 
ml DIG Easy Hyb containing I gg DIG-labelled DNA probe, which had been boiled for 
10 minutes and transferred immediately to ice prior to use. Probes were generated by 
PCR, followed by purification and labelling by incorporating DIG-labelled dUTPs using 
the Roche DIG High Prime DNA Labelling and Detection Starter Kit 11 according to the 
manufacturer's instructions. The probe solution was incubated overnight at 42"C. 
The membrane was washed twice in 2X washing solution (2 X SSC, 0.1% (w/v) SDS 
(Sigma)) for 5 minutes at room temperature and then twice in 0.1 X washing solution 
for 20 minutes at 68"C. It was then equilibrated in washing buffer (0.1 M maleic acid, 
0.15 M sodium chloride, pH 7,0.3% (v/v) tween 20) for I minute at room temperature 
and blocked in blocking buffer (included in the Roche High Prime Kit) for 1 hour at 
room temperature. The membrane was incubated in blocking buffer containing anti- 
digoxigenin antibody (1: 10,000 dilution [Roche]) for 30 minutes at room temperature, 
followed by two washes in washing buffer for 15 minutes at room temperature. It was 
then equilibrated in detection buffer (100 mM Tris HCI, pH 9.5,100 mM sodium 
chloride) for 2 minutes at room temperature. The membrane was then placed on an 
acetate sheet and I ml of chemiluminescent substrate CSDP Star (Roche) was added, 
followed by a second acetate sheet. This was incubated for 5 minutes at room 
temperature followed by 10 minutes at 37*C, and exposed to X-ray film (Amersham 
Pharmacia Biotech). 
2.8 RNA analysis 
To minimise RNase contamination all RNA work was carried out in a designated clean 
area which was cleaned with RNaseZap (Sigma). All equipment was also wiped over 
with RNaseZap prior to use. RNase clean tips and microfuge tubes (Eppendorf) were 
used at all times. Water used to make up solutions was treated with DEPC by adding I 
ml DEPC to I litre of water, mixing and leaving at room temperature for approximately 
3 hours before autoclaving. 
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2.8.1 Prevaration of total RNA from C sporo-aenes (method I 
AI ml volume of C sporogenes broth culture was added to 2 ml RNA Protect (Qiagen) 
in a 50 ml falcon tube and mixed by vortexing for 5 seconds. Cells were incubated for 5 
minutes at room temperature and then harvested by centrifugation at 5 000 Xg for 10 
minutes at room temperature. All of the supernatant was removed by dabbing the lip of 
the tube on a tissue. A 100 pl aliquot of 3 mg/ml lysozyme (Sigma), dissolved in DEPC 
treated water, was then used to resuspend the pellet. The cell suspension was transferred 
to a microfuge tube and mixed by vortexing for 10 seconds. Tubes were incubated at 
room temperature for 10 minutes, vortexing every 2 minutes. Total RNA was extracted 
from the cell lysate using Qiagen's RNeasy kit: 350 gl buffer RLT, to which 0- 
mercaptoethanol had previously been added, was added to the lysate and mixed by 
vortexing. A 250 gl volume of cold ethanol was added and mixed by pipetting. The 
solution was then applied to an RNeasy column and centrifuged in a bench top 
centrifuge for 15 seconds at 8000 X g. The flow through was discarded and an on- 
column DNase treatment carried out as follows: 
70 gl TURBO DNase buffer (Ambion) containing 10 gl TURBO DNase was added to 
the column and incubated at room temperature for 30 minutes. The Qiagen RNeasy 
protocol was then continued. A 350 ILI volume of RWI buffer was applied to the 
column and centrifuged for 15 seconds at 8000 X g. The flow through was discarded 
and the column washed by the addition of 500 gl RPE buffer. Centrifugation was 
carried out as before. The column was washed with 500 gl RPE buffer for a second time 
and centrifuged for 2 minutes at 8000 X g. The flow through was discarded and the 
column centrifuged for I minute at full speed. RNA was eluted by the addition of 50 gl 
RNase free water and centrifugation for I minute at 8000 X g. 
Z8. L I Removal of contaminating genomic DNA from total RNA 
Contaminating DNA was removed from RNA samples using TURBO DNase (Ambion). 
A 40 ýtl aliquot of RNA was mixed with 5 ýd 10 X buffer and 5 gl TURBO DNase, and 
incubated at 37*C for 30 minutes. 
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Z& 1.2 DNase treated RNA sample clean up 
RNA which had been treated with TURBO DNase was cleaned up prior to use in RT- 
PCR as described in the Qiagen RNeasy kit instructions. The RNA sample was adjusted 
to 100 gI with RNase free water. A 350 pl volume of RLT buffer was added to the 
sample and mixed, followed by addition of 250 gl cold ethanol. The solution was mixed 
by pipetting, applied to an RNeasy column and centrifuged for 15 seconds at 8000 X g. 
The column was washed by the addition of 500 gI RPE buffer and centrifuged as 
before. The column was washed a second time using another 500 gl RPE buffer and 
centrifuged for 2 minutes at 8000 X g. The RNA was eluted by the addition of 30 gl 
RNase free water and centrifugation for I minute at 8000 X g. 
2.8.2 Preparation of total RNA from C sporo-genes (method 2) 
Samples of C sporogenes broth culture were collected in 10 ml volumes and 2 ml of 
phenol-ethanol solution [phenol pH 4.3-ethanol (1: 9)] added immediately. The tubes 
were shaken well to halt any changes in gene expression or degradation of RNA. Tubes 
were placed on ice for 30 minutes before centrifuging at 3000 rpm for 20 minutes at 
4'C. The supernatant was discarded and the cell pellets resuspended in 500 PI ice cold 
TES buffer (50 mM Tris, 5 mM EDTA, 50 mM NaCI). AI ml aliquot of silica beads 
was added to 2 ml tubes along with 600 pI acid phenol and 100 pl chloroform (all 
Sigma). The tubes were vortexed and the cell suspensions added. Tubes were heated to 
60'C and vortexed for 3 times 30 seconds, before chilling on ice. Tubes were 
centrifuged at 5000 rpm for 10 minutes at VC. A 600 pI volume of acid phenol and 100 
ýd chloroform were added to 500 pI aqueous phase, before vortexing and centrifuging at 
14000 rpm for 5 minutes at 4C. A 600 pl aliquot of chloroform was added to 350 pI 
aqueous phase and the contents mixed and centrifuged as before. Finally, 20 Al 3M 
sodium acetete, pH 4.8 (Sigma) was added to 200 pl aqueous phase along with 550 jil 
ice cold 95% ethanol. The tubes were inverted to mix and the RNA precipitated at 
-80*C 
for 20 minutes, before centrifugation at 14 000 rpm for 20 minutes at 4*C. The 
supernatant was discarded and the pellet washed with 600 PI 70% ethanol. The tubes 
were once again centrifuged at 14 000 rpm for 10 minutes at 4C before discarding the 
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supernatant and air-drying the pellet. This was then resuspended in 200 pI DEPC treated 
water. 
Z8. ZI RNase inhibitorlDNase treatment 
To 200 pI RNA solution was added: 4 pI RNase inhibitor mix (Promega), 20 pI 
TURBO DNase 1 Ox reaction buffer (Ambion) and 4 pl TURBO DNase (Ambion). The 
mixture was incubated at 37C for 30 minutes. 
2.8.2.2 Sample clean up 
A 0.5 ml volume of saturated phenol (pH 4.3): Chlorofonn: lsoamylalcohol OAA) 
(25: 24: 1) (Sigma) was pipetted into 'Phase Lok Gel' tubes (Eppendorf) and the RNA 
samples added. Samples were mixed well by repeated inversion and centrifuged at 
15 000 rpm for 5 minutes at 40C. A 0.5 ml aliquot of Chloroform: LkA (24: 1) (Sigma) 
was pipetted into fresh phase lock tubes and the top layer of the centrifuged sample 
added before mixing well. Samples were centrifuged as before. The supernatants were 
transferred to fresh eppendorf tubes and 50 pl 3M sodium acetate buffer solution 
(Sigma catalogue no. S-7899) added, along with 2.5 volumes of 96% ethanol. Samples 
were mixed and placed at 
-80'C for I hour. Tubes were centrifuged at 15 000 rpm at 
20C for 20 minutes before discarding the supernatant. AI ml volume of 70% ethanol 
was added and the tube inverted gently. Tubes were then centrifuged at 15000 rpm for 5 
minutes at 40C, the supernatant removed and tubes centrifuged again at the same speed 
for 30 seconds. Any remaining supernatant was removed and the tubes placed at 37C to 
dry the RNA pellet. This was then dissolved in 100 pl DEPC water. 
2.8.3 Quantification of RNA and DNA 
RNA/DNA was quantified using a NanoDrop NDIOOO spectrophotorneter (NanoDrop 
Technologies, USA). 
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2.8.4 One-steD Reverse TranSCriDtase (RT)-PCR 
All RNA samples were prepared according to 2.8.1. RT-PCR was carried out using 
Qiagen's One-Step RT-PCR kit as described in the manufacturer's instructions. The 
reaction mix was composed of 10 pl 5X buffer, 2 ýd dNTP mix, 3 ýd each primer (10 
gM) and 2 pl enzyme mix and 20 ng (antisense expression) or 50 ng (linkage of 
expression) of RNA. The volume was adjusted to 50 ýd with RNase free water. The 
reaction was started by heating to 500C for 30 minutes to allow reverse transcriptase 
activity and then to 95T for 15 minutes for DNA polymerase activation and reverse 
transcriptase inactivation. A total of 30 cycles of the following was then carried out: 
denaturation at 940C for 1 minute, annealing at an appropriate temperature for I minute, 
and elongation at 720C for an appropriate time. The final step in the reaction was a hold 
at 72T for 10 minutes. The annealing temperature used was dependent on the melting 
temperatures of the primers used, and the elongation time was dependent on the length 
of the template (I minute per kilobase). 
RT-PCR products were visualised on an agarose gel as described in section 2.7.7. 
2.8.5 Real Time Ouantitative PCR 
Z8.5.1 Primers 
Three sets of PCR primers were designed using the Primer Express programme 
(Applied Biosystems, USA). The two sets of test gene primers were designed against 
the agrDI and agrD2 genes of C. sporogenes (CsRTagrDl/lF & IR and 
CsRTagrD2/IF & IR). The set of control primers was designed against the 16S gene, 
which was to be used as the endogenous control (CsRT16S/IF & IR). The Absolute 
Quantification (AQ) method was used. 
Z8.5.2 RNA extraction 
RNA was extracted at five time points during C sporogenes growth. Triplicate 100 ml 
broth cultures were grown in TYG broth and growth monitored using OD. At each of 
the five time points, 10 ml culture was removed and RNA extracted according to 2.8.2. 
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RNA was quantified according to 2.8.3 and the quality checked on an Agilent 
Technologies 2 100 Bioanalyser before proceeding to the reverse transcription step. 
Z&5.3 Reverse transcription 
Reverse transcription was carried out using SuperScript II Reverse Transcriptase 
(Invitrogen) according to the manufacturer's instructions. A final concentration of 5 ýtg 
RNA was used in the reaction, and after completion, the cDNA was purified according 
to 2.7.8. 
Z8.5.4 Real time PCR 
The real time PCR method used the double stranded DNA-specific dye SYBR Green. 
Real time PCR reaction mixes contained 12.5 pl Power SYBR Green PCR Master Mix 
(Applied Biosystems) and 2 gl cDNA template (0.05 ng/pl). Primers were used at a 
concentration of 10 pM stock. For the two sets of agrD primers, the reaction contained 
0.75 gl forward primer and 2.25 pl reverse primer (300/900 ratio). For the 16S primers 
the reaction contained 2.25 pl forward primer and 0.75 pl reverse primer (900/300 
ratio). The reaction mix was made up to 25 gl with water. The PCR programme was as 
follows: 
60*C 
-2 min 
95*C 
- 
10 min 
95"C 
- 
15 s 
58"C 
-I min 
40 cycles 
After the 40 cycles were complete, a dissociation step was added to check for any non- 
specific product formation. This consisted of 95"C for 15 seconds, 60*C for I min and 
95* C for 15 seconds. The reaction was carried out in an AB7500 Real Time PCR 
System (Applied Biosystems). Each reaction was set up in triplicate wells in a 
MicroAmp Optical 96-well reaction plate (Applied Biosystems). 
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Z8.5.5 Standard curve generation 
When using the AQ method, a standard curve must be run for both the test gene and the 
control gene for every run carried out. Curves were constructed using 10-fold dilution 
series of C sporogenes cDNA. Concentrations used ranged from 100 
- 
0.001 ng per 
reaction. The curve plotted gave the log of the concentration of cDNA in the sample 
against the threshold cycle (the cycle at which fluorescence rose above the background). 
Z&5.6 Data analysis 
Analysis was carried out using the 7500 System software provided with the apparatus. 
The software provided amplification plots for each reaction, and for each gene tested, it 
determined the unknown concentrations of cDNA in each reaction. This was done by 
using the CT value of the unknown sample, and reading the value for the cDNA 
concentration from the standard curves. The average value from each set of triplicate 
wells was calculated. Expression levels of the agrD genes were then normalised against 
the endogenous control, 16S, giving final values as relative amounts of agrD mRNA- 
2.8.6 Northem hybridisation 
RNA was quantified according to 2.8.3 and diluted so that equal concentrations were 
loaded in each gel lane. Two volumes of RNA sample buffer (50 ILI JOX MOPS [200 
mM MOPS, 50 mM sodium acetate, 10 mM EDTA, pH 7], 87.5 ýtl formaldehyde, 250 
tLI formamide (Sigma) and 112.5 gl DEPC treated water (Ambion)) were added to one 
volume of each RNA sample and the mixture heated to 65*C for 5 minutes. Loading 
dye (250 ttl formamide, 83 ttl formaldehyde, 50 VI 10 X MOPS, 0.1% bromophenol 
blue (Sigma), 50 pl glycerol (Courtin and Warner Ltd, UK) and 67 lil DEPC treated 
water) was added to each sample at a dilution of 1: 10 before loading. Formaldehyde 
gels were prepared by melting 1.8 g agarose in 130.5 ml DEPC treated water, allowing 
to cool to 50'C and adding 6 ttl ethidiurn bromide (10 mg/ml), 15 ml 10 X MOPS and 
4.5 ml formaldehyde. Once mixed, the gels were poured and allowed to set. Samples 
were loaded and the gel run in IX MOPS at 100 V until the dye front had moved half 
way down the gel. 
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The gel was rinsed briefly in DEPC treated water and the blotting apparatus set up as 
follows. The gel tray used to cast the gel in was turned upside down in a tray containing 
20 X SSC (3 M sodium chloride (Sigma), 300 mM sodium citrate (Sigma), pH 7). A 
layer of filter paper (Whatman) was placed on top to form a wick, and the gel placed on 
top of the paper. A piece of N+ nylon membrane (Roche) was placed on top of the gel, 
followed by five pieces of blotting paper (Sigma), all of which had been soaked in 2X 
SSC. A weight was placed on the top to maximise blotting efficiency and the apparatus 
incubated at room temperature overnight. 
Following transfer, the membrane was removed, wrapped in cling film and exposed to 
LTV light for 2 minutes on each side to crosslink the RNA. Blots were incubated in 8 ml 
DIG Easy Hyb (Roche) in hybridisation cylinders for I hour at 50*C using a Techne 
Hybridiser HB-ID. The Easy Hyb was discarded and replaced with 10 ml DIG Easy 
Hyb containing I pg DIG-labelled DNA probe, which had been boiled for 10 minutes 
and transferred immediately to ice prior to use. Probes were generated by PCR, 
followed by purification and labelling by incorporating DIG-labelled dUTPs using the 
Roche DIG High Prime DNA Labelling and Detection Starter Kit II according to the 
manufacturer's instructions. The probe solution was incubated overnight at 50*C. 
The membrane was washed twice in 2X washing solution (2 X SSC, 0.1% (w/v) SDS 
(Sigma)) for 5 minutes at room temperature and then twice in 0.1 X washing solution 
for 20 minutes at 68'C. It was then equilibrated in washing buffer (0.1 M maleic acid, 
0.15 M sodium chloride, pH 7,0.3% (v/v) tween 20) for I minute at room temperature 
and blocked in blocking buffer (Roche High Prime Kit) for I hour at room temperature. 
The membrane was incubated in blocking buffer containing anti-digoxigenin antibody 
(1: 10,000 dilution [Roche]) for 30 minutes at room temperature, followed by two 
washes in washing buffer for 15 minutes at room temperature. It was then equilibrated 
in detection buffer (100 mM Tris HCl, pH 9.5,100 mM sodium chloride) for 2 minutes 
at room temperature. The membrane was then placed on an acetate sheet and 1 ml of 
chemiluminescent substrate CSDP Star (Roche) was added, followed by a second 
acetate sheet. This was incubated for 5 minutes at room temperature followed by 10 
minutes at 371C, and exposed to X-ray film (Amersharn Pharmacia Biotech). 
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2.9 Estimation of segregational stability of plasmids in Bacillus sublilis and 
Clostridium spp 
Segregational. stability was assessed using a method modified from Bron & Luxen 
(1985). Bacillus cultures were incubated aerobically, clostridial cultures anaerobically. 
Day I- Two overnight broth cultures were grown in LB (Bacillus) or TYG (clostridia) 
with appropriate antibiotic; one containing 0.1 mM IPTG and one without IPTG. 
Day 2- 50 pI each overnight culture was added to 5 ml fresh culture medium without 
antibiotic, one with IPTG and one without. These were incubated at 370C with agitation 
(Bacillus) or statically (clostridia) for 9 hours, by which time the culture had reached 
approximately 10 generations of growth. A 50 gl aliquot was subcultured into 5 ml 
fresh broth as before. These cells were again incubated overnight. 
Day 3- The following morning serial dilutions were carried out on each broth from 10-1 
to 10-7 in fresh liquid medium. A 100 pI aliquot of each dilution was plated out as 
follows: broth containing IPTG; cells plated onto LB or TYG with selection and 0.1 
mM IPTG, and onto LB or TYG alone. Broth without IPTG; cells plated onto LB or 
TYG with selection and onto LB or TYG alone. A 50 PI aliquot was subcultured into 5 
ml fresh broth. After a further 9 hours incubation, 50 ttl was again subcultured into 5 ml 
fresh broth. 
Day 4- The procedures carried out on day 3 were repeated 
Day 5- the procedures carried out on day 3 were repeated with the exception of the two 
50 pI subcultures into 5 ml fresh broth. 
All colonies were counted and the percentage plasmid loss was calculated using the 
difference between the total counts (on LB or TYG) and counts of resistant colonies (on 
LB or TYG with selection). 
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2.10 Induction of gene' replacement using integrative vector in Clostridium 
sporogenes 
Induction of integration of a knockout cassette into the host target gene, and loss of the 
unstable plasmid was carried out according to a method supplied by Philipe Soucaille, 
National Institute of Applied Science, Toulouse, France (personal communication). 
Day I- Two overnight broth cultures were grown in TYG with appropriate antibiotic; 
one containing 0.1 mM IPTG and one without IPTG. 
Day 2- 50 pl each 24 h culture was added to 5 ml fresh culture medium without 
antibiotic, one with IPTG and one without. These were incubated at 3TV for 24 hours. 
Day 3- Serial dilutions of the 24 h culture were carried out from 10-1 to 10-6 in fresh 
liquid medium. A 100 pl aliquot of each dilution was plated out as follows: broth 
containing IPTG; cells plated onto TYG containing 0.1 mM IPTG and either 
thiamphenicol, erythromycin or no selection. Broth without 1PTG; cells plated onto 
TYG containing either thiamphenicol, erythromycin or no selection. A 50 111 aliquot of 
24 h culture was subcultured into 5 ml fresh broth and incubated for 24 h. 
Day 4 and day 5- the procedures carried out on day 3 were repeated. 
Day 6- the procedures carried out on days 4 and 5 were repeated with the exception of 
the 50 gl subculture into 5 ml fresh broth. 
Colonies were enumerated after 48 hours' growth. Percentage plasmid loss was 
calculated and a selection of colonies was picked from plates obtained on days 4,5 and 
6, both with and without IPTG. These were streaked out in duplicate onto TYG agar 
containing either thiamphenicol or erythromycin. Any colonies exhibiting 
thiamphenicol resistance and erythromycin sensitivity could be treated as suspected 
integrative mutants, which had been cured of the plasmid. 
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2.11 Induction of target gene knockout using the ClosTron System 
2.11.1 Using plasmid RMTL007 
Transconjugants were obtained as described in the Chapter 5 results section. TYG broth 
(0.5 ml) containing 10 pg/ml (C botulinum) or 7.5 ýtg/ml (C sporogenes) 
thiamphenicol was inoculated with a clostridial transconjugant, containing the 
retargeted pMTL007 vector, and incubated overnight. A 100 PI aliquot of an overnight 
culture was used to inoculate I ml fresh TYG broth + thiamphenicol and the culture 
incubated until growth was visible (approximately I hour). IPTG was added to the 
culture to a final concentration of I mM to induce integration, and the culture incubated 
for 3 hours. Cells were harvested by centrifugation at 8000 rpm for I minute and the 
supernatant discarded. The cells were washed by resuspending in 0.5 ml sterile PBS. 
The cells were harvested and the supernatant discarded as before. The pellet was 
resuspended in 1 ml TYG broth without selection and incubated for a further 3 hours. A 
100 ýd aliquot of the integration mixture was plated out onto TYG agar containing 20 
ýLg/ml (C botulinum) or 10 pg/ml (C sporogenes) erythromycin in neat, 10'2 and 5x 
concentrations. Plates were incubated for 48 hours. 
2.11.2 Using plasmid DMTLO07CE-2 
A large colony of a clostridial transconjugantý containing the retargeted pMTLO07CE-2 
vector was thoroughly resuspended in 100 gI TYG broth. Serial dilutions from neat to 
10-7 were carried out on this cell suspension and 100 gl each plated out onto agar 
containing 20 99/ml (C. botulinum) or 10 gg/ml (C sporogenes) erythromycin. Plates 
were incubated for 48 hours. 
For both 2.11.1 and 2.11.2, frequency of integration was determined by carrying out 
serial dilutions of the integration mixture up to 10-7, and plating out 100 PI of dilutions 
10-4 to 10-7 onto TYG plates without selection. Plates were incubated overnight and 
colonies enumerated. The percentage frequency of integration was calculated by 
comparing these counts to those obtained from the selective integration plates. 
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Any potential integrants were re-streaked onto fresh selective TYG agar and their DNA 
extracted for PCR screening. Any correct integrants were subcultured several times onto 
non-selective TYG agar in order to cure them of the pMTL007 or pMTLO07CE-2 
plasmid. 
2.12 Measurement of spore formation in Clostridium species 
A5 ml overnight culture was grown in TYG broth under anaerobic conditions. The 
following day the culture was diluted 1: 100 in 5 ml fresh medium, and incubated for 72 
hours. After incubation a 0.3 ml sample of culture was heated to 80*C for 20 minutes. 
Serial dilutions were then carried out and 100 pI aliquots of the heat-treated cell 
suspension plated onto TYG agar. Plates were incubated for 48 hours (C. sporogenes) 
or 72 hours (C. botulinum) and colonies enumerated. 
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Chapter 3.0 
Identification and Characterisation of 
Clostridial agr Systems 49.7 0; 
Chapter 3- Identification and Characterisation of Clostridial agr 
Systems 
3.1 Introduction 
The recent completion of the sequencing of the C botulinum genome at the Sanger 
Institute, Cambridge UK, has revealed the presence of agr gene homologues which 
correspond to those existing in S. aureus. Figure 3.1 shows the agr regions identified to 
date in four different species of clostridia. Interestingly, C botulinum possesses two 
agrD and two agrB homologues. To date, C acetobutylicum is the only clostridial 
species found to possess all four agr genes corresponding to those identified in S. 
aureus. However, early studies suggest that some hypervirulent strains of C difficile 
also possess homologues of all four agr genes (Ian Davis, University of Nottingham, 
UK, personal communication). 
The C botulinum genome contains 28 two-component systems, but none showing 
similarities to agrAlagrC are situated in the vicinity of the agr regions (Sebaihia et al., 
2007). The only two-component system identified in the C botulinum genome which 
shows similarity to the staphylococcal agrA and agrC genes (genes CBOI 186 and 
CBOI 187) is present elsewhere in the genome (Sebaihia et al., 2007). Furthermore, 
these genes exhibit relatively low percentage identities with the staphylococcal agrCIA 
genes. CBOI 187 shares 13.4% protein identity with S. aureus AgrA, and CBOI 186 
shares 12.9% protein identity with S. aureus AgrC. 
In S. aureus, the agr system is known to be a global regulator of a battery of virulence 
factors, but the mechanism of its function and the identification of its target genes in 
clostridia remain to be elucidated. 
At the commencement of the project, facilities were not available for handling C 
botulinum. The project was therefore initiated using C sporogenes. The high sequence 
similarity and absence of toxin production render this species an ideal model organism 
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for C botulinum. As the genome sequence of C sporogenes has yet to be determined, 
the first step was to obtain the nucleic acid sequence of the agr regions in this 
Clostridium. This would allow the subsequent investigation of their expression profiles. 
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Figure 3.1 
- 
agr gene regions in four species of clostridia. Different colours, represent 
homologous genes. White genes do not show any homology. Gene pairs 
CB003311agrBl, agrBlIagrDl and CB00337/agrB2 have separate coding sequences 
but overlap. agrDl was not allocated a CBO number, as this gene was not annotated by 
the Sanger Institute when the genome was first sequenced. It was later allocated the 
identifier C1300332A. 
3.2 Results 
3.2.1 Sequencing of the agar egions of C. sporoggenes 
C sporogenes 10696 DNA was used as the template for amplification of various 
fragments of the two regions by PCR. Primers were designed against the C botulinum 
genome and C botulinum Hall A DNA used as a positive control. The fragments were 
selected to ensure that the entirety of the two agr regions was amplified at least three 
times, to allow for sequencing error. Primers used for sequencing are shown in 
Appendix 1. Fragments were cloned into the Invitrogen pCR2.1-TOPO vector and 
sequenced. Sequencing results were analysed using the DNAStar Seqrnan program to 
obtain a consensus sequence of both C sporogenes agr regions. The agr regions 
existing in different species of clostridia were then compared. In addition, AgrD and 
AgrB protein sequences were aligned with those of several Gram-positive bacteria. The 
flanking genes were also aligned and were subjected to BLAST searches on the NCBI 
website. This would provide information on the function of these flanking regions and 
give an idea of how well conserved the positions of the agr genes were among the 
clostridia. 
Table 3.1 shows the percentage protein identity between the products of the genes in the 
agr regions of C sporogenes and C botulinum. Detailed alignments can be found in 
Appendix 2. This illustrates how similar the two species are, with all percentage 
identities exceeding 60%. 
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Protein % Protein Identity 
0330 89.2 
0331 89.7 
AgrBI 86.9 
AgrDl 88.9 
0333 84.0 
0335 61.5 
0336 84.8 
0337 74.4 
AgrB2 67.1 
AgrD2 88.9 
0340 90.6 
Table 3.1 
- 
Percentage protein identity between gene products in the agr regions of C 
sporogenes and C botulinum. Identifier numbers are those allocated to the C botulinum 
genes by the Sanger Institute, but equivalent genes have been identified in C 
sporogenes. 
3.2.2 Comparison of agr region gcnc products amongst clostridia and othcr Gram- 
Rositivc bacteria 
Sequence alignments were carried out on AgrD, AgrB and flanking regions of various 
clostridia and other Gram-positive bacteria. 
3. ZZ I AgrD alignments 
Figure 3.2 shows a phylogenetic tree of the AgrD proteins. It is evident that the C 
acetobutylicum AgrD protein, and one of the AgrD proteins from Clostridium 
beijerinckii are less closely related than those from other clostridial species. C 
sporogenes and C botulinum AgrDI proteins are more closely related to C perftingens 
AgrD than to C sporogenes and C botulinum AgrD2. In fact, the clusters in the 
phylogenetic tree indicate that the AgrDl and AgrD2 of C bolulinum and C 
sporogenes are quite different. This is reinforced by the sequence identity data in Table 
3.2. 
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All of the AgrD proteins of the staphylococci are closely grouped together, but AgrD of 
Enterococcusfaecalis is not closely related to any of the other proteins, and is found on 
a branch of its own. This is probably due to the fact that the mature signalling peptide 
formed in this organism is actually longer than those found in other Gram-positive 
bacteria; it is, in fact, made up of eleven amino acids (Nakayama et al., 2006). 
Generally the staphylococcal AgrD proteins show a greater number of highly conserved 
regions than those of the clostridia (Figure 3.3). 
Figure 3.4 shows an alignment of the putative clostridial AlPs, along with those from 
the four S. aureus groups. All proteins in this alignment show a conserved cysteine 
residue (shown in bold red), and the clostridial proteins appear to show their own 
conserved sequences, which do not correspond to those observed in the staphylococcal 
AIP groups. For example, almost all of the clostridial sequences exhibit a serine and an 
alanine residue immediately N terminal to the conserved cysteine. In addition, the 
clostridial proteins mostly share a common glutamine and proline residue six residues C 
terminal to the conserved cysteine residue. Neither of these conserved sequences is 
observed in the S. aureus AIP groups. 
Interestingly, the putative AgrD protein from C acetobutylicum is quite different to 
those of the other clostridial species. Figure 3.413 demonstrates that there is an 
additional residue involved in the formation of the thiolactone ring structure. In the 
other clostridial species there appear to be four residues C terminal to the conserved 
cysteine, which would potentially form the thiolactone ring (shown in purple in Figure 
3.413). In C acetobutylicum, there is an additional leucine residue present, which would 
produce a larger ring structure. This clostridial species is also the only one known to 
possess homologues of all four S. aureus agr genes (B, D, A and Q. Its agr system 
clearly differs significantly to those identified in other clostridial species. 
The possible tail sequence of the mature clostridial AlPs is also indicated in Figure 3.4B 
in green. There appears to be very high conservation among these residues. However, it 
has yet to be confirmed how many of these residues are indeed involved in the 
formation of the tail. This number may vary, as is seen in S. aureus, with the different 
AIP groups possessing tails from two to four amino acids in length. 
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Figure 3.2 
- 
Phylogenetic tree of AgrD proteins of various Gram-positive bacteria. 
Clostndial species are highlighted in red; S. aureus in green. 
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3.2.2.2 AgrB alignments 
Figure 3.5 shows a phylogenetic tree of the AgrB proteins. As with AgrD, the C. 
acetobutylicum and one of the C. beijerinckii AgrB proteins are less closely related than 
the proteins of the other clostridial species, and the AgrBI of C. botulinum and C 
sporogenes are more closely related to C. peýfringens AgrB than to the AgrB2 in the 
same organisms. Detailed alignments of the AgrB proteins can be found in Appendix 2. 
Again, there are several regions that are highly conserved amongst Gram-positive 
bacteria. 
S. lugdunensis I 
S. lugdunensis 2 
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S. aureus gt I 2-ct5 
S. aureus gt7l 
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Figure 3.5 
- 
Phylogenetic tree of AgrB proteins of various Gram-positive bacteria. 
Clostridial species are highlighted in red; S. aureus in green. 
75 
3. ZZ3 Differences between the two intraspecies AgrD and AgrBproteins in C. 
botulinum and C. sporogenes 
Aligments, revealed that the two AgrB proteins in C botulinum and C sporogenes are 
quite different (39% and 37.6% protein identity 
- 
see Table 3.2). The two AgrD 
proteins show slightly higher identity but still show significant differences. Alignments 
can be found in Appendix 2. 
Proteins compared Protein identity 
C botulinum Ag rDl and Ag rD2 40 
C sporogenes Ag rD I and Ag rD2 40 
C botulinum Ag rB I and Ag rB2 39 
C. sporogenes Ag rB I and A grB2 37.6 
Table 3.2 
- 
Protein identity between the two AgrD and two AgrB proteins of C 
botulinum and C sporogenes 
3. ZZ4 Analysis of regionsflanking agrB and agrD in clostridia 
Figure 3.6 shows that the proteins immediately upstream of AgrB in C botulinum, C 
sporogenes and C perftingens (shaded green in Figure 3.1) are relatively well 
conserved, but the corresponding gene in C acetobutylicum shows less conservation. 
The regions further upstream in C botulinum and C perftingens (shaded pink in Figure 
3.1) were also aligned. Figure 3.7 shows this alignment and demonstrates the high 
similarity between the two. These results would suggest that the position of agrB in C 
sporogenes, C botulinum and C perfringens is well conserved, as they are all flanked 
by similar genes. 
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Figure 3.6 
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Protein alignment of regions immediately upstream of AgrB in C. 
botlifinum, C sporogenes, C peýfringens and C acetobttývlicum 
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Protein alignment of regions upstream of AgrB in C peýfringens and C 
botulinum 
The regions downstream of agrD (shaded yellow and orange in Figure 3.1) show high 
similarity between C. peýfringens CPE1560 and C. botulinum CB00333 and between 
C botulinum CB00340 and C botulinum CB00336 (see Appendix 2 for alignment). 
Again, the corresponding regions in C. acetobuývlicum and C difficile (CAC0082 and 
CD2749) are less well conserved. 
3.2.3 BLAST searches on agr and flanking region 
To deten-nine the nature of the genes flanking the agr regions, Entrez BLAST searches 
were carried out on all pink, green, yellow and orange shaded regions shown in Figure 
3.1. The results are summansed in Table 3.3. Generally, the genes flanking the agr 
genes in C botulinum and C peýfringens are very similar, suggesting that the agr 
system is well conserved between these two species. In fact, the assembly of C 
botulinum region I is virtually identical to the C perfringens agr region, suggesting that 
the two are directly related, and that the C botulinum region 2 may have been inserted 
at a later point in evolution. However, the regions flanking the agr genes of C. difficile 
and C. acetobutylicum show very little conservation with those from C botillinum and 
C peýfringens, indicating a much weaker relationship. 
78 
r- oc e fN oc rA 
CD rn 't 
r) r4 - 
r- 
rn rq 
OC 
fli 
CD V) 
e 
CD 0 cý CD ýc cý CD t- 
l 
0 
r-1 
N r) rn 't f ) r, 1 0, A 
40 
Q) u CD cý a) rq Q) u CD CD Ij u CD di > rn CD CD c; rn rn oc e rn 
fi 
Ge ýE W) 
CD 
c> 00 
0 t-: 
<D r, 1 oý oc 
oc 
CD CD ýc CD 
eN 
o 
r-i 
. 
r, 
0,00 :: 
v) 
r- cý CD 
0 
't 
`0 rn 
' V'ý rn rn rq rn r- r-i r) V) Z f') rn f-1 FA rn ri cý V-ý - L ! 
0 0 m r- 
t 
r u u 
_ 
-0 
CL 
ri. 
Z-- 7 ce z2 ý - -9 ci L. 
cc 2ý Eý fl) ýi 
- 
! ý, ' f') ' rl. ý 
- , 
> rD. < zi 
r) 
- 
e ý, 
-2 , 
Eý ýý 12 Eý 
- 
r) 00 Z 
u 
-r 
GA 
2 2 ZI '-
- 
r Z 
' " 
- 
i U 
-jz 
>, >, cz 
Z 
-- -- ;ý ý C ") t. , ý- ý2 
< lýI Z 
* 
.i ýý e Z0 r. 0 
lý (j Z 
ýý Z, 
Z ch 
ýn 
Z ý2 
_se 
rz >, e Z r, - 
e 
r- 
Z %, 2 %1 u C-) 
- 
Eý zý 
;Z ýý 
C) 11,0 rz ýi zý -0 E sz Z 0U Z 
, 
sz 
Z 
"M C "0 < < 
CD E 0 
, 
u u 
C, Z r, m u 92 Eý Eý (Z CD * 2 
ce 
Co ý-; Co k. ýj ll u (, j
- ýj ýj E . - 2 c) ýj :: - *v Gr *u Gr, ýz u Z ýj 
ýi 
zý 
CD 0 
E tZ EE E E r M v 
- Eý -Z %, M 
' 
UM 
. 
r- "e 
e *-ä *ý * * *- 't -0 n. cZ Z Z cu -2 - ( m ý2 r_ E; 
, 
-" 0 
CD 
* 
u 
0 rn cu e m E5 ri r- c ' rý .E 0 
-a 
e-i c 'E eM cý U 1. ) 11, l I l I 
ý2 1) 
(U > 
ý2 u 
Q) 
'- 
2 
c V'l r- tr) r- vý 
Z 
V) 
. 
V'ý 17! (f) (rý 'Z *uuE 
- 
- 
ý 
n 7ei 
ý 
e r- 
72 
ýö 5-, 
r- 73 
CCD ýr-- CD CD <= (U 
r, 1 -zi E E- C"D ö 
r_ eU M r- r0Z r CD CD r- 
-: u 
.u .u 
< < 
, Eý ' Eý tr = z f2 
- , -13 C - 1) ME 2 CU 0 0 
r- 
- 
u 
"0 Gr -FC u rz 
5, c2 - c2 Z t ei . 
,i -- ->, -Z 
.ý 
-5, Z ýM- 2* 1'-- 0 Z ý= r, >C 2 ll : >. ý, 0 ýý 0 .;. Z u -j-- e) 0 
-0 l> 
_, 
-0 - - ' 5, m, x, Fý = 9: qý 5i p5-, CD 9, a a r -' 5 ý, ý 5 0 =< *eE < -e = iz. < = ý- = . = CA cn 
. u c- C =m m , (A + 
VX ý- 0. < , Z Z" 
-i 
CD 
fl) 
r- v-, " 
- 
1 (-) Z ý, 0 CD 
fl) CD rn C> 
4 1 
- CD 
rn rn 
CD CD 
CD CD CD Ilý - ý CD 
CD CD 
Z m 42. -2r r- ý g u u CD i 
- z 
'A 
,A 
-Z 
22 
CD 
:i 
rD 
10 5- 
.E ýj CA " r- 0 
ýý J. -
r- 2 
Q) u 
Im 
-9-- 
r. 15 
. E; i. 
-0 (A 
.= 
IZ; 
cz ri 
(A *Z: 
-v Z 
r- 
3.2.4 ExDression analvsis of azr izenes in C sporozenes 
Little is currently known about how, when and, indeed, if the agr genes are expressed in 
clostridia. The control, timing and mechanism of expression of the system in S. aureus 
have been well characterised (Arvidson, 1983; Janzon & Arvidson, 1990; Novick et al., 
1995), but no published data on clostridial agr expression is currently available. Various 
methods can be utilised to assess gene expression, including reverse transcriptase PCR 
(Carter et al., 2005), Northern blotting (Ji et al., 1995) and real time RT-PCR 
(Couesnon et al., 2006). 
3. Z4.1 Reverse Transcriptase PCR analysis to investigate linkage of agr gene 
expression in C. sporogenes 
RT-PCR was used to ascertain whether there was transcriptional linkage between the 
agr genes within each of the two regions. RNA was extracted, according to 2.8-1, 
during early and late exponential growth, when OD readings were 0.53 and 2.21. The 
same amount of total RNA (50 ng) was used in each reaction. Nine sets of primers were 
designed, each of which spanned two genes within the agr regions (Figure 3.8(a)). 
Primer sequences can be found in section 2.6.1. A positive result from the RT-PCR 
would indicate that a pair of genes was co-expressed. Control reactions were carried out 
without the reverse transcriptase enzyme, to confirm that the presence of a product was 
not due to DNA contamination. A positive control was also set up using DNA as the 
template to confirm that the PCR conditions used were effective. 
Figure 3.8(b) suggests that all of the genes in agr region I are transcriptionally linked, 
and that transcription occurs during both early and late exponential growth. The RT- 
PCR results also suggest that, in region 2, gene pairs Cs0336/CsO337 and 
agrD2lCsO340 are not co-expressed, but the other genes in region 2 appear to be co- 
expressed. Again, all pairs which are co-expressed show expression throughout early 
and late exponential growth (pairs Cs0335/CsO336, Cs03371agrB2 and agrMlagrD2). 
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Reverse transcriptase PCR to show linkage of agr gene expression in C 
sporogenes. (a) Growth curve of C sporogenes culture used for RNA extraction. RNA 
was extracted from samples taken at time points 3 and 9- indicated by red arrows. (b) 
The two agr regions of C sporogenes 10696 are indicated by I and 2. Bold bars 
indicate the fragments (A-1) amplified by RT-PCR. (c) RNA used in RT-PCRs to 
amplify fragments A-1 was extracted during early (E) and late (L) exponential growth. 
Negative control reactions were carried out with no reverse transcriptase (no RT) and 
positive controls using a DNA template in place of RNA (DNA). Positive results in 
reactions A-D indicate that all genes in agr region I are transcriptionally linked. A lack 
of product in reactions F and I indicate that gene pairs CSP0336/CSP0337 and 
agrD21CSP0340 are not linked. However, genes CSP0337, agrB2 and agrD2 appear to 
be linked. 
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3.14.2 Real Time RT-PCR to analyse expression of agrDI and agrD2 in C. 
sporogenes 
Since RT-PCR is only a crudely quantitative technique, ftn-ther investigations were 
carried out in order to quantitate expression of the agr genes throughout the growth 
curve. Northern blots were attempted to confirm the linkage of expression of the agr 
genes, and to give an indication of the transcript sizes. However, this method proved 
unsuccessful after several attempts. 
An effective and sensitive way of assessing levels of gene expression is by Real Time 
Reverse Transcriptase PCR. This method avoids the visualisation of PCR products on 
an agarose gel using ethidium bromide staining, which can be insensitive, and is also a 
much more sensitive and quantitative method than Northern blotting. It allows the 
amplification and detection of even tiny amounts of mRNA and enables the 
quantification of differences in mRNA expression. PCR also has the added advantage of 
being able to discriminate between very similar mRNAs (Hunt, 2006), and so is useful 
in this instance where the two agr systems will be studied. Real time RT-PCR has been 
used to assess the levels of expression of various genes, including the neurotoxin genes 
of C. botulinum (Couesnon et al., 2006; Shin et al., 2006; Lovenklev et al., 2004). 
The real time PCR method used in this study utilised the double stranded DNA-specific 
dye SYBR Green. This dye binds to the amplified double stranded DNA and emits a 
signal 1000 times greater than when unbound (Stratagene, 2007). As the amount of 
amplified product increases, the amount of fluorescence increases, until it reaches a 
threshold where it can be detected. The cycle of amplification at which this occurs is 
referred to as the CT or threshold cycle, and is determined by the amount of starting 
template present. A reaction profile obtained from a real time PCR can be found in 
Appendix 3. 
This method was employed to assess the levels of expression of the two agrD genes in 
C. sporogenes. Initial problems were encountered whilst attempting the Relative 
Quantification (RQ) method, favoured by many research groups. The possible low level 
of expression and the AT-rich sequences in the clostridial agr regions resulted in the 
seeking of an alternative method. Eventually, the Absolute Quantification (AQ) method 
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was used to successfully assess the level of expression at five time points during 
growth. Primers were designed against the two agrD genes and the 16S rRNA gene, 
which was to be used as the endogenous control. 16S is a popular choice of endogenous 
control as its expression does not change throughout growth (Kouguchi et al., 2006; 
Couesnon et al., 2006; Lovenklev et al., 2004). 
Triplicate 100 ml broth cultures of C sporogenes were grown in TYG broth and growth 
was monitored using OD (Figure 3.9A). At each of five time points, 10 ml culture was 
removed and RNA extracted according to 2.8.2. Samples were taken during early, mid 
and late exponential growth, along with early and late stationary growth. OD readings at 
these time points were approximately 0.4,1.1,2.0,2.6 and 2.5 respectively. 
The AQ method necessitates the construction of a standard curve for both the test gene 
and the control gene for every run carried out. Curves were constructed using 10-fold 
dilution series of C sporogenes cDNA. Concentrations used ranged from 100 
- 
0.001 
ng per reaction. The curve was constructed by plotting the log of the concentration of 
cDNA in the sample against the threshold cycle. A typical standard curve graph 
obtained is shown in Appendix 3. The level of expression of each agrD gene could then 
be calculated using the standard curves, and this was normalised to the level of 
expression of the 16S gene. This was carried out for all three samples from each of the 
five time points, giving average values as relative amounts of agrD mRNA. 
Figure 3.9 (B and C) suggests that agrD gene expression increases with time during 
exponential growth, and then falls dramatically once stationary phase is reached. This 
corresponds with what has previously been demonstrated in S. aureus, where the genes 
of the agr system are maximally expressed towards late exponential to early stationary 
growth (Arvidson, 1983; Janzon & Arvidson, 1990; Novick et aL, 1995). 
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Triplicate growth curves of C. sporogenes 10696 for extraction of RNA for 
use in Real Time RT-PCR 
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Real Time RT-PCR to assess agrD expression in C. sporogenes. A, 
growth curve of triplicate C. sporogenes broth cultures used for RNA extraction. 10 ml 
samples were taken at early, mid and late exponential growth, along with early and late 
stationary growth. B, relative agrDI mRNA expression at the five time points. C, 
relative agrD2 mRNA expression at the five time points. Both agrD genes show an 
increase in expression throughout exponential growth, reaching maximal expression at 
late exponential growth. 
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3.3 Discussion 
3.3.1 Seauencinp- of the a2r reRions of C Worozenes 
The completion of the sequence of the C sporogenes agr regions has confirmed that the 
protein identity between the gene products of the C botulinum and C sporogenes agr 
regions is relatively high. Experimental procedures used in C s'porogenes should 
therefore be easily transferred to C botulinum. The determination of the sequences of 
the agr regions has allowed a much better understanding of the genes that comprise 
them, and their relationship with other clostridial agr gene homologues. 
3.3.2 Comparison of AUD and AgrB amongst clostridia and other Gram-positiv 
bacteria 
The two intraspecies AgrD and AgrB proteins, found in C botulinum and C. 
sporogenes, are quite different. Figures 3.2 and 3.5 show that C botulinum AgrD I and 
AgrB I are more closely related in their primary sequence to C perfringens AgrD and 
AgrB than to the C hotulinum AgrD2 and AgrB2. This was also the case in C 
sporogenes. This suggests that the first agr system in C botulinum is directly related to 
that of C perftingens, and that the second agr system evolved, or duplicated at a later 
point in evolution. It is possible that the function of this second region may differ from 
that of the first. Dufour et al. (2002) proposed that, in staphylococci, different species 
have developed divergence in the agr genes without the same divergence in the rest of 
the genome. They proposed that this might be due to adaptation to different 
environments at specialised infection sites. This could also be the case in C sporogenes 
and C botulinum; the two intraspecies agrD and agrB genes could have evolved at 
different times to suit particular environmental conditions. Dufour et al. (2002) also 
proposed that agr divergence may represent environmental adaptations, whose effects 
on pathogenesis could be merely incidental, and that the locus is also important in the 
control of catabolic pathways, nutrient uptake and energy metabolism. 
Interestingly, the E. faecalis AgrD was not closely related to that of any of the other 
Gram-positive bacteria, as shown in the aligriment in Figure 3.3. It is known that E. 
faecalis AgrD is very different to other AgrD proteins (Sturme el aL, 2002; Nakayama 
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et aL, 2006). This organism uses a GBAP (gelatinase biosynthesis-activating 
pheromone) cyclic lactone AIP, whose precursor is coded for by thefsrD gene, and 
which does not have the well-conserved cysteine that AIPs of most other Gram-positive 
bacteria share. This is commonly the key residue in the formation of the thiolactone ring 
of the AIP, but in E. jaecalis formation involves a serine residue. Figure 3.3 shows that 
the proteins in the alignment that do not possess the highly conserved cysteine residue 
belong to: one strain of C thermocellum, Staphylococcus intermedius and Moorella spp 
(which have a serine in its place) and E. faecalis. AlPs of strains of S. intermedius lack 
the conserved cysteine residue and contain a cyclic lactone, rather than a thiolactone 
(Kalkum et al., 2003). 
Also highly conserved among the staphylocccal AgrD proteins is the region 
immediately downstream of the AIP (Figure 3.4). In S. aureus groups I and IV this 
sequence is DEVEVP, and varies only slightly in groups I and III. This region is likely 
to be involved in C terminal processing in the formation of the AIP (Lyon & Novick, 
2004). Interestingly, this sequence is not found in any of the clostridial species 
analysed; the only conserved residue is the proline. However, the clostridia appear to 
share their own conserved putative processing site based on the sequence YQPKEP. 
The clostridial AIP sequences show little similarity to those found in S. aureus. This is 
not surprising, as the two genera are found in completely different environments, where 
they will have developed their own systems to suit very different environmental niches. 
The N terminal processing site is not as conserved in either the staphylococci or the 
clostridia. It is understandable that more conservation is found in the C terminal regions 
as, in staphylococci, the C terminal of the protein is located in the cytoplasm and the 
group specific processing of AgrD is determined by this terminal. The conservation of 
the N terminal is therefore not so critical (Zhang et aL, 2004). 
The processing of the AgrD propeptide to form the mature AIP differs from other 
quorum sensing systems. AgrD is subject to two proteolytic cleavage events, with the 
AIP sequence being located in the middle of the protein. In other systems, the precursor 
is subject to only one cleavage, with the C terminal portion serving as the signal 
molecule (Qiu et aL, 2005). 
87 
Novick (2003) demonstrated that the last two residues of the AlPs in S. aureus were 
usually limited to the hydrophobic residues F, L, V, Y and sometimes M. This is the 
case with the putative AIPs in C botulinum and C sporogenes, but not in C. 
perftingens or C difficile. In fact, none of the clostridial putative AIPs show much 
similarity to the S. aureus AIPs, except for the conserved cysteine; again suggesting that 
the two species' agr systems are highly divergent. The different putative clostridial 
AlPs are also very different from each other, which could be explained by the different 
species of clostridia occupying different environmental niches and therefore developing 
different systems to suit that niche. The similar AIPs found in S. aureus all belong to 
one species, whereas the different putative AlPs analysed in the clostridia all belong to 
different species. It is therefore no surprise that they show limited similarity. 
In general, the staphylococci seem to show more regions of conservation in AgrD than 
the clostridia. The staphylococci also share a conserved glycine eight or nine residues N 
terminal to the conserved cysteine (Lyon et al., 2004). Again, this tight conservation is 
not seen in the clostridia. 
There are extensive regions of conservation in the AgrB proteins of the staphylococci. 
However, many of these are not shared by the clostridia, which generally show fewer 
regions of similarity. There are, however, some regions that are highly conserved 
among all organisms in the alignment (see Appendix 2). Generally, the AgrB proteins 
show more regions of conservation throughout both the staphylococci and the clostridia, 
than were observed in the AgrD proteins. This is to be expected, as the sequence of the 
AIP must be highly specific in order to bind to the receptor region of AgrC. AgrB is 
involved in the processing of AgrD so it is not so critical that its sequence must differ 
greatly from other AgrB proteins. Indeed, the interaction between AIP and AgrC is 
specific between staphylococcal AIP groups, but the specificity of the interaction 
between AgrB and AgrD is not so strict (Zhang & Ji, 2004). 
The most notable conserved residue amongst the AgrB proteins is the cysteine at 
position 116, which is absolutely conserved among all organisms in the alignment (see 
Appendix 2). Lyon and Novick (2004) proposed that this conserved cysteine in the 
AgrB proteins of S. aureus may play a role in the formation of a thioester acyl-enzyme 
intermediate, which is important in the processing of AgrD. 
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Also absolutely conserved among the AgrB proteins of all organisms in the alignment is 
a histidine at position 109. Qiu et al. (2005) found that replacing the conserved histidine 
or cysteine with an alanine residue in S. aureus group I AgrB totally eliminated the 
ability to process AgrD, showing that the two residues are required for post-translational 
processing. All S. aureus AIP groups also share a serine residue at position 113, but the 
only clostridia that have this residue are C perfringens and C acetobutylicum. Qiu et al. 
(2005) proposed that this residue is also required for processing of AgrD, but found that 
its replacement with alanine had no inhibitory effect on processing. This indicated that 
this serine is not required for post-translational processing, and explains why it is not 
conserved among the clostridia. Qiu et al. (2005) concluded that the histidine and 
cysteine residues are putative catalytic residues that form the catalytic centre, and are 
located on the inner surface of the cytoplasmic membrane. However, it is so far unclear 
how the interaction between AgrB and AgrD occurs, and how this results in the 
generation of the mature AIP (Zhang & Ji, 2004). 
3.3.3 Analysis of regions flanking agrB and agrD in clostridia 
The results obtained from alignments of the proteins encoded by the genes flanking the 
agr genes indicate that the position of agrB and agrD in C sporogenes, C botulinum 
and C perfringens is well-conserved. The corresponding regions in C acetobutylicum 
and C difficile are less well conserved, but this analysis confirms that all five clostridial 
species contain regions showing some homology to the S. aureus agr regions. 
The BLAST searches carried out on proteins encoded by the flanking regions confirmed 
the conservation of the position of the agr genes. In the searches on the regions 
upstream of agrB the closest match for CB00331, CB00335 and CB00337 was 
CPE1562 from C. perfiringens. This protein also shows some similarity to a histidine 
kinase (Table 3.1), which may play some role in the agr system (although it does not 
bear any resemblance to any agrC gene products). The proteins encoded further 
upstream (CB00330 and CPE1563) also showed high similarities. This confirms that 
the two regions upstream of agrB in C perfringens, and agrBI in C botulinum and C 
sporogenes are all homologous. CPE1563 was identified as the putative protease 
component of an ABC-type branched-chain amino acid transport system. ABC-type 
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transport systems are known to be involved in quorum sensing in Gram-positive 
bacteria, but as yet, these genes' involvement in the agr system of clostridia is 
unknown. 
As yet, it has not been determined precisely how the AgrD protein is processed and 
exported. Until recently, the only published hypothesis proposed that the AgrB protein 
is responsible for both of these processes (Sturme et al., 2002). However, Saenz et al., 
(2000) demonstrated that over-expression of AgrB and AgrD in S. epidennidis did not 
cause an increase in the production of AIP. This led them to the conclusion that the 
processing or secretion of the AIP might require an additional factor besides AgrB. 
Indeed, a recent publication by Kavanaugh et al. (2007) has proposed that a type I 
signal peptidase, SpsB, may in fact be responsible for the N-terminal cleavage of AgrD. 
The fact that its activity was unaltered in an agr mutant indicated that the peptidase is 
chromosomally encoded outside the agr locus (Kavanaugh et al., 2007). However, this 
group did not determine the mechanism by which the AIP is exported. 
Most quorum sensing systems identified to date in Gram-positive bacteria involve the 
processing of the AIP, followed by its secretion via an ABC transporter. Usually the 
proteins involved in these processes are encoded by genes in the same operons as those 
that encode the pro-peptide and the two component signal transduction systems (for 
example the L. lactis nisin operon) (Zhang et al., 2002; Kleerebezern & Quadri, 2001). 
This fact, taken with the proposal that there may be some other factors involved in the 
processing and excretion of the AIP, may provide some substance to the theory that an 
ABC transporter is involved in C botulinum and C sporogenes. Interestingly, genes 
0330 and 0331 (identified as an ABC-transporter and sensor kinase respectively) were 
shown to be transcriptionally linked to the agr genes in 3.2.4.1. Indeed, agrB genes 
investigated by Zhang et aL (2002) did not exhibit a recognisable ATP binding motif It 
is therefore possible that this function is carried out by a separate ABC transporter gene 
(0330 in the case of C botulinum and C sporogenes). 
The gene products encoded upstream of AgrB in C difficile and C acetobutylicum 
seem less closely related to those of C botulinum, C sporogenes and C perfiringens, 
but were both matched with proteases. 
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The regions downstream of agrD show high similarity in C botulinum (CB00333) and 
C perfringens (CPE1560). The nearest match for the proteins of both genes was 
CPE 1560. The top hit in the BLAST search of this protein is a HD-GYP domain from 
Clostridium thermocellum. HD proteins are a super family of metal-dependent 
phosphohydrolases. A sub-class of these proteins possess an additional GYP motif, and 
evidence suggests that this class of proteins is involved in bacterial signal transduction. 
In the plant pathogen Xanthomonas campestris pv. campestris, virulence factor 
production and biofilm dispersal are positively controlled by a two component signal 
transduction system whose response regulator, RpfG contains such a domain (Ryan et 
al., 2006). It was demonstrated that the HD-GYP domain of the RpfG protein was 
involved in the degradation of cyclic di-GMP, and that mutation of the H and D residues 
resulted in the loss of enzymatic activity against cyclic di-GMP and the regulation of 
virulence factor production. Increased levels of the cyclic di-GMP second messenger 
promoted biofilm formation, whereas reduced levels promoted virulence factor 
production (Ryan et al., 2006). HD-GYP domains have been shown to be conserved 
among a wide range of bacteria and are therefore of significant importance in gene 
regulation. These proteins of the agr system exhibiting homology to a HD-GYP region 
could therefore be involved in signal transduction or possibly quorum sensing. 
The products of the two genes either side of agr region 2 in C botulinum (CB00336 
and C1300340) are also similar, and were matched against a sensory transduction 
histidine kinase of C. acetobutylicum. Again, histidine kinases are also known to be 
involved in quorum sensing. 
Generally, there appear to be several genes in the agr regions of C botulinum and C 
perfringens, which show similarities to genes involved in signal transduction. Their role 
in the agr response in clostridia is not yet known, but it is possible that they are 
somehow involved in the signalling of this system, particularly in view of the fact that 
the identification of agrA and agrC homologues has not been confirmed in these 
species. The data obtained also suggest that the agr region 1 in C botulinum is directly 
related to that of C perftingens. The arrangement of the genes in these two species is 
identical, as are their identifications from the BLAST search. It appears that somewhere 
during evolution, the C botulinum agr system has been duplicated and inserted further 
downstream. 
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The downstream regions of C acetobutylicum and C. difficile did not show close 
matches with any of the other clostridial agr region genes investigated. This would 
indicate that the agr region position is not well conserved between these species and C 
perfringens, C botulinum and C sporogenes. C acetobutylicum has been shown to 
possess its own agrA and agrC genes, and so there may not be the need for other genes 
involved in signal transduction. in close proximity. Furthermore, the putative AgrD 
protein in C acetobutylicum shows very little similarity to other clostridial AgrD 
proteins, indicating that this species' agr system evolved quite separately from the 
others. 
It appears that the C difficile agrB and agrD genes are isolated, and are not 
immediately flanked by any genes that could possibly be involved in signal 
transduction. Their presence could therefore be due to an insertion or a duplication 
somewhere in evolution, leaving any related genes elsewhere in the chromosome. 
In summary, further work is clearly necessary to investigate the precise mechanism of 
action of the agr systems in the clostridia. It is also, as yet, unclear which genes or 
processes the systems control. The agr systems which exist in the clostridia. bear a 
strong resemblance to those in the staphylococci, although their mechanism of action is 
clearly different. It is not clear how the flanking genes are involved in the agr response, 
but it is quite apparent that, certainly in C botulinum and C perfiringens, the agr 
systems are closely related and that there are various genes flanking them which may be 
involved in signal transduction. The system identified in C difficile is much less closely 
related, and C acetobutylicum appears to have evolved independently of the other 
clostridial species; a hypothesis which is reinforced by the presence of all four agr 
genes. 
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3.3.4 Expression analysis of aggr genes in C. Worogenes 
RT-PCR analysis indicated transcriptional linkage of all genes in agr region I of C. 
sporogenes 10696. This is consistent with expression in S. aureus, where the agr A CDB 
genes are transcribed together as part of the P2 operon (Novick et al., 1995). All 
reactions demonstrated the presence of this transcript during both early and late 
exponential growth. Fragments A, B and D (Figure 3.8 (b)) appear to show more intense 
bands in the reactions using RNA from early exponential growth. However, because of 
the limitations of this technology, these data cannot be used to draw conclusions on the 
quantity of expression of this transcript. This theory is reinforced by the fact that the 
genes spanning fragment C (agrBlIagrDI) appear to be co-expressed (albeit weakly) at 
equal levels during early and late exponential growth (Figure 3.8 (b) Q. However, their 
flanking genes (which, according to the results, appear to be co-expressed) show a 
higher intensity band during early exponential phase. A more reliable technique should 
therefore be used for quantification of the expression of these genes. 
All of the genes in agr region 2 do not appear to be co-expressed as a single operon, as 
pairs Cs0336/CsO337 and agrD2/Cs0340 did not show co-expression. It is no 
coincidence that genes Cs0336 and Cs0340 are both orphan kinases, which have an, as 
yetý unknown function in the agr regions of C sporogenes and C botulinum. To date, 
agrC and agrA homologues have not been identified in these agr systems. It could be 
proposed that one, or both, of the Cs0336 and Cs0340 genes, which are very closely 
homologous, may function as the agrC of the system. However, these results suggest 
that, if this is indeed the case, the kinase(s) are not transcribed with the other genes of 
the agr system, in contrast to what is observed in S. aureus. 
It is certain that these results must be confirmed in further investigations. Although RT- 
PCR is an extremely sensitive technique, and has been used previously to demonstrate 
transcriptional linkage in C difficile (Carter et al., 2005), it cannot be relied on as a 
quantitative technique, and the reverse transcriptase reaction may be inhibited by the 
presence of contaminating RNase enzymes. The technique may also be hindered by 
difficulties in amplifying templates with large amounts of secondary structure (Roche, 
2006). Northern blot analysis was therefore attempted to confirm the RT-PCR results, 
and ascertain the definitive transcript sizes. Afler a number of attempts, no bands were 
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observed in Northern blot experiments, despite loading up to 15 ýLg RNA onto the gel. 
This is probably because the agr genes, as in S. aureus, are naturally expressed at very 
low levels, which are too low to be detected using Northern blotting. Groups who have 
successfully used Northern blotting to demonstrate agr expression have all probed 
against either the RNAIII gene (Traber & Novick, 2006; Ji et al., 1995) or the cc or 8 
haemolysin genes (Janzon et al., 1989; Janzon & Arvidson, 1990; Traber & Novick, 
2006). These genes are not available for targeting in the clostridia. In addition, most 
groups to carry out this technique in staphylococci have used laboratory strains of S. 
aureus, which express the agr genes at higher than natural levels (Geisinger et al., 2006; 
Ji, et al., 1995; Janzon et al., 1989). This is because most laboratory strains are 
derivatives of strain NCTC 8325, which has recently been shown to behave differently 
to clinical isolates of S. aureus (Cassat et al., 2006). Derivatives of this strain, such as 
RN6390, contain a mutation in the rsbU gene, which reduces sigB expression and in 
turn results in higher expression of RNAIII than that found in clinical isolates (Cassat et 
al., 2006). This is a result of sigB being a negative regulator of the agr system. Indeed, 
Cassat et al. (2006) demonstrated that RN6390 showed higher RNAIII and protease 
expression than the clinical isolate UAMS-1. It was confirmed, using quantitative PCR, 
that RN6390 produced approximately 200-fold more RNAIII than UAMS-1 during 
exponential growth. Expression was also compared to nine other clinical isolates and 
found to be higher than all of these. The absence of RNAIII and haemolysin genes in 
clostridial species meant that there was no other option but to probe for the agr genes 
themselves. Unfortunately, it appeared that their low level of expression was not 
sufficient to enable detection using this technique. 
To determine reliably the precise time of expression of the agrD genes, quantitative real 
time PCR was the method of choice. This is an excellent method for quantifying 
changes in gene expression (Ambion, 2006) and was used by Couesnon et aL (2006) to 
demonstrate that expression of the C. botulinum botRIA, bontIA and antp (associated 
non-toxic protein) genes occurred concomitantly at the transition between exponential 
and stationary growth. They were also able to demonstrate that thý'botRIA expression 
level was approximately 1 00-fold less than those of the bontIA and antp genes. This 
group also used the absolute quantification technique, indicating that problems may 
have been encountered with the more favourable relative quantification technique. 
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Quantitative RT-PCR data can be expressed relative to an internal standard (relative 
quantification) or an external standard curve (absolute quantification) (Bustin & Nolan, 
2004). The RQ technique relies upon consistent and highly efficient amplification of the 
cDNA template. Initial standard curve reactions are carried out to demonstrate that the 
efficiency of the PCR of the control gene is similar to that of the test gene. Software 
provided with the real time PCR machine plots a standard curve of cDNA template 
concentration against threshold cycle. The efficiency of the reaction can be determined 
from the slope of the line. A slope of 
-3.32 indicates a PCR efficiency of 100%. A 
more negative slope indicates a less efficient reaction. This method can only be used 
accurately if the standard curves of both the test and control gene are efficient, and the 
two are similar. This means that the results from the RQ run for each gene can be 
directly compared. 
Several attempts at standard curve generation were made, using both the agrB and agrD 
genes as target genes. Unfortunately, the standard curves obtained consistently showed 
very poor PCR efficiency. There was also no similarity between the test and control 
curves and the curves were not reproducible. This meant that the RQ method could not 
be employed using the C sporogenes RNA. These findings were unusual, but not 
altogether surprising. Clostridial DNA is notoriously AT rich, which causes problems 
when designing efficient PCR primers (the overall GC content of the C. botulinum 
genome is only 28.2% [Sebaihia et al., 2007]). Although the primers were designed 
using the Primer Express software (Applied Biosystems), initial searches did not yield 
any primers. The parameters were therefore altered in order for suitable primers to be 
obtained. This meant that even the best possible primers from the sequence provided 
were not ideal and there was no guarantee that they would produce an efficient PCR. 
The priming of the primers greatly affects the efficiency of the PCR, which would 
explain why the reaction efficiency was poor; there was a poor choice of primers in the 
AT rich sequence. Primers were re-designed, but the efficiency did not improve. 
Altering the concentrations of cDNA used to produce the standard curves also failed to 
improve them. The only option was therefore to use the absolute quantification method. 
This method is not ideal, as it involves the use of many more wells than the RQ method 
and if the efficiencies are different each time, one run cannot be easily compared to 
another. Standard curves for the test and control genes must be amplified in the same 
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plate, and the test data are then normalised to the control gene by dividing the target 
amount by the control gene amount. The fact that the efficiencies were so different for 
each run carried out meant that they could not easily be compared between runs. 
However, this problem is overcome to a certain extent by normalising each set of data to 
the control gene. Other groups carrying out real time PCR on clostridial RNA have also 
resorted to alternative methods, indicating that they may also have experienced 
problems with the RQ method. Along with Couesnon et al. (2006), who used the 
absolute quantification method, Kouguchi et al. (2006) used a similar method where the 
standard curve was constructed using plasmids containing the gene of interest, so that 
the exact template copy number in the reaction could be determined. 
The problems encountered with the real time PCR experiments must be borne in mind 
when interpreting the results. Standard curves in this study were generally of poor 
quality, indicating the poor efficiency of the reactions. This occasionally necessitated 
the removal of some of the data points from the curve, in order to improve it. In doing 
so, there was the danger that the test samples may not have fallen into the range of the 
standard curve. This problem was accounted for by reducing the quantity of template 
added to each test reaction to 0.1 ng. In theory, if inhibitors were present in the samples, 
and were responsible for the poor efficiency of reaction, reducing the amount of 
template would therefore reduce the amount of inhibitor and improve the efficiency of 
the reaction. As this had no effect on efficiency it can be concluded that the poor 
standard curves were probably not due to the presence of inhibitors in the test samples. 
With AQ, since small differences in nucleic acid input can lead to large differences in 
PCR product yield, the amount of starting material must be quantified extremely 
accurately in order to normalise sample data and correct for tube to tube differences 
(Bustin & Nolan, 2004). However, the cDNA was quantified using the extremely 
accurate NanoDrop spectrophotometer before being added to the PCR so this should not 
have been a problem. 
One of the most obvious explanations for the poor efficiency is the AT rich target 
sequence, which could have resulted in poor primer annealing. The temperature used for 
annealing was reduced from 60*C to 58"C but this failed to improve the efficiency. 
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In summary, the results obtained using the AQ method suggest that agrD expression is 
maximal during late exponential growth and then drops off significantly once stationary 
phase is reached. The higher expression of the agr genes later on in growth seems 
logical, as this suggests similarities to the expression levels observed in the 
staphylococci. In addition, as the agr system in C sporogenes appears to be involved in 
sporulation (see Chapter 4), it seems logical that its genes are expressed maximally 
towards late exponential growth when sporulation is initiated. The real time PCR 
reactions were repeated and, although the magnitude of the results varied, the 
expression pattern did not, leading to the conclusion that the agr system in C 
sporogenes is maximally expressed during late exponential growth. 
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Chapter 4.0 
Gene Modulation Techniques in 
Clostridium sporogenes 
Chapter 4- Gene Modulation Techniques in Clostridium sporogenes 
4.1 Introduction 
Until recently, methods for knockout mutagenesis in clostridia through allelic exchange 
had long eluded the clostridial scientific community. Most attempts have been based on 
the inactivation of target genes through homologous recombination but efforts over the 
last 20 years have been largely unsuccessful. Recently, two areas have been focussed on 
as alternative methods of gene inactivation or modulation in clostridia. One area utilises 
the replication machinery of unstable plasmid vectors; the other relies on the production 
of antisense RNA fragments which interfere with translation of target proteins. 
4.2 Unstable plasmids as a tool for gene knockout in clostridia 
Focus of attention has recently been turned to integrative vector systems in an attempt 
to achieve gene knockout through double crossover allelic replacement. This strategy 
exploits the replication mechanism of the unstable single stranded or rolling circle (RC) 
plasmids. Early investigations into the problems of cloning in B. subtilis indicated that a 
contributory factor could be the fact that the vector plasmids used in the cloning 
experiments accumulated large amounts of single stranded DNA which was unstable 
and recombinogenic (Niaudet et aL, 1982; Projan et aL, 1987). It was later 
demonstrated that replication of unstable plasmids stimulates DNA recombination 
(Noirot et aL, 1987). In fact, Gruss & Ehrlich (1989) demonstrated that recombination 
was stimulated 150-1500-fold in rolling circle plasmids, compared with the 
chromosome or plasmids that do not generate single stranded DNA. Many Gram- 
positive bacterial plasmids replicate via the RC mechanism, which is illustrated in 
Figure 4.1 and proceeds as follows. 
A plasmid-encoded initiator protein, known as a Rep protein, and possessing specific 
nicking activity, binds to a specific binding site of approximately 30 base pairs, 
contained within the double stranded origin (dso) or + origin of the plasmid (Khan, 
1996; Khan, 2000). The Rep protein then nicks the leading strand of the double stranded 
DNA, causing it to bend at the origin of replication. Cleavage by the Rep protein results 
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in a free 3' OH group, whilst the Rep protein is attached to the 5' phosphate of the 
DNA. A host helicase unwinds the DNA, allowing the 3' OH group to serve as a primer 
for synthesis by DNA polyrnerase III (Khan, 1996; Khan, 2005). 
After the new leading strand has been completely synthesised, the Rep protein carries 
out a second nicking event, releasing a single stranded DNA molecule, corresponding to 
the original leading strand of the plasmid. This molecule contains a single stranded 
origin (sso) or 
- 
origin, which is required for the conversion of this single stranded 
molecule back to a double stranded one (Khan, 2005). The single stranded DNA 
intermediate is highly unstable and highly recombinogenic. These properties can be 
exploited in an attempt to induce homologous recombination with the host 
chromosome, and subsequent inactivation of a target gene. The unstable plasmid should 
then be easily lost from the population. 
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Figure 4.1 
- 
Replication in rolling circle plasmids (Khan, 1996). A single stranded 
intermediate is produced which is highly unstable and therefore highly recombinogenic. 
An attempt to utilise the properties of RC plasmid replication to induce double 
crossover events was previously carried out by Pennington (2006). The plasmid 
constructed (pMTL5112) possessed the B. subtilis pIM13 replication region and an 
erythromycin resistance cassette. The plasmid was deficient in the negative origin so 
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that any single stranded DNA produced could not be converted back into double 
stranded DNA and may integrate into the host chromosome, inactivating any given 
target gene. This attempt was unsuccessful, so the plasmid was developed further in this 
investigation to render repL under inducible control. 
The overall strategy involved the replacement of the B. subtilis pIM13 replicon region 
of plasmid pMTL5112 with the pIM13 double stranded origin and the lac operon 
repressor lacI, which is under control of the C acetobutylicum ptb 
(phosphotransbutyrylase) promoter. repL from pIM13 was then inserted under the 
control of the Clostridium pasteurianum ferredoxin promoterfacH. This promoter is 
fused to the lac operator, rendering it inducible by IPTG. The plasmid should then 
function in the following way to achieve double crossover mutagenesis: 
In the absence of IPTG, LacI should bind to the lac operator, preventing transcription of 
the lac operon. On addition of IPTG, an artificial inducer of the lac operon, Lad will be 
displaced, allowing transcription to proceed from the jacH promoter, driving the 
transcription of repL. The RepL protein will act in trans on the double stranded origin, 
allowing replication to proceed. The single stranded intermediate generated via this 
replication process is lacking in the 
- 
origin, and therefore fails to be converted back 
into double stranded DNA. Consequently, the cell should contain large amounts of 
highly unstable, highly recombinogenic single stranded DNA. A mutant version of a 
target gene of interest, containing an antibiotic cassette, may be inserted into the BamHI 
site of the integrative vector. Once this is introduced into a clostridial strain, and 
induced, single stranded DNA containing the mutant gene should be produced and 
double crossover recombination should take place between the single stranded mutant 
gene and the chromosomal target gene. The unstable single stranded DNA should be 
lost after allelic exchange, leaving only the clostridial chromosome containing the 
mutant gene. 
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4.2.1 Results 
The strategy used to generate the integrative vector is shown in Figure 4.2. First, the 
repL gene and the dso from plasmid pMTL5112 were amplified by PCR and cloned into 
the pCR2.1-TOPO vector (Figure 4.2A). The primers for the repL gene (RepL-PI and 
RepL-P2) were designed to incorporate Xbal and EcoRV restriction sites at the 5' and 
3' termini of the PCR product. Those for the dso (Ori-P I and Ori-P2) were designed to 
incorporate NheI and Sall sites at the 5' and 3' termini. ptblacI was then isolated from 
the pAMP I 
-based vector pMTL21 EP I OlacIfacoriT using AIwNI (before blunt ending) 
and EcoRI (Figure 4.213). ptblacI was cloned into the pMTL23 'holding' vector as a 
SmaIlEcoltl fragment. pIM13 dso was then cloned as a SaIlINhel fragment into the 
same vector, downstream of ptblad (Figure 4.2Q. The whole ptbllacIldso fragment 
was then excised as a SalllBgllI fragment and cloned back into the original pMTL5112 
vector. Finally, the pIM13 repL fragment was isolated as an XbaIlEcoRV fragment 
from pCR2. I 
-TOPO and cloned into the final vector downstream of the facII promoter. 
This resulted in the integrative plasmid pMTL51121acI (Figure 4.21)). Three separate 
double restriction digests, using NdellSall, HindIIIIBamHl and NdeIlXbaI, were carried 
out to confirm the correct assembly of the final integrative vector. 
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Figure 4.2 
- 
Strategy used to generate integrative vector pMTL5 I l2lacl. 
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Figure 4.2 
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continued. 
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D- Assembly of final integrative vector. Fragment 4 was cloned into the 
original pMTL5112 vector as a SalllBglll fragment. Fragment I (Repl-) was 
isolated from pCR2.1 (Figure 4.2A) as an AballEcoRV fragment and cloned 
in to pMTL5112 under the control of thefacH promoter. This resulted in the 
final vector pMTL51121acl. 
Figure 4.2 
- 
continued. 
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4. ZLI Plasmid segregational stability in BaciBus subtifis 
Confirmation of the plasmid's instability in clostridia needed to be carried out. 
Bacillus subtilis Cu2l89 was used as an initial recipient, as problems in introducing 
the vector into clostridia were foreseen. Firstly, the vector was expected to be highly 
unstable and secondly there was the risk that all components of the vector system 
may not function fully in clostridia. Attempts were made to transform the plasmid 
into B. subtilis using transformation method I (see 2.7.14). However, problems were 
encountered in obtaining a sufficient optical density of the B. subtilis culture, and 
several attempts were unsuccessful. An alternative method (see 2.7.15) was 
attempted, which allowed the successful transformation of the integrative vector into 
B. subtilis. Again, the correct composition of the plasmid was confirmed by 
restriction analysis of the isolated plasmid. 
Assessment of segregational. stability of the plasmid was carried out according to 
method 2.9. Stability is expressed as percentage plasmid loss in Table 4.1, which 
illustrates that the plasmid proved highly unstable, even in the absence of IPTG 
induction. 
IPTG Percentage Plasmid Loss 
Day 3 Day 4 Day5 
+ 99.997 100 100 
99.990 99.999 100 
Table 4.1 
- 
Scgregational stability of integrative vector pMT51121acl in R Subtilis 
168, expressed as percentage plasmid loss. 
4. ZL2 Plasmid segregational stability in Clostridium sporogenes 
The promising instability of the plasmid in B. subtilis allowed the progression to the 
introduction of the plasmid into C sporogenes, the organism originally intended as 
the target. The plasmid was first transfonned into the conjugation donor E. coli 
CA434 and the plasmid isolated from resulting clones in order to confirm its identity 
using restriction digests. Conjugation was then attempted with C sporogenes 10696 
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using two different conjugation methods (methods 2.7.17 and 2.7.18), and the 
addition of IPTG concentrations of 0,0.01 and 0.1 mM to the agar culture media. 
Several attempts using both methods proved unsuccessful. As a last resort, the 
conjugation was repeated using an uncharacterised. mutant strain of C sporogenes. 
This strain had previously contained a plasmid over-expressing a recombinant 
nitroreductase enzyme (Pennington, 2006), and had then been cured of the plasmid. 
The strain was found to be much more receptive to conjugation, which was possibly 
due to an unidentified mutation. Conjugation into this strain (C sporogenes 10696-1) 
using the 'spot' method was successful in producing up to 3 10 transconjugants/ml. 
Plasmids of those subcultured were screened using restriction analysis and 
sequencing of the lacI and repL genes. 
Segregational stability was determined using the same method as for B. subtilis and 
is shown in Table 4.2. The plasmid appeared to be slightly more stable in C 
sporogenes 10696-1 than had previously been observed in B. subtilis, showing 
0.00005% (+ IPTG) and 0.00006% (- IPTG) of the plasmid remaining after day 6, 
whereas complete loss was observed by day 5 in B. subtilis. However, the plasmid 
was still highly unstable. 
IPTG Percentage Plasmid Loss 
Day 3 Day 4 Day 5 Day 6 
+ 99.62069 99.98808 99.99956 99.99995 
F77 1 99.85100 99.99083 99.99952 99.99994 
Table 4.2 
- 
Segregational stability of integrative vector pMTL51121acI in C 
sporogenes 10696-1, expressed as percentage plasmid loss. 
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4. ZI. 3 Construction and insertion of a pyrF knockout cassette for use with 
integrative vector pMTL51121acI 
The final stage of this investigation was to attempt to produce a double crossover 
knockout mutant using pMTL51121acI, which had proved highly unstable; a property 
required for integration into the host chromosome and plasmid loss to occur. The 
pyrF gene was selected as a target for knockout, as a relatively simple assay can be 
utilised to test for mutants. pyrF codes for the orotidine S'-phosphate decarboxylase 
protein, which is an essential enzyme in pyrimidine biosynthesis. Inactivation of this 
gene would result in uracil auxotrophic mutants, which could be screened by a 
simple assay, streaking putative mutants onto minimal agar medium in the presence 
and absence of uracil. The knockout cassette was constructed by first isolating the 
catP (chloramphenicol acetyltransferase) gene which had previously been cloned 
from C perfringens into the pCR2.1 TOPO vector to make pCR2. lCatPABsrGI 
(Pennington, 2006). This was to be used as the antibiotic resistance cassette. The 
catP fragment was excised by restriction digestion with Null, resulting in a blunt- 
ended fragment. The C. sporogenes pyrF gene, along with partial sequences of its 
flanking genes pyrK and pyrC, had also been previously cloned into pCR2.1, 
resulting in pCR2.1: -. pyrF (Pennington, 2006). The pyrF gene was cut centrally, 
using AM, and blunt ended. The calP gene was then ligated into the middle of the 
pyrF gene, resulting in an inactive pyrF gene contained within the pCR2.1 vector. 
Clones were verified using restriction analysis and sequencing, and then the whole 
knockout cassette excised as an EcoRl fragment, before blunt ending. The integrative 
vector pMTL51121acl was digested at the BamHI site and also blunt ended. The pyrF 
knockout cassette was then ligated into the integrative vector, and verified using 
restriction analysis (using NdellSaII, BsrGllHpaI and NotIlBgRI), PCR screening and 
sequencing. After transforming the completed vector into E. coli CA434, 
conjugation was carried out using the 'spot' method with C sporogenes 10696 wild 
type and C sporogenes 10696-1. As was encountered before the knockout cassette 
was inserted, the conjugation was only successful when the cured strain was used; no 
transconjugants were obtained from C sporogenes 10696 wild type. Plasmids were 
isolated, transformed back into E. coli TOPIO and confirmed using restriction 
analysis. Induction of plasmid loss and integration was carried out according to 
method 2.10 which was supplied by Philippe Soucaille (personal communication). 
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Plasmid loss was not nearly as high as before the knockout cassette was inserted, 
suggesting that the plasmid had become more stable (Table 4.3). Numbers of 
colonies isolated on TYG + erythromycin and TYG + thiamphenicol. were very 
similar (data not shown), which would indicate that there were no thiamphenicol 
resistant, erythromycin sensitive colonies present. Ten colonies were picked from 
various plates during the induction experiment and plated in duplicate onto both 
TYG containing erythromycin and TYG containing thiamphenicol. All isolates grew 
on both plates, confirming that the plasmid had not been lost from these isolates. The 
induction of plasmid loss and integration was repeated but similar, erratic results 
were obtained. 
IPTG Percentage Plasmid Loss 
Day 3 Day 4 Day 5 Day 6 
+ 45.143 8.995 57.647 18.750 
9.615 0.829 
-143.836 1.429 
Table 4.3 
- 
Segregational stability of integrative vector pMTL51121acl containing 
pyrF knockout cassette in C sporogenes cured strain, expressed as percentage 
plasmid loss. 
Another possibility was that a single crossover event had occurred instead of a 
double crossover. This would mean that the plasmid itself had inserted into the 
chromosome, and would explain the existence of thiamphenicol resistant, 
erthromycin resistant colonies. The two possibilities which could occur from a single 
crossover event are shown in Figure 4.3. In order to investigate this possibility, a 
colony from day 6 of the induction experiment (named SC3) was subcultured and 
used in further investigations. The plasmid DNA from this strain was isolated and 
transformed into E. coli TOP 10, after which two clones were analysed. PCR 
screening was carried out to verify whether the plasmid was still present. Primers 
RNA/2F and PyrC/IF(R) (which both bind in the plasmid) were used to screen both 
the E. coli clones containing the re-transformed plasmid (ECSC3a and ECSC3b), 
along with the plasmid prepared straight from the clostridial SO isolate. Results of 
this PCR (screen 1) are shown in Figure 4.4B, along with the binding sites of the 
primers (Figure 4.4A). 
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Figure 4.3 
- 
Representation of the chromosomal arrangements which may arise from 
the two possible single crossover events (A and B). PCR screen 2 using primers 
Ori/2R (binds in the plasmid) and PyrK/ I R(F) (binds in chromosome) would give a 
2.7 Kb product if single crossover event A had occurred. PCR screen 3 using primers 
PyrC/2F (binds in the chromosome) and RNA/2F (binds in plasmid) would give a 2.8 
Kb product if single crossover event B had occurred. 
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The expected 2.5 Kb products were observed in all three reactions confirming that 
the integrative vector was present in all three isolates. The fact that the plasmid could 
be isolated from the clostridial SO strain, transformed back into E. coli and re- 
isolated indicated that the plasmid had indeed not been lost from the clostridial 
population. To further confirm that the plasmid had not been lost from C. sporogenes 
SC3, restriction digests were carried out on ECSC3a and ECSC3b using three sets of 
double digests. These were the same digests that had been carried out when the 
plasmid was first constructed, to confirm the correct assembly of its components. 
The same restriction pattem was obtained as was observed in these first digests, 
confirming that the same plasmid was still present (Figure 4.4C), even after day 6 of 
induction of plasmid loss. 
To verify that the PCR results obtained were not as a result of the plasmid being 
present in the chromosome as single crossover event A (Figure 4.3), a second PCR 
screen was carried out using primers PyrK/lR(F) (which binds in the chromosome) 
and Ori/2R (which binds in the plasmid). If single crossover event A (Figure 4.3) had 
occurred, the product obtained would be 2.7 Kb. Results from this screen are shown 
in Figure 4AD, and confirm that this product was not obtained. The fact that there is 
a product present in the reaction containing template from the SO chromosome, 
albeit the incorrect size, suggests that some sort of recombination event may have 
occurred, which does not correspond to either of those outlined in Figure 4.3. 
A third PCR screen was then carried out to confirm that the plasmid was not present 
as single crossover event B (Figure 4.3). Primers PyrC/2F (which binds in the 
chromosome) and RNA/2F (which binds in the plasmid) were used. If event B 
(Figure 4.3) had occurred, a 2.8 Kb product would be obtained. Results from this 
screen are shown in Figure 4AE, and again, confirm that this product was not 
obtained. 
It is impossible to ascertain precisely the nature of the rearrangements which have 
occurred. The only certainties are that the integration had not occurred as intended, 
the plasmid had not been lost and that pyrF knockout mutants were not obtained. 
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- 
Plasmid map and screening results on SO DNA 
A- Vector map of pMTL51121acI indicating restriction sites and primer binding 
sites used for screening. PCR screen I using primers RNA/2F and PyrC/lF(R) was 
carried out to confirm the presence of the plasmid. 
B- PCR screen I of two E coli clones containing re-transformed plasmid from 
clostridial strain SC3, along with the PCR screen of the SO plasmid. Primers used 
were PyrC/IF(R) and RNA/2F. Lane 1, ECSC3a; lane 2, ECSC3b; lane 3, clostridial 
SO plasmid; lane 4, negative control using integrative vector plasmid DNA without 
the pyrF knockout cassette; lane 5, negative control using water as template; lane 6, 
2 log DNA ladder. The 2.5 Kb product confirmed that the plasmid was still present in 
all strains screened. 
C- Restriction analysis confirming the presence of integrative vector in C 
sporogenes SCI Lanes 1,4 and 7,2 log DNA ladder; lanes 2,5 and 8, ECSC3a; 
lanes 3,6 and 9, ECSC3b. Bands obtained were the same as when the plasmid was 
originally constructed, and confirmed its presence in all strains screened. 
D- PCR screen 2 of clostridial SO chromosomal DNA to confirm that the plasmid 
had not integrated. Primers used were PyrK/lR(F) and Ori/2R. Lane 1,2 log DNA 
ladder; lane 2, SO chromosomal DNA; lane 3, ECSC3a plasmid DNA; lane 4, 
ECSC3b plasmid DNA; lane 5, negative control using integrative vector plasmid 
DNA without the pyrF knockout cassette; lane 6, negative control using C 
sporogenes 10696 wild type chromosomal DNA as template; lane 7, negative control 
using water as template. A 2.7 Kb product would indicate that single crossover event 
A (Figure 4.3) had occurred. This size band was not observed. 
E- PCR screen 3 of clostridial SO chromosomal DNA to confirm that the plasmid 
had not integrated. Primers used were PyrC/2F and RNA/2F. Lane 1,2 log DNA 
ladder; lane 2, SO chromosomal DNA; lane 3, ECSC3a plasmid DNA; lane 4, 
ECSC3b plasmid DNA; lane 5, negative control using integrative vector plasmid 
DNA without the pyrF knockout cassette; lane 6, negative control using C. 
sporogenes 10696 wild type chromosomal DNA as template; lane 7, negative control 
using water as template. A 2.8 Kb product would indicate that single crossover event 
B (Figure 4.3) had occurred. This size band was not observa 
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Final confirmation that the plasmid was still unstable and un-integrated was carried 
out using segregational stability tests, as described in method 2.9. Results indicated 
that the maximum plasmid loss was only 65.3 1% (Table 4.4). If the plasmid had 
integrated, it would be expected that loss would be much greater than this. These 
results therefore confirm that the plasmid was not lost from the population, 
suggesting that it had not integrated into the host chromosome and that this method 
for attempted gene knockout had been unsuccessful. 
IPTG Percentage Plasmid Loss 
Day 3 Day 4 Day 5 Day 6 
+ 2.00 40.91 65.31 60.94 
33.33 8.82 21.05 44.44 
Table 4.4 
- 
Segregational stability of integrative vector pMTL51121acI containing 
pyrF knockout cassette in C sporogenes SC3, expressed as percentage plasmid loss. 
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4.2.2 Discussion 
Along with Philippe Soucaille, who has successfully used a rolling circle plasmid to 
generate knockout mutants in C acetobutylicum (Saint-Prix et al., 2006) two other 
groups have recently published attempts to exploit the properties of unstable 
plasmids in order to generate knockout mutants in clostridia. Harris et al. (2002) used 
an unstable vector to introduce a mutation into the spoOA gene of C acetobutylicum 
by double crossover recombination. The resulting mutant was sporulation deficient 
and showed reduced solvent production. Although the mutant was obtained, 
sequencing demonstrated that the second crossover event did not take place as 
predicted, due to a crossover event taking place between two 10 base pair 
homologous sequences in the 3' end of the repL structural gene. This confirms the 
unpredictable nature of this method. 
The second group to publish an attempt at this method ironically obtained their 
mutant accidentally (O'Connor et aL 2006). This group introduced an unstable 
plasmid containing target gene sequences into C difficile, and found subsequently 
that the plasmid could not be recovered. Further investigations confirmed that the 
plasmid had integrated into the host chromosome, producing two unstable mutants of 
the rgaR and rgbR genes. These mutants were, however, produced by a single 
crossover event, rather than the more desirable double crossover, and PCR screens 
showed that there was a small amount of wild type gene product present. 
Both of these groups demonstrated that, although unstable plasmids can be used to 
generate mutants in clostridia, the unstable, and therefore unpredictable, replication 
mechanism of these plasmids means that the process does not always proceed as 
predicted. 'Mis may be the reason for the failure to obtain mutants in this study. 
Indeed, Gruss & Ehrlich (1989) emphasised the infidelity of the rolling circle 
mechanism of replication and noted that almost every step in the mechanism can 
digress from its usual function, therefore affecting the rearrangements that occur. It is 
impossible to control this mechanism of replication, due to the fact that the 
abundance of single stranded DNA stimulates intermolecular homologous 
recombination, which does not necessarily occur in the desired manner. Another 
contributory factor could be that the single stranded DNA produced might have 
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formed secondary structures with itself, thus preventing it from effectively 
integrating into the host chromosome. The catP sequence possesses significant 
secondary structure which may form a hairpin loop. This could have been acting as a 
negative origin, hence rendering the system inefficient. Negative origins contain 
numerous imperfect inverted repeats, forming hairpin structures (Ehrlich et al, 
1991). The mechanism of plasmid pMTL51121acl is based on the absence of the 
negative origin preventing the conversion of single stranded to double stranded 
DNA. The catP sequence acting as a negative origin would mean that the single 
stranded DNA could be converted back, preventing the accumulation of single 
stranded DNA and reducing the occurrence of recombination. This would explain 
why the plasmid was lost at a much less efficient rate once the knockout cassette was 
introduced; the restoration of a single stranded origin-like structure allowed 
replication to proceed as normal, and stabilised the plasmid. 
Another possibility could be the unusually high expression of repL in plasmid 
pMTL51121acI. Gruss & Ehrlich (1989) proposed that a factor which prevented 
runaway replication was that the Rep protein in E. coU plasmid RK6 was less active 
at high concentrations. The fact that repL is under control of the strong facII 
promoter in pMTL51121acI means that repL is over-expressed and therefore may be 
less active, causing a decrease in replication and therefore a decrease in single 
stranded DNA production. 
A problem also obviously lies with the fact that difficulties were encountered when 
transferring the plasmid into its intended host. Several attempts were made before it 
was successfully transformed into B. subtilis and it was never successfully 
conjugated into C sporogenes 10696. This is not a practical situation to have if such 
a plasmid is to be used as a routine knockout too]. The only way the plasmid could 
be conjugated into C sporogenes was to use the cured strain as a host. This is an 
uncharacterised mutant, which obviously has some differences to the wild type. It is 
therefore impossible to determine why the conjugation was successful in this strain, 
and also whether an unknown mutation could be responsible for the integration being 
unsuccessful. The fact that this strain is more susceptible to conjugation than the wild 
type would also indicate that plasmids are more stable in this strain. This is not ideal 
when using an integrative plasmid system that relies on instability. 
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Moreover, the high instability of the plasmid may mean that it was too unstable to 
replicate successfully in the wild type and explain why conjugation was not 
successful. 
Clearly there are many unanswered questions surrounding the use of integrative 
vector pMTL51121acl. The mechanisms underlying the functioning of the plasmid 
remain to be explained. Future investigations could be carried out to aid the 
characterisation of the mechanism of action of this plasmid. Southern blots would 
confirm that single stranded DNA is indeed being produced. The efficiency of the 
induction of repL could be determined using reverse transcriptase PCR on RNA from 
induced and uninduced cultures. The problem of the catP gene possibly acting as the 
negative origin could also be addressed. Gruss & Ehrlich (1989) demonstrated that 
rifampin addition inhibited negative origin function. All of the negative origins tested 
in their study were dependent on RNA polyrnerase action, which is inhibited by 
rifampin. Therefore its addition to the culture rendered the negative origin inactive, 
allowing the accumulation of single stranded DNA. This could be attempted to 
prevent the possibility of catP acting as a negative origin. 
These fiirther investigations may contribute to the understanding of why this method 
was unsuccessful, and suggest future directions for the pursuit of an integrative 
vector system which can be used for the routine inactivation of genes in clostridia. 
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4.3 Gene modulation in C. sporogenes using antisense RNA technology 
An alternative gene modulation strategy utilises 'antisense' oligonucleotides, which 
can block the expression of a single gene, or multiple genes of an operon (Kemodle 
et al., 1997; Schlingensiepen & Schlingensiepen, 1997). Antisense oligonucleotides 
(oligos) are short stretches of nucleotides which are complementary to a region of 
mRNA in the gene of interest (Jen & Gewirtz, 2000). These oligos bind specifically 
to the target mRNA, interfering with translation into protein. It is thought that this 
leads to the destruction of the mRNA (Jen & Gewirtz, 2000). Antisense RNA can be 
expressed from a plasmid vector which has been introduced into the bacterial cell of 
interest (Jen & Gewirtz, 2000). 
Bacteria naturally produce antisense RNA to regulate their own gene expression 
(Schlingensiepen & Schlingensiepen, 1997) and one of the first groups to exploit this 
fact was Kernodle et al. (1997). They targeted the a toxin h1a gene of S. aureus with 
antisense RNA molecules and observed a 16-fold decrease in the amount of (x toxin 
detected in culture supernatants. There was also a corresponding decrease in the 
bacterium's lethal activity in mice. Antisense RNA has also been produced against 
the h1a gene downstream of a tetracycline promoter, resulting in an inducible 
antisense system (Ji et al., 1999). 
Several mechanisms of action of antisense RNA have been proposed 
(Schlingensiepen & Schlingensiepen, 1997): 
1. The antisense RNA molecules prevent elongation of the polypeptide 
chain by steric block of the ribosome on the RNA (Figure 4.5 A). 
2. Initiation of translation is prevented by the antisense RNA molecule 
binding to the promoter region or near the initiation codon (Figure 4.5 B). 
3. The cellular enzyme RNaseH recognises the duplex of the oligonucleotide 
and the mRNA, and cleaves the mRNA, leaving the oligonucleotide intact 
(Figure 4.5 
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Figure 4.5 
- 
Proposed mechanisms of action of antisense RNA (Schlingensiepen & 
Schlingensiepen, 1997). The antisense RNA may inhibit translation by several 
mechanisms. A, antisense RNA prevents elongation of the polypeptide chain by 
blocking movement of the ribosome along the mRNA; B, the antisense RNA blocks 
binding of the ribosome to the mRNA near to the initiation codon; C, a cellular 
RNaseH recognises the duplex of antisense RNA and sense mRNA and cleaves the 
mRNA. 
Since the introduction of antisense technology to modulate staphylococcal virulence 
gene expression in 1997, various groups have applied this technology in clostridia. 
Tummala et al. (2003b) produced antisense RNA against both acetoacetate 
decarboxylase and co-enzyme A-transferase in C acetobutylicum and demonstrated 
that co-enzyme A-transferase is the rate-limiting enzyme in acetone formation. The 
same group went on to use antisense RNA, combined with gene over-expression, to 
increase the butanol/acetone ratio in C acetobutylicum (Tummala et al., 2003a). 
Marvaud et al. (1998b) demonstrated partial inhibition of the botRIA regulatory gene 
in C. botulinum, which resulted in a reduction in neurotoxin production. 
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4.3.1 Antisense target gene selection for this stud 
Target genes were selected, firstly for their possible involvement in the agr quorum 
sensing response, and secondly for their involvement in the sporulation cascade in C 
sporogenes. The two agrB genes were firstly selected, in an attempt to inhibit the 
processing of the putative autoinducing peptide, and therefore inhibit the agr 
response. Ideally, the agrD gene, encoding the precursor of the AIP signalling 
molecule should be targeted, but its short (44 amino acid) sequence rendered it 
unsuitable for targeting with antisense RNA. 
Along with the two agrB genes, two other genes were also selected. These were 
identified in Chapter 3 as showing homology to orphan sensor kinase genes. All 
target genes selected are indicated in red in Figure 4.6. 
CSP0329 CSP0330-] CSP0331 aerBI 
-FagrDl CSP0333 
CSP0336_ 
ýCSP0340 
Figure 4.6 
- 
Schematic representation of the agr regions in the C sporogenes 10696 
genome (not to scale). Genes targeted for antisense modulation are shown in red. 
Extensive research has been carried out on the initiation of sporulation in B. subtilis 
and to a lesser extent in the clostridia. Research shows that, in B. subtilis, external 
sporulation signals are received by five orphan histidine kinase proteins (KinA 
- 
KinE), usually under conditions of nutrient deprivation (Hoch, 1993). These proteins 
in turn trigger a phosphorylation cascade involving the transfer of a phosphate group 
from SpoOF to SpoB, and finally to SpoOA, the master regulator of sporulation 
(Piggot & Hilbert, 2004). Many other sigma factors are involved in the process, but 
ultimately SpoOA in its phosphorylated form allows sporulation to proceed. This 
process is depicted in Figure 4.7. 
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Figure 4.7 
- 
Schematic representation of the sporulation phosphorylation cascade in 
B. subtifis. Inputs are shown in red, with the core phosphorelay shown in black. 
Taken from Piggot & Hilbert (2004). 
Although spoOA, along with many genes involved in the later stages of sporulation, is 
also found in the sequenced species of clostridia, most of the genes involved in the 
earlier stages of sporulation have not been identified (Parades et al., 2005). This 
includes the five kin genes, along with spoOF and spoOB. A spoOB homologue has 
been identified in C. tetani but it is not known whether it is functional (Stephenson & 
Lewis, 2005). The fact that SpoOA has been shown to be involved in the initiation of 
sporulation in various species of clostridia (Huang & Sarker, 2006; Ravagnani et al., 
2000) would indicate that the initiation of sporulation in clostridia occurs through a 
different mechanism. This may occur via a novel phosphorelay system, but the most 
likely hypothesis is that SpoOA is phosphorylated directly by a sensor kinase 
(Parades et al., 2005). Indeed, in the C botulinitm genome, five orphan kinases have 
been identified, which may be involved in the phosphorylation of SpoOA (Womer et 
al., 2006). Two of these orphan kinase genes (0336 and 0340) are found within the 
agr regions of C botulinum and C sporogenes and were therefore selected as targets 
for antisense modulation. 
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4.3.2 Results 
4.3.2.1 Construction of antisense 'mutants' 
Two antisense 'mutants' were created for each target gene. Two fragments of each 
target gene were PCR amplified from C sporogenes 10696 genomic DNA. One 
encompassed the first 33% of the gene, and the other the first 66%, and both included 
the ribosome binding site. Primers used to amplify the fragments are shown in 2.6.2 
and contained Notl and Kpnl restriction sites, which were incorporated into the 5' 
and 3' termini of the PCR product. The fragments were cloned in the reverse 
orientation into the inducible antisense expression vector pMTL9361 under the 
control of thefacH promoter. This vector is illustrated in Figure 4.8. The vector was 
then transformed into the E. coli CA434 donor strain. Restriction digests and PCR 
were used to confirm the presence of the insert before conjugating into C. 
sporogenes 10696. Plasmids from transcorijugants were isolated, re-transformed into 
E coli TOPIO and the presence of the insert verified using restriction digests and 
PCR. The resulting 'mutants' were named as illustrated in Table 4.5. 
FT 
fac 
Kpn I 
lacZ 
celAT 
oriV 
ErmR 
oriT 
trai 
pMTL9361 
repA 
/ orfS 
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Figure 4.8 
- 
Plasmid map of inducible antisense delivery vector pMTL9361. The 
antisense fragments are inserted between the Notl and KpnI restriction sites. 
Expression of the antisense RNA fragment is driven from the fac promoter on 
addition of IPTG and de-repression of Lacl from the lac operator. The MAT 
terminator prevents transcriptional read-through. An erythromycin resistance cassette 
is located on the plasmid backbone for positive selection of clones carrying the 
antisense vector. 
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Target Gene Name of 'Mutant' 
Small antisense fragment Large antisense fragment 
agrBI agrBI ASI agrBI AS2 
agrB2 agrB2 AS I agrB2 AS2 
CSP0336 336 ASI 336 AS2 
CSP0340 340 ASI 340 AS2 
Table 4.5 
- 
Nomenclature of eight antisense 'mutants' created in C sporogenes 
The inducible production of antisense RNA in all four 'mutants' was then confirmed 
using RT-PCR. 5 ml broth cultures of all 'mutants' were grown in the presence and 
absence of I mM IPTG for 6 hours. RNA was extracted from each strain according 
to 2.8.1 and 20 ng RNA from each 'mutant' was subjected to RT-PCR as described 
in 2.8.4. The reverse primer used in all reactions was CodAS I /F, which binds in the 
facII promoter sequence of the plasmid. Forward primers which bound in the 
antisense fragment were used and are as follows: agrBI 
- 
CsagrBIAS/IF; agrB2 
- 
CsagrB2AS/IF; 336 
- 
336AS/IF; 340 
- 
340AS/IF. Primer sequences can be found 
in 2.6.2. Two control reactions were carried out without the addition of the reverse 
transcriptase enzyme. Firstly, DNA was used as the template to illustrate that the 
reaction was efficient under the given conditions. Secondly, RNA was used as a 
template to illustrate that there was no contaminating DNA in the sample. Results 
shown in FigUres 4.9 and 4.10 demonstrate that antisense RNA was expressed in 
both the presence and absence of IPTG induction. In fact, in all 'mutants', antisense 
RNA was expressed at higher levels in the presence of IPTG than in the absence. 
This dernonstrates the inducible nature of the pMTL9361 expression vector. 
However, these results also demonstrate that in all cases, except 340 AS2, expression 
of antisense RNA was still able to occur even in the absence of IPTG, indicating that 
'leaky' transcription was occurring from thefac promoter. 
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Figure 4.9 
- 
Confinnation of antisense RNA expression in agrBI (A) and agrB2 (B) 
4mutants'. 1, RNA from culture containing I mM IPTG; 2, RNA from culture 
without IPTG; 3, DNA from + IPTG culture, with no reverse transcriptase; 4, RNA 
from + IPTG culture with no reverse transcriptase; 5, DNA from 
- 
IPTG culture, with 
no reverse transcriptase; 6, RNA from 
- 
IPTG culture with no reverse transcriptase; 
7, negative control using water as template. All 'mutants' analysed demonstrated 
higher levels of antisense RNA expression under IPTG induction. 
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Figure 4.10 
- 
Confirmation of antisense RNA expression in 336 (A) and 340 (B) 
6mutants'. 1, RNA from culture containing I mM IPTG; 2, RNA from culture 
without IPTG; 3, DNA from + IPTG culture, with no reverse transcriptase; 4, RNA 
from + IPTG culture with no reverse transcriptase; 5, RNA from 
- 
IPTG culture, with 
no reverse transcriptase; 6, negative control using water as template. All 'mutants' 
analysed demonstrated higher levels of antisense RNA expression under IPTG 
induction. 
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4.3. Z2 Effect of antisense production on sporulation 
Potential phenotypes which may be affected by agrB modulation were considered 
and sporulation selected as a possible candidate. Sporulation was also the obvious 
phenotype to assay in the 336 and 340 'mutants' due to their possible role in the 
phosphorylation cascade in the initiation of sporulation. This is also a relatively easy 
phenotype to assay, using the method of heat inactivation of vegetative cells. Spore 
assays were carried out on all antisense 'mutants', along with a strain containing the 
empty pMTL9361 vector control which did not contain an antisense fragment. 5 ml 
broth cultures were grown for 72 hours and spore assays carried out in triplicate 
according to 2.12. Growth was monitored throughout the incubation period before 
heat treatment to ensure that all strains grew at a similar rate. Spore assay results are 
shown in Figures 4.11 and 4.12. 
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Sporulation in C. sporogenes agrB 2 antisense mutants 
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Figure 4.11 
- 
Sporulation in C sporogenes agrB 'mutants' in the presence and 
absence of IPTG. In the agrBI ASI 'mutant', the gene was down-regulated even in 
the absence of IPTG induction, resulting in an equivalent reduction in sporulation 
with or without IPTG. The agrBI AS2 fragment appears to be ineffective in down- 
regulating the agrBI gene. In both agrB2 'mutants' down-regulation of sporulation 
was more apparent in the presence of IPTG induction of antisense RNA. 
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Sporulation in C. sporogenes 336 antisense mutants 
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Figure 4.12 
- 
Sporulation in C sporogenes 336 and 340 kinase 'mutants' in the 
presence and absence of IPTG. The 336 AS I fragment appears to be inefficient, as 
does the 340 AS2 fragment. A small reduction in sporulation in the 336 AS2 
ýmutant' may indicate an antisense fragment with poor efficiency, or that this gene 
plays little part in sporulation. A huge reduction in sporulation was observed under 
IPTG induction of the 340 AS I fragment. 
Figure 4.11 illustrates that there was a significant reduction in sporulation in the 
agrBI ASI 'mutant' in the presence of IPTG, compared to the pMTL9361 control. 
Sporulation in both agrB2 'mutants' was also reduced by at least two orders of 
magnitude. All three of these results were shown to be statistically significant at a 
confidence interval of 95% using the pair wise Student's T test. However, the agrB I 
AS2 'mutant' showed no reduction in sporulation. 
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Figure 4.12 demonstrates that 336 ASI and 340 AS2 showed no reduction in 
sporulation. However, 336 AS2 and 340 ASI showed statistically significant 
reductions, with 340 AS I showing by far the largest reduction of all eight 'mutants'. 
4.3.3 Discussion 
Down-regulation of the agrB genes in C sporogenes was shown to significantly 
inhibit spore formation in three out of four antisense 'mutants'. This suggests that the 
agr system plays a part in the control of sporulation (an early stationary phase 
process). From these results it cannot be determined how the agr system affects this 
process; however, as the system is known to be a global regulator in S. aureus, it is 
possible that it may affect (either directly or indirectly) other genes involved in the 
sporulation process, for example spoOA. The phosphorylated form of this protein 
allows sporulation to proceed so it is a possibility that the agr system may affect the 
transcription of this gene, or may be involved in its phosphorylation. Microarray 
technology could be employed to assess whether the transcription of genes such as 
spoOA is affected by the agr system, by comparing the antisense 'mutants' to the 
wild type. However, more valuable data would be obtained from a complete 
knockout mutant, rather than an antisense 'mutant', which still possesses some agr 
activity. 
The only significant reduction in sporulation in the kinase 'mutants' was observed in 
340 AS 1. This showed a reduction of over six orders of magnitude in the presence of 
IPTG induction, which suggests that, firstly, the 340 kinase is involved in the control 
of sporulation, and that, secondly, the larger antisense fragment used against this 
target gene was not effective. It is therefore a possibility that gene 340 may be 
involved (possibly with other orphan kinase genes) in the initiation of sporulation via 
the phosphorylation cascade. It is not possible to say from these results whether the 
336 gene is involved in sporulation or not. Its down-regulation did not appear to 
significantly affect sporulation, but this could be due to the selection of ineffective 
antisense RNA fragments. The only way to address this would be to completely 
knock out this gene. 
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The recent sequencing of the C botulinum genome has revealed the presence of three 
other orphan kinase genes 
- 
C1300780, CB02762 and CBOI 120 (Worner et al., 
2006), which can be assumed to also be present in C sporogenes. It is therefore 
possible that one or more of these could also be involved in the initiation of 
sporulation, along with 0336 and/or 0340. An alternative hypothesis could be that a 
single kinase is involved in the phosphorylation of SpoOA, rather than the 
involvement of a cascade, as identified in B. subtilis. Indeed, it has been 
demonstrated that in B. subtilis, KinA can directly phosphorylate SpoOA, albeit at 
low levels (Trach & Hoch, 1993). Tberefore the possibility of a single kinase directly 
phosphorylating SpoOA in order to trigger sporulation cannot be discounted. Clearly 
more work must be carried out on this process, investigating all five orphan kinases, 
in order to determine exactly how sporulation is controlled in C. sporogenes and C 
botulinum. 
The different agrB 'mutants' showed inhibition of sporulation to varying degrees, 
indicating that some antisense RNA oligonucleotides selected were more effective 
than others. The antisense oligonucleotides, selected covered 33% and 66% of the 
agrB gene, based on antisense RNA generation by Tummala et al. (2003b). 
However, without computational analysis of the antisense oligonucleotides selected, 
it is difficult to determine how effective the oligonucleotide will prove. Indeed, the 
complex secondary structure of mRNA molecules means that much of the molecule 
may be inaccessible to antisense RNA. Scherr & Rossi (1998) introduced a system to 
determine the most effective target sites by using RNaseH cleavage. This showed 
which sites were accessible to the enzyme and therefore which sites would be 
accessible to antisense RNA. Tummala et al. (2003b) also sought ways of increasing 
the efficiency of antisense RNA. They used computer programs and theoretical 
analyses to obtain important information on the structure of antisense RNA, which 
may affect its hybridisation with mRNA. They concluded that, as the (no. 
components)/(no. total nucleotides) ratio decreased, the number of free nucleotides 
decreased, meaning more nucleotides were intramolecularly bound, making it more 
difficult for RNases to degrade the antisense RNA. (Free nucleotides are nucleotides 
in an antisense RNA molecule that are not involved in intramolecular bonding, 
providing potential interaction sites with target mRNA. Components are structural 
features that contain regions of high complementarity with an antisense RNA 
molecule (Tummala et al., 2003b)). In the future, the use of in silico analysis will 
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provide information on optimal antisense olignucleotides to use. In fact, Bo et al. 
(2006) reported a database (AOBase) which stores published oligonucleotide 
sequences and aids selection of efficient antisense oligonucleotides. However, 
computer programs were not available for use in this instance, so the fragments were 
selected purely on the basis of their covering the first 33% and first 66% of the target 
gene. It is therefore possible that the fragments selected were not ideal, and this 
would explain the differing effects that the two antisense fragments had on each 
target gene. An ideal solution would be to produce knockout mutants of the four 
target genes, which would give a much 'cleaner' picture of their true function. It 
must be remembered that the use of antisense technology does not result in the 
complete abolition of target protein synthesis, but merely down-regulates it. This can 
be an advantage when modulating genes which may be essential, but also hinders the 
interpretation of phenotypic assays. 
Another interesting factor to note is the need for IPTG induction to produce the 
antisense RNA. The RT-PCR results indicated that in all 'mutants', antisense RNA 
was produced, even in the absence of IPTG induction. This is a result of 'leaky' 
expression from the fac promoter, which is not tightly controlled. This was 
confirmed in the spore assays by the fact that, when a reduction in sporulation was 
observed, this occurred in both the presence and absence of IPTG, albeit to a lesser 
extent in its absence in most cases. This would indicate that even a small amount of 
antisense RNA is sufficient to have some down-regulatory effect. However, it would 
be more useful for the expression of the antisense RNA to be more tightly regulated, 
in order to control the exact timing of target gene down-regulation. 
Although these findings indicate that agrB is involved in sporulation, they do not 
prove conclusively that an AIP is involved. Cross-feeding assays, using wild type 
supernatant, could not demonstrate the restoration of sporulation in agrB I AS I (data 
not shown). To ascertain whether there is in fact a signalling molecule involved, it 
would need to be detected and ideally purified. Multistage mass spectrometry has 
previously been used for precisely this purpose (Kalkum et aL, 2003) and enabled the 
characterisation of secreted quorum sensing peptides in S. aureus. This would also 
provide more evidence as to whether sporulation is under the influence of a system 
utilising a secreted AIP. 
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In summary, the data obtained in this study provide important information as to how 
sporulation is controlled in C sporogenes. This may also prove relevant in C 
botulinum, which would be of great value to the food industry in the search for 
methods of inhibiting sporulation, and therefore improving food safety. However, 
antisense technology is not an ideal method of gene modulation, and further work 
should preferably be carried out using knockout mutants. 
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Chapter 5.0 
Gene Inactivation in Clostridium 
botulinum and Clostridium sporogenes 
using the ClosTron System 
Chapter, 5- Gene Inactivation in C botulinum and C sporogenes Using 
the ClosTron System 
5.1 Introduction 
Until recently, the lack of an effective method of clostridial gene knockout has meant 
that other methods have had to suffice. However, neither of the alternatives described in 
Chapter 4 are ideal. The use of unstable plasmids is unreliable in that the homologous 
recombination events occurring are not tightly controlled and therefore undesired 
recombination events may occur. Antisense RNA technology also has drawbacks, as 
absolute gene inactivation is not achieved. In addition, the intended target gene may not 
be the only gene affected by the antisense fragment. Indeed, the agrBl and agrB2 
antisense fragments used in the construction of the 'mutants' in Chapter 4 show 
relatively high similarity, and so the possibility of either fragment acting on both agrB 
genes cannot be discounted. Similarly, the smaller antisense fragments used in the two 
orphan kinase mutants exhibit 59.2% sequence identity, again suggesting that it may be 
possible for a given fragment to interfere with the translation of both proteins. 
As discussed in Chapter 1, the use of suicide vectors to induce double crossover allelic 
exchange mutagenesis is practised in many bacteria, but has been largely unsuccessful 
in the clostridia. The only clostridial species on which successful reports of double 
crossover mutations can be found is C. peýfiringens. Sarker el al. (1999) and Huang et 
al. (2004) used suicide vectors to construct mutants against the enterotoxin gene and the 
spoOA gene respectively. However, the latter group found it necessary to screen 3000 
colonies before a double crossover mutant was isolated. To date, mutants obtained in all 
other clostridial species by this method have all been through single crossover events. 
Clearly, a much more efficient alternative to this method must be utilised in order to 
obtain stable clostridial knockout mutants. 
An alternative method of gene inactivation in Gram-positive bacteria has been the focus 
of attention over the past few years and recently has been developed into a universal 
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clostridial gene knockout system (Heap et aL 2007). This system utilises a mobile group 
II intron, originally isolated from Lactococcus lactis, to induce site-specific mutations in 
the bacterial chromosome. Group II introns are perhaps more commonly recognised in 
eukaryotic cells, and are nucleotide sequences which interrupt protein-coding genes. 
However, they are also found in bacterial genomes where they are able to self-splice out 
of the RNA transcripts of the host gene. Some group 11 introns encode an Intron 
Encoded Protein (IEP) which contains various enzymatic activities (reverse 
transcriptase, maturase [promotion of RNA splicing] and site-specific DNA 
endonuclease). These render the intron a mobile element, allowing it to insert into 
intron-less copies of the host gene within the same cell, by a highly efficient and 
specific process known as retrohoming. The host DNA target site is recognised by a 
Ribo Nuclear Protein (RNP) complex, consisting of the IEP and the excised intron 
RNA. The intron RNA reverse splices into the double stranded target DNA and is then 
reverse transcribed by the intron-encoded reverse transcriptase (Mohr et aL, 2000). 
This insertion ability of mobile group II introns was originally capitalised on by Alan 
Lambowitz and co-workers at the University of Texas, who proposed that group II 
introns might be adapted for use in targeted gene disruption in bacterial genomes (Mohr 
et al., 2000). They utilised the mobile group II intron from the ltrB gene of Lactococcus 
lactis. This gene is found on conjugative plasmids, allowing its insertion into intron-less 
copies of the gene after introduction into a new host cell by conjugation. The IEP of this 
system is the LtrA protein, whose ORF is located within the group II intron. This 
research group proposed that altering the intron recognition sites would allow the re- 
targeting of the group II intron to almost any desired DNA target (Mohr et al., 2000; 
Karberg et al., 2001). 
Recognition of the DNA target site occurs primarily through sequences in the intron 
RNA. Three sites, known as exon binding sites (EBS) 1,2 and 18, which are 
approximately 5 bases long, base pair with complementary sequences in the target DNA 
known as intron binding sites (IBS) 1,2 and 18' (Mohr et aL, 2000). It was discovered 
that, as the IEP recognises only a few additional bases in the flanking regions of the 
DNA target site, altering the sequence of the EBSI and EBS2 regions of the intron 
altered its specificity, allowing it to re-target to a given gene selected for knockout 
(Karberg el al., 2001). These re-targeted introns became known as 'TargeTrons'. The 
132 
structure and recognition sites of the L. lactis ItrB group 11 intron are shown in Figure 
5.1. 
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Figure 5.1 
- 
Secondary structure and recognition sites of the L. lactis ItrB group 11 
intron. 
A- Secondary structure of the intron. The EBSI, EBS2 and 6 recognition sites are 
indicated in domain 1. The LtrA IEP is indicated in the non-structural loop of domain 
IV. 
B- Interaction of the EBSI/IBSI, EBS2/IBS2 and 8/8' sites in the intron and target 
gene respectively. Interactions between the IEP and target nucleotides are shown in 
grey. 
Adapted from Mohr et al., 2000 and Zhong et al., 2003. 
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The fact that the mechanism has only minimal dependence on host factors makes it an 
attractive method for use in a wide range of bacteria. For example, the L lactis ItrB 
intron has been utilised for gene knockout in both E. coli and Grain positive bacteria 
(Karberg et al., 2001). This group went on to develop a PCR-based method for 
generating the re-targeted introns. This was a two-step PCR, using three unique primers 
and one constant primer, and was used to make the EBSI, EBS2 and 8 sequences 
complementary to the desired target gene. The IBSI and IBS2 sites were then made 
complementary to the altered EBSI and EBS 2 sites, allowing the intron to re-target to 
the desired target gene, inactivating it. Subsequent developments have allowed these 
alterations to be carried out using a one-tube SOEing (Splicing by Overlap Extension) 
PCR. 
A further advancement in the development of this method for target gene inactivation 
was the use of a Retrotransposition Activated selectable Marker (RAM). Zhong et al. 
(2003) developed a TargeTron containing a RAM, which enables the positive selection 
of knockout mutants through the presence of a selectable marker. This marker contains 
its own promoter, and is inserted in the reverse orientation into domain IV of the group 
11 intron. However, initially, the marker is disrupted by an efficiently self-splicing group 
I intron from the td gene of phage T4, in the forward orientation. During 
retrotransposition, the group I intron splices out, activating the marker (usually an 
antibiotic resistance cassette) and allowing selection of colonies whose chromosomes 
have received the group II intron, after being cured of the delivery plasmid. Curing of 
the plasmid after insertion has occurred, and hence removal of the IEP, also prevents 
any further mobilisation of the intron, and any further mutations from occurring (Heap, 
2006). 
The use of these re-targeted group II introns was simplified by the development of a 
computer algorithm which predicts optimal L. lactis ItrB intron insertion sites, and 
designs primers for modifying the intron to re-target to these sites (Perutka et aL, 2004). 
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5.1.1 Adaptation of the group 11 intron for use in Clostridium sl2p. 
The construction of the group 11 intron delivery vector pMTL007 has recently been 
carried out by Heap et al. (2007). This group modified the commercialised 'TargeTron' 
vector pACD4K-C, provided by Sigma, for use in clostridial species, as some of its 
features were non-functional in clostridia. In the pMTL007 vector, the sequence 
encoding the IEP, LtrA has been removed from within the intron, and relocated further 
downstream in the plasmid. This relocation allows the protein to act in trans, without 
affecting mobility of the intron. 
Expression of the intron in pACD4K-C is driven by the T7 promoter, which does not 
function in clostridia. Therefore, Heap et al. (2007) replaced this promoter with the 
ferredoxin promoter from C pasteurianum, which functions strongly in a wide range of 
clostridial species. The IacI gene was introduced to allow for inducible expression of the 
intron, as the ferredoxin promoter is fused to the lac operator. They also introduced the 
pCB 102 replicon region to allow replication in clostridia. The catP cassette (coding for 
chloramphenicol acetyltransferase from C. perftingens) was also introduced into the 
plasmid backbone to allow for selection of thiamphenicol resistance in clostridia. The 
RAM used in vector pACD4K-C contains a kanamycin resistance cassette, which is 
ineffective in clostridia due to their natural kanamycin resistance. A new RAM 
containing an erythromycin resistance cassette from the E. jaecalis pAMPI plasmid, 
and driven by the thiolase promoter was therefore constructed, which would function 
efficiently in clostridial species. This 'ErmRAM' was inserted into the non-structural 
loop in which the ItrA sequence had previously been located. The final vector was 
named pMTL007 (Figure 5.2), and the modified group II intron which could be 
successfully used in clostridial species was termed the 'ClosTron'. 
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Figure 5.2 
- 
Plasmid map of the pMTL007 ClosTron vector. The vector contains both 
Gram-positive and Gram-negative replication machinery for use in both E. coli and 
clostridia. The 350 bp region of the intron, retargeted to the gene of choice, is inserted 
between the HindllI and BsrGI sites. Inducible expression of the retargeted intron is 
carried out from the jac promoter once Lad is de-repressed by IPTG induction. The 
catP gene is used to positively select for the presence of the vector by 
chloramphenicol/thiamphenicol resistance. Once the ErmRAM is spliced and inserted 
chromosomally, erythromycin resistance is conferred. The LtrA protein is located 
outside of the intron region but is able to act in trans with the spliced intron and 
facilitate the retrohoming process. 
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5.1.2 Generation of multiple gene knockout mutants using the ClosTron System 
Until recently, the construction of single gene knockout mutants in clostridia has been 
problematic, but creating multiple gene knockouts has been even more difficult. Along 
with the fact that the tools available for this have been inadequate, only a few natural 
antibiotic resistance genes have been identified that can be used in clostridia, which has 
rendered it impractical to produce mutants carrying multiple inactivated genes (Chen et 
al., 2005). However, the ClosTron has the potential to overcome these limitations. 
Double knockout mutants can be created in a two-step process. A modified RAM is 
used which is flanked by Flp Recombinase Target sites (FRT sites). These sites are 
recognised by a site-specific Flp recombinase enzyme, from Saccharomyces cerevistae. 
The modified RAM is introduced, on a plasmid, to the clostridial strain of interest, to 
induce knockout of the first target gene in the same manner as single knockouts are 
created. However, the mutants obtained are subsequently cured of this first plasmid and 
a second plasmid expressing Flp recombinase is introduced. This enzyme induces the 
excision of the first RAM by catalysing homologous recombination between the two 
FRT sites. After curing of the recombinase-carrying plasmid, the process is repeated to 
induce disruption of a second target gene. This process has been used in E. coli (Zhong 
et al., 2003), but until recently has not been attempted in clostridia. In this study it was 
used in an attempt to create an agrDlIagrD2 double mutant in C botulinum, using 
plasmid pMTLO07C-E2. This plasmid is illustrated in Figure 5.3. 
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Figure 5.3 
- 
Plasmid map of pMTLO07C-E2. The vector is used to deliver retargeted 
group 11 introns in the generation of multiple gene knockout mutants. The vector differs 
from the original pMTL007 vector in that the expression of the group 11 intron is under 
constitutive control from the spofdx promoter. The ErmRAM is also flanked by FRT 
sites which should allow the RAM to be removed by the Flp recombinase enzyme. This 
would allow subsequent genes to be inactivated using the same procedure. 
A detailed description of the generation of mutants using the ClosTron system is 
illustrated in Figure 5.4. 
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SOEing PCR carried out on L. lactis 1trB group Il intron. 
The resulting 'retargeted' intron is rendered specific for the target gene of interest. 
Initially products I and 2 are amplified from the IBSI/EBS and EBS2/EBS18 
primer pairs respectively. The tails on the EBS universal and EBS2 primers cause a 
mutation in the two products. The 3' end of product I is complementary to the 5' 
end of product 2, resulting in the hybridisation of the two products. The full 350 bp 
product is then amplified by the IBS I and EBS 16 primers. This all occurs in a one- 
tube reaction. 
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- 
Ligation of retargeted vector into pMTL007 plasmid. 
The 350 bp retargeted region of the intron is purified, digested and ligated into the 
pMTLO07/pMTLO07C-E2 plasmid between the Hindlll and BsrGI restriction sites. 
The retargeted vector is then introduced into the target organism by conjugation. 
Cells carrying the plasmid are selected for using thiamphenicol. 
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- 
Expression of intron RNA and retrohoming of RNP. 
i) Expression of the intron from the pMTL007 plasmid is induced using IPTG. 
Expression from the pMTLO07C-E2 plasmid is constitutive. Once the intron is 
expressed, retrohoming can occur. At this point, the group I intron is spliced out of 
the erythromycin resistance gene of the RAM 
- 
see Figure 5.41). 
ii) The intron RNA folds into its functional configuration and binds to the LtrA protein. 
iii) This results in the ribonuclear protein RNP complex consisting of the LtrA protein 
with the intron RNA wound around it. 
iv) The RNP complex scans the chromosomal DNA in search of a target site. The LtrA 
protein first recognises the foui bases shown in grey, which allows unwinding of thk 
target DNA. The intron RNA can then bind to the 13 bases of the IBS2, IBS I and 
IBS15 sites. 
v) The intron RNA reverse splices into the double stranded target DNA and is reverse 
transcribed by the intron-encoded reverse transcriptase. Host enzymes repair the DNA 
to create a permanent insertion. 
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Splicing of the ErmRAM in ClosTron mutants. Adapted from Heap 
(2006). 
The only scenario in which erythromycin resistance is conferred on the cell is when the 
group I intron is spliced out of the RAM and the group 11 intron is inserted into the 
chromosome. 
A. Expression of the ErmRAM from the pMTLO07/pMTLO07C-E2 plasmid. No 
erythromycin resistance is conferred because the mRNA produced retains the td group I 
intron insertion. This element cannot splice out because it is in the wrong orientation. 
R. Once group 11 intron production is induced, transcription proceeds from the 
faclspofdx promoter. The td group I intron is now in the correct orientation and splices 
out. The group 11 intron inserts into the chromosome, conferring erythromycin 
resistance on to the cell, due to the transcription of the erythromycin resistance gene 
from the thiolase promoter. 
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5.2 Results 
5.2.1 Generation of single knockout mutants 
The ClosTron vector pMTL007 was used to generate the first documented knockout 
mutants in C. botulinum ATCC 3502. Four genes were targeted; agrDl, agrD2 and two 
orphan kinase genes within the C botulinum agr regions 
- 
genes CB00336 and 
C1300340. These four genes are highlighted in red in Figure 5.5. 
The same two orphan kinase genes were also targeted in C sporogenes. The 
inactivation of these two genes was required in order to compare the effect on 
sporulation in the mutants obtained to that observed in the antisense 'mutants' 
constructed in Chapter 4. In the construction of these two mutants the pMTLO07C-E2 
vector, containing the FRT sites, was used rather than the original pMTL007 plasmid. 
CB00329 CB00330 CB-00331 agrB I CB00333 
CB00336 CB00337 I 
ýazrý [-C 
Figure 5.5 
- 
Schematic representation of the agr regions in the C botulinum ATCC 
3502 genome (not to scale). Genes targeted for knockout using the ClosTron system are 
shown in red. Genes 0336 and 0340 were also targeted in C sporogenes. 
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The target sites selected and the primers designed by the computer algorithm (available 
at http: //www. sigma-genosys. com/targetron/) for use in the re-targeting PCR are shown 
in Table 5.1. The SOEing PCRs used the three unique primers indicated, along with the 
EBS universal primer. 
Target Intron insertion Orientation Primers used to generate 
Gene 
_ 
site (bp into gene) of intron re-targeted intron 
C bot 23 Antisense Cb-agrDI-283la-IBS 
agrDl Cb-agrDI-283la-EBSId 
Cb-agrDI-283la-EBS2 
C bot 47 Antisense Cb-agrD2-2990a-IBS 
agrD2 Cb-agrD2-2990a-EBS Id 
Cb-agrD2-2990a-EBS2 
C. bot 1203 Sense Cb-336-617/618s-IBS 
CB00336 Cb-336-617/618s-EBSId 
Cb-336-617/618s-EBS2 
C. bot 690 Sense Cb-340-776/777s-IBS 
CB00340 Cb-340-776/777s-EBSId 
Cb-340-776/777s-EBS2 
C sporog 1207 Sense Cs-336-617/618s-IBS 
CSP0336 Cs-336-617/618s-EBSId 
Cs-336-617/618s-EBS2 
C sporog 711 Sense Cs-340-776/777s-IBS 
CSP0340 Cs-340-776/777s-EBS Id 
I I Cs-340-776/777s-EBS2 
Table 5.1 
- 
Target sites and primers utilised for gene knockout of four genes in C 
botulinum ATCC 3502 and two genes in C sporogenes 10696. 
The SOEing PCR was then carried out to alter the region of the group II intron 
responsible for its specificity. This was done using the primers indicated in Table 5.1, 
along with the EBS universal primer, and was carried out in a single one-tube reaction. 
A four-primer mix was first set up as follows: 
2 gl 100 gM IB S primer 
2 ýtl 100 ýM EBS Id primer 
lil 20 ýM EBS2 primer 
2 ýtl 20 ýM EBS universal primer 
12 pl water 
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This primer mix was then used to set up a 50 ýtl PCR reaction mix (see method 2.7.9) 
using 5 gI four-primer mix and I ýd 1: 10 Intron PCR Template, provided in the Sigma 
TargeTron Gene Knockout System Kit. The PCR was then carried out in triplicate using 
the following conditions: 
94'C for 30 seconds 
94'C for 15 seconds 
55'C for 30 seconds 30 cycles 
72'C for 30 seconds 
72'C for 2 minutes 
An example of the PCR products generated in these reactions is shown in Figure 5.6. 
Triplicate reactions were pooled before running on an agarose gel and purifying the 
required 350 bp product. The products were ligated into the pCR2.1 TOPO vector 
before sequencing to confirm the correct product. 
350 bp re-targeted 400 bp 
group 11 intron 300 bp 
Figure 5.6 
- 
Products obtained from the re-targeting SOEing PCR carried out on the L. 
lactis group 11 intron. The example shown is from the C. botidinum agrDl PCR and the 
350 bp product was purified. 
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The required products were re-isolated from the pCR2.1 vector by digesting with 
HindIll and Bst-GI. The pMTL007 or pMTLO07C-E2 vectors were cut with the same 
two enzymes, allowing each of the inserts to be ligated into the vectors. This resulted in 
the intron. delivery vectors containing a re-targeted intron with specificity for one of the 
six target genes. The vectors were then transformed into E. coli TOPIO by 
electroporation, and selected for using chloramphenicol. Plasmids were isolated from 
the resulting colonies and sequencing carried out again to further confirm the correct re- 
targeted intron sequence. Primers used for sequencing were 5402F-Fl & pMTLO07-RI 
(for pMTL007 plasmid) and Spofdx-seq-Fl & pMTLO07-RI (for pMTLO07C-E2 
plasmid). The plasmids were finally transformed into the conjugation donor strain E. 
coli CA434, before being conjugated into C botulinum or C sporogenes using the 
'spot' method. Transconjugants, were selected for using thiamphenicol. Induction of 
target gene knockout by integration of the group II intron was then carried out as 
described in methods 2.11.1 and 2.11.2. Results from the conjugation and integration 
experiments are shown in Table 5.2. 
Target Gene Transconjugants 
(cfU/ml) 
Integrants 
(cfu/ml) 
Frequency of 
integration 
C bot agrDl 2.73 x 10' 1.2 x 104 6.32 x 10-4 
C bot agrD2 1.84 x 103 
- 1.38 xW 1.45 x 10-5 
CB00336 5.6 x 10' 1.6 x ICý 8.0 x 10-6 
CB00340 1.8 x 103 1.52 x 105 7.0 x 10-3 
CSP0336 8.4 x IW 3.93 x 103 7.87 x 10'4 
CSP0340 9.2 x IW 2.26 x 107 7.53 
I 
Table 5.2 
- 
Results from conjugation and integration experiments for knockout of 
genes in C botulinum and C sporogenes. 
5.2.2 Screening Of Rutative single knockout mutants 
Four to six putative knockout mutants were picked for each gene. Genomic DNA was 
prepared from each isolate and used to perform three PCR screenings, which are 
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outlined in Table 5.3 and Figure 5.7. A pool was also screened, where the colonies from 
an entire induction agar plate were harvested using 1 ml PBS, and the DNA extracted. 
This was to determine whether a correct integrant was present in the population if none 
of the individual colonies screened were correct. 
PCR Screen Target Primers Expected 
Gene product(bp) 
1- Amplifies product C bot 0 Target R(Cb-agrD I /R) 289 
across intron-exon agrDl 
- 
EBS universal 
junction and confirms C. bot 0 Target R(Cb-agrD2/R) 294 
that intron has inserted agrD2 a EBS universal 
into desired gene. CB00336 Target F(Cb0336F) 492 
EBS universal 
CB00340 Target F(Cb0340F) 449 
EBS universal 
CSP0336 Target F(Cs0336F) 492 
EBS universal 
CSP0340 Target F(Cs0340F) 448 
EBS universal 
2- Confirms that intron C bot Target F (Cb-agrDl/F) 1700 
is present in the desired agrDl Targ R (Cb-agrD I /R) 
target gene and that C bot Target F (Cb-agrD2/2F) 1700 
RAM is spliced. agrD2 Target R (Cb-agrD2/R) 
CB00336 
- 
Target F (Cb0336F) 2000 
0 Target R(Cb0336R) 
CB00340 
- 
Target F (Cb0340F) 2000 
0 Target R (Cb0340R) 
CSP0336 
- 
Target F (Cs0336F) 2158 
0 Target R(Cs0336R) 
CSP0340 
- 
Target F (Cs0340F) 2240 
0 Target R (Cs0340R) 
3- Indicates that RAM C. bot 900 
is either spliced and I 
therefore integrated, or C bot 900 
presence of full length, agrD2 
- 
ErmRAM F 
unspliced RAM. CB00336 0 ErmRAM R 900 
CB00340 900 
CSP0336 900 
CSP0340 900 
Table 5.3 
- 
Primers used in three different PCR screens of C botulinum and C 
sporogenes putative knockout mutants. Primer sequences can be found in 2.6. 
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Figure 5.7 
- 
Schematic representation of PCR screens carried out on putative 
integrants. A, pMTLO07/pMTLO07C-E2 plasmid DNA; B, chromosomal DNA with the 
ClosTron inserted into a target gene in the sense orientation (e. g. CBO/CSP0336 and 
CBO/CSP0340); C, chromosomal DNA with the ClosTron inserted into a target gene in 
the antisense orientation (e. g. C bot agrDI and agrD2). Red, target gene; blue, group 11 
intron; purple, Erin RAM; yellow, group I intron. Primers are represented by black 
arrows. Expected product sizes and regions amplified are shown in Table 5.3. 
PCR screen I results are shown in Figure 5.8. Results of PCR screens 2 and 3 can be 
found in Appendix 4. 
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Figure 5.8 
- 
PCR screen I on four C. botulinum and two C. sporogenes mutants. 
Primers used and expected product sizes are shown in Table 5.3 and Figure 5.7. Non- 
specific binding of primers to the plasmid control is occasionally observed. This was 
previously been seen during development of the ClosTron knockout method (Heap et 
al., 2007), but does not affect interpretation of results. 
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A-C botulinum agrD mutant screen: 1,11,12 & 22,2 log DNA ladder; 2-6, 
genomic DNA from 5 putative agrDI mutants; 13 
- 
17, genomic DNA from 5 putative 
agrD2 mutants; 7& 18, genomic DNA from pools; 8& 19, C botulinum wild type 
genomic DNA; 9& 20, pMTL007 plasmid DNA, 10 &21, water negative control. 
B-C botulinum 0336 and 0340 mutant screen: 1,10 & 19,2 log DNA ladder; 2-5, 
genomic DNA from 4 putative 0336 mutants; 11 
- 
14, genomic DNA from 4 putative 
0340 mutants; 6& 15, genomic DNA from pools; 7& 16, C. botulinum wild type 
genomic DNA; 8& 17, pMTL007 plasmid DNA; 9& 18, water negative control. 
C-C sporogenes 03 36 and 03 40 mutant screen: 1,11,12 & 22,2 log DNA ladder; 2- 
6, genomic DNA from 5 putative 0336 mutants; 13 
- 
17, genomic DNA from 5 putative 
0340 mutants; 7& 18, genomic DNA from pools; 8& 19, C sporogenes wild type 
genomic DNA; 9& 20, pMTLO07C-E2 plasmid DNA; 10 &21, water negative control. 
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In addition, Southern hybridisation was used to confinn that only a single intron 
insertion had occurred. Wild type and mutant chromosomal DNA was digested using 
Hindlll, which fragments the DNA but does not cut inside the inserted group 11 intron. 
The probe used was designed to hybridise to the spliced En-nRAM sequence. Figure 5.9 
confirms that only one copy of the En-nRAM, and therefore one intron is present in each 
of the mutants. 
234567 
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Figure 5.9A 
- 
Southern blot to demonstrate the presence of a single intron insertion in 
four C botulinum mutants. 1, Lambda DNA/Hitzdlll markers; 2, pMTL007 vector; 3, 
agrDl mutant; 4, agrD2 mutant; 5, CB00336 mutant; 6, CB00340 mutant; 7, C. 
botulinum wild type. Chromosomal DNA from all strains was digested overnight with 
HindIII, along with the pMTL007 plasmid DNA. The DIG-labelled probe was designed 
to target the ErrnRAM sequence and the results demonstrate the presence of only one 
RAM in each mutant. 
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Figure 5.9B 
- 
Southern blot to demonstrate the presence of a single intron insertion in 
two C. sporogenes mutants. 1, Lambda DNA/HindIII markers; 2, pMTLO07C-E2 
vector; 3,0336 mutant; 4,0340 mutant; 5, C. sporogenes wild type. Chromosomal 
DNA from all strains was digested overnight with HindIII, along with the pMTLO07C- 
E2 plasmid DNA. The DIG-labelled probe was designed to target the ErrnRAM 
sequence and the results demonstrate the presence of only one RAM in each mutant. 
Confirmation of the stability of the mutants was carried out by growing a 48-hour broth 
culture of the mutant and plating this out onto TYG agar in duplicate, in the presence 
and absence of erythromycin selection. Both plates gave similar colony counts, 
indicating that the mutants were stable and that erythromycin selection was not required 
to maintain the mutations. 
Genomic DNA from all C botulinum mutants was used to amplify both intron-exon 
junctions. The products were then sequenced and were found to be correct (data not 
shown). 
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5.2.3 Generation of Dutative double knockout mutants 
A derivate of pMTL007, containing FRT sites, was used in an attempt to generate an 
agrDlIagrD2 double mutant in C botulinum. This would involve removing the RAM 
from a single mutant, with the subsequent insertional mutation of a second gene. The 
removal of the RAM in any single mutants would also be desirable in order to avoid any 
polar effects caused by the strong promoter of the RAM. 
5. Z3.1 Step I- Generation of agrDl mutant 
pMTLO07C-E2 was used as the initial intron delivery vector to inactivate the agrDI 
gene in the same manner as for the generation of the single mutants. The vector map is 
shown in Figure 5.3. The retargeted agrDl sequence which had been cloned into the 
pCR2.1 TOPO vector during the original single knockout process was re-isolated and 
cloned into the pMTLO07C-E2 vector. This was subsequently transformed into the E. 
coli conjugation donor CA434 and conjugated into C. botulinum using the single mutant 
methodology. Since the intron in pMTLO07C-E2 is constitutively expressed, induction 
with IPTG was not required. Instead, one thiamphenicol resistant transconjugant was 
resuspended in 100 gl TYG broth. This was then serially diluted and 100 gl of each 
dilution spread onto TYG plates containing erythromycin. Dilutions were also plated 
onto TYG without selection to allow calculation of integration frequencies. Any 
putative knockouts were repeatedly subcultured onto fresh TYG erythromycin or 
thiamphenicol plates, until thiamphenicol. sensitivity was detected, indicating that 
plasmid loss had occurred. Results from the conjugation and integration experiments are 
shown in Table 5.4. 
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Target Gene Transconjugants 
(cfu/ml) 
Integrants 
(cfU/ml) 
Frequency of 
integration 
agrDl 1.6 x 103 4.3 x 105 4.7 x 10-3 
Table 5.4 
- 
Results from conjugation and integration experiments for the knockout of 
agrDI in C botulinum using plasmid pMTLO07C-E2. This was the first stage of the 
double knockout process. 
PCR screens were then carried out on genomic DNA isolated from five putative 
knockout mutants along with a pool. This was carried out using the same screens used 
for the single knockout mutant, described in 5.2.2. Results of the screen are shown in 
Figure 5.10A-C, and indicate that four out of the five putative knockout mutants were 
correct. 
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Figure 5.10A 
- 
PCR screen I on C. botulinum agrDI mutant generated using 
pMTLO07C-E2. Primers used were the same as those given in Table 5.3.1 & 11,2 log 
DNA ladder; 2-6, genomic DNA from 5 putative agrDI mutants; 7, genomic DNA 
from pool; 8, C. botulinum wild type genomic DNA; 9, pMTLO07C-E2 plasmid DNA, 
10, water negative control. Results show that four out of the five putative mutants gave 
correct products. 
LMA"d 
114" 
2 Kb 
1.5 Kb 
2345 
Figure 5.10B 
- 
PCR screen 2 on C. botulinum agrDI mutant generated using 
pMTLO07C-E2. Primers used were the same as those given in Table 5.3.1,2 log DNA 
ladder; 2, genomic DNA from putative agrDl mutant 1; 3, C. bottifinum wild type 
genomic DNA; 4, pMTLO07C-E2 plasmid DNA, 5, water negative control. Genomic 
DNA from putative mutant I gave the correct size product. 
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Figure 5.10C 
- 
PCR screen 3 on C. bottilinum agrDl mutant generated using 
pMTLO07C-E2. Primers used were the same as those given in Table 5.3.1,2 log DNA 
ladder; 2, genomic DNA from putative agrDI mutant 1; 3, C bottilinum wild type 
genomic DNA; 4, pMTLO07C-E2 plasmid DNA, 5, water negative control. Genomic 
DNA from putative mutant I gave the correct size product. 
5. Z3.2 Step 2- Construction ofplasmid expressing Flp recombinase 
The flp recombinase gene from Saccharomyces cerevisiae was PCR amplified from 
plasmid pCP20 using primers FLP-FI and FLP-RI. These primers incorporated Xbal 
and Xhol restriction sites onto the 5' and 3' ends of the PCR product respectively. The 
fragment was cloned into the Invitrogen pCR2.1 TOPO vector and checked by 
sequencing. It was then excised from the pCR2.1 vector and sub-cloned as an AballXhol 
fragment into plasmid pMTL5402F, under the inducible control of thefiac promoter. 
This gave plasmid pMTL5402F-FLP, which is shown in Figure 5.11. 
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Figure 5.11 
- 
Plasmid map of vector pMTL5402F-FLP. The vector was used to express 
the Flp protein and therefore remove the ErmRAM in an attempt to construct aC 
botulinum double agrD mutant. The Saccharomyces cerei, isiaeflp recombinase gene is 
under inducible control of thefac promoter. Addition of IPTG removes repression by 
Lacl, allowing expression offlp, which can then, in theory, 'flip' out the ErmRAM from 
the chromosome of the first mutant by recombination of its flanking FRT sites. 
5.2.3.3 Step 3- Excision of removahle RAM 
Plasmid pMTL5402F-FLP was conjugated into the agrDI mutant using the standard 
conjugation method. Transconjugants were selected for using thiamphenicol. Induction 
of the expression of the flp recombinase gene was then carried out using IPTG as 
described in 2.11.1. This was permitted by the fact that the gene is under the inducible 
control of the fac promoter. Colonies were selected for using thiamphenicol and 80 were 
picked for further investigation. These colonies were streaked in duplicate onto TYG 
agar containing erythromycin or thiamphenicol. Colonies exhibiting erythromycin 
sensitivity, combined with thiamphenicol resistance had potentially lost the ErmRAM. 
However, after overnight incubation, all colonies showed erythromycin resistance, 
indicating that the ErmRAM had not been lost. 
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A second attempt at removal of the ErmRAM was therefore made, using an alternative 
induction method. In the first attempt, induction was carried out for a relatively short 
period of time (3 hours). In this second attempt induction was carried out over 48 hours 
as follows: 
A5 ml overnight broth culture of the agrDI mutant containing the pMTL5402F-FLP 
plasmid was set up. Both thiamphenicol and 4 mM IPTG were added to this culture 
(previously, only I mM IPTG had been used). After 15,23 and 39 hours, 50 RI broth 
culture was inoculated into 5 ml fresh TYG broth containing thiamphenicol and 4 mM 
IPTG. After 48 hours the broth culture was serially diluted to 10-7 and 100 RI aliquots of 
each dilution plated onto TYG agar containing thiamphenicol. After incubation, 105 
colonies were streaked in duplicate onto TYG agar containing erythromycin or 
thiamphenicol. as in the previous attempt. Again, after overnight incubation, all isolates 
exhibited erythromycin resistance indicating that the ErmRAM had not been removed. 
This attempt at marker removal and the subsequent generation of a double knockout 
mutant was therefore unsuccessful. 
5.2.4 Characterisation of clostridial mutants generated using, the ClosTron syýtem 
Mutants generated were phenotypically characterised. Firstly, growth, in TYG broth, of 
all mutants was assessed by following optical density hourly. Growth was not affected 
in the C botulinum agrDl and agrD2 mutants (Figure 5.12A). The C botulinum 0336 
and 0340 mutants showed a reduction in growth rate compared to the wild type, but the 
final OD obtained was no different (Figure 5.12B). Curiously, the C. sporogenes 0336 
and 0340 mutants showed a slight increase in growth rate compared to the wild type 
(Figure 5.12C). 
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Figure 5.12 
- 
Growth of six clostridial mutants compared to wild type. A-C. 
botulinum agrDl and agrD2 mutants. B-C bottifinum 0336 and 0340 mutants. C-C. 
sporogenes 0336 and 0340 mutants. 
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The ability to sporulate was then assessed in all mutants, due to the importance of this 
phenotype in the pathogenesis of C botulinum. Figure 5.13 demonstrates that all C 
botulinum mutants showed a reduction in sporulation, the most marked effect being 
observed in the agrDl mutant. However, the C sporogenes 0336 and 0340 mutants 
showed no reduction in sporulation (Figure 5.14). 
Sporulation in C. botulinum rn utants 
1. OOE+07 
1. OOE+06 
1. OOE+05 
1. OOE+04 
0 CL 
0 1. QOE+03 
cm 
«2 1. OOE+02 
1. OOE+01 
1. OOE+00 
Strain 
Figure 5.13 
- 
Sporulation in four C botulinum mutants. The largest reduction in 
sporulation was observed in the agrDl mutant, with the agrD2 mutant also showing a 
significant reduction. These results correspond to what was observed in the C. 
sporogenes antisense 'mutants'. Little reduction in sporulation was observed in the 0336 
mutant, which also corresponds to the results seen in the C. sporogenes antisense 
'mutant'. The small reduction in sporulation in the 0340 mutant is in marked contrast to 
the huge reduction observed in the 0340 antisense 'mutant'. 
160 
C botVVF agrDl rrutant aqrD2 mutant 336 mutant 340 Want 
Sporulation in C. sporogenes mutants 
1. OOE+08 
1. OOE+07 
1. COE+06 
1. OOE+05 
1. OOE+04 
0 1. OOE+03 
cm 
.21. OOE+02 
1. OOE+01 
1. OOE+00 
strain 
Figure 5.14 
- 
Sporulation in two C sporogenes mutants. Neither mutant showed any 
difference in sporulation to that observed in the wild type. Results observed in the 0336 
ClosTron mutant correlate well to those observed in the C botidinum 0336 ClosTron 
mutant and the C. sporogenes 0336 antisense 'mutant'. However, the results observed in 
the C sporogenes 0340 ClosTron mutant strongly contrast with those seen in the C. 
sporogenes 0340 antisense 'mutant'. 
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5.3 Discussion 
Previous attempts to produce mutants in C botulinum have been unsuccessful. Attempts 
have been made using transposon mutagenesis but this method cannot produce the 
directed mutants that are obtained using the ClosTron system. Lin & Johnson (1991) 
used the E. faecalis Tn916 conjugative transposon in an attempt to produce knockout 
mutants in C botulinum. They found that after conjugation, stable tetracycline 
resistance was transferred to C botuUnum strains, but this kind of mutagenesis is 
random, and 200 transconjugants were screened for auxotrophic mutations. It was also 
apparent after Southern blotting that multiple transposons had sometimes inserted. This 
kind of approach, although the only one available at the time, is a long-winded and 
random way of producing mutants, and has many limitations. 
Other groups have been forced to rely on the use of antisense RNA technology for the 
modulation of gene expression in C botulinum. Marvaud et aL (1998b) used this 
technique in their investigations into the function of botRIA in C botulinum toxin 
regulation. They down-regulated expression of botRIA using antisense RNA, but this 
inhibition was only partial, and one can never be sure that antisense RNA is not 
affecting the expression of other genes or processes. 
There has been one published example of gene knockout in clostridia using the group 11 
intron technology, but this method stopped short of utilising a RAM for selection of 
mutants. Chen et aL (2005) used the L. lactis group 11 intron to disrupt the ple gene of 
C perfringens, but the absence of a RAM necessitated the screening of many colonies 
in order to detect a mutant. In this instance, screening was made easier by the fact that 
alpha toxin activity could be screened for by observation of a halo around the colonies 
on egg yolk agar. However, if other genes were targeted which were not so easily 
screened, this would mean a very time-consuming PCR screen of many colonies. 
This study is the first documented case of directed gene knockout in C botulinum and 
this method promises to open up many more areas of research into the understanding of 
gene expression in this organism. 
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Sporulation in the C botulinum agrD knockout mutants corresponds to that observed in 
the C sporogenes agrB antisense 'mutants'. If the agr systems in C botulinum and C 
sporogenes function in a similar way to that of S. aureus, then essentially, inactivating 
the agrB or the agrD gene should have a similar effect; inhibiting the production of the 
AIP signalling molecule. The C sporogenes agrBl and agrB2 antisense 'mutants' 
showed a reduction in sporulation of 5.5 logs and 2.5 logs respectively. The C 
botulinum agrDl and agrD2 mutants showed a reduction in sporulation of 4 logs and 
2.5 logs respectively. The differences may be attributed to the experiments being 
conducted in two different species of clostridia, and two different gene modulation 
techniques being employed. These data suggest that the agrBID genes are involved in 
the control of sporulation in C botulinum and C sporogenes, with the agrBlIDI genes 
having the greatest effect. To our knowledge, this is the first time that a link between the 
agr quorum sensing system and the control of sporulation in these organisms has been 
made. 
The spore assay results obtained from the kinase mutants were not so easy to interpret. 
The C sporogenes 0336 antisense 'mutants' showed no reduction in sporulation, and 
the same result was observed in the knockout mutant. There was a small reduction in 
sporulation in the C botulinum knockout mutant, but this difference could be attributed 
to the mutant being produced in a different species of clostridia. 
The spore assay results observed in the 0340 mutants of C. sporogenes and C 
botulinum did not correlate well, suggesting that there may be some other factor 
affecting the behaviour of these mutants. The C sporogenes 0340 antisense 'mutant' 
showed more than a6 log reduction in sporulation compared to the wild type (see 
Chapter 4). The observed reduction in the C botulinum knockout mutant was only 1.5 
logs. This was a huge difference in results, so, in an attempt to confirm which was 
actually the case, the 0340 gene was knocked out in C sporogenes using the ClosTron. 
However, rather than confirming one of the previous results, these spore assays 
produced a third result 
- 
no effect on sporulation at all. This then posed the question: 
are these mutants giving a clear picture of how the 0340 kinase is involved in 
sporulation in C botulinum and C sporogenes? Clearly the methods used must be 
called into question, and the most reliable one determined. It could be proposed that 
antisense modulation is not an ideal method, as discussed in Chapter 4. The fact that a 
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huge reduction in sporulation. was observed in the 0340 antisense 'mutant' might be 
explained by the antisense fragment possibly affecting other genes which were involved 
in sporulation, as well as the intended target gene. This may be a contributory factor, but 
it seems unlikely that such a huge difference in results (i. e. a6 log reduction, compared 
to zero reduction) could be caused solely by the non-specific binding of an antisense 
fragment. The two ClosTron mutants were also produced using two different plasmids 
containing slightly different ErmRAMs (pMTLO07C-E2 contains the ErmRAM flanked 
by the FRT sites). This may be a contributory factor, along with the fact that the mutants 
were constructed in two different organisms. However, again, it is unlikely that these 
theories fully explain the difference. 
Another possibility is that the genes targeted by the ClosTron system are not completely 
inactivated. In theory, knockout mutants give a much 'cleaner' picture of any 
phenotypic changes than antisense 'mutants, as they completely inactivate the target 
gene. However mutants obtained using the ClosTron are actually insertional mutants, 
and when targeting proteins composed of different functional domains, the nature of the 
insertion of the group II intron may mean that the whole gene is not inactivated. 
Histidine kinase proteins are composed of several domains, which carry out different 
functions. The 0336 and 0340 genes investigated in C sporogenes and C botulinum 
were found to contain a PAS domain. These domains are sensory modules which 
typically sense signals in the form of oxygen tension, redox potential or light intensity 
(Vreede et aL, 2003). They also possessed a histidine kinase domain, which is the key 
element in two-component signal transduction and is responsible for the 
autophosphorylation of the histidine with ATP, and the phosphotransfer from the kinase 
to an aspartate residue of a response regulator (Schultz el aL, 1998). The domains of the 
0336 and 0340 kinase proteins are outlined in Figure 5.15. These domains were 
analysed using the SMART website (Schultz et aL, 1998). In the 0336 mutants, the 
group Il intron was inserted into the histidine kinase domain, which would inactivate 
this domain, preventing phosphotransfer and therefore subsequent activation of a 
response regulator. It can be assumed, therefore, that the 0336 genes were effectively 
inactivated in both C botulinum and C sporogenes. 
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However, in the 0340 mutants, the intron was inserted further upstream in the PAS 
domain. It is therefore possible that a transcriptional fusion could be produced, which 
included part of the intron, and the downstream portion of the kinase gene, 
encompassing the histidine kinase domain. In-frame start codons exist in this fusion, but 
it is unlikely that any fusion would be transcribed due to the lack of an efficient 
ribosome binding site. However, if a weak RBS was utilised, a truncated protein could 
in theory be produced, with a functional histidine kinase domain. It is unlikely that 
autophosphorylation could occur, due to the insertion of the intron in the signal sensing 
domain, but in the absence of any clear explanation of these results, this possibility 
cannot be discounted. The spore assay results on the 0340 mutants may therefore give 
an inaccurate picture of the effects of inactivating the 0340 gene. Complete inactivation 
of this gene may have caused a much larger inhibition of sporulation, if this gene is 
indeed involved in the phosphorylation of SpoOA. 
The possibility of transcriptional fusions complicating knockout procedures may also be 
applicable to the agrD ClosTron mutants. The nature of the location of the AIP 
sequence in the middle of the agrD gene means that the AIP may not be completely 
inactivated. Due to the small size of the AgrD protein, there was little choice of intron 
insertion site. Indeed, the algorithm only detected one retargeting site in agrD2 and two 
in agrDl. The agrDl site selected was chosen because of its lower e value, indicating 
that there would be a greater chance of successful retargeting. Therefore the sites 
selected in the agrD genes were in fact upstream of the AIP sequence. This is depicted 
in Figure 5.16. In the agrDI mutant, there is an in-frame methionine start codon 15 
residues upstream of the AIP sequence. Again, there is no clear ribosome binding site 
(the sequence 9 bp upstream of the start codon is ATCTGGGQ, but if there were to be 
weak binding of the ribosome to this sequence, then in theory, an N-terminally 
truncated agrD gene, containing the AIP sequence may be translated, allowing some 
agr signalling to occur. The strong thiolase promoter of the ErmRAM may also be a 
contributory factor, allowing transcription of the fused intron and agrD genes. This may 
explain why sporulation still occurred in the mutant (which showed approximately 102 
spores/ml). It is therefore unknown whether the agrDI gene was completely inactivated, 
and whether a greater decrease in sporulation may have been observed in an absolute 
knockout. 
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However, it is highly unlikely that this would occur, as the N-terminal of the AgrD 
protein has been shown to be vital for processing into the mature AIP to occur (Zhang et 
aL, 2004). The AgrD protein was found to integrate into the cytoplasmic membrane via 
an (x-helical amphipathic motif in its N-terminal region, which was required for 
stabilisation of AgrD, in order for processing by the membrane bound AgrB to occur. 
This region would be missing in the truncated protein, and processing of the AgrD 
propeptide would therefore almost certainly not occur. 
The transcriptional fusion issue was not encountered with the agrD2 mutant, as no start 
codon was present between the final stop codon and the AIP sequence, preventing any 
such transcriptional fusion from occurring. 
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Figure 5.15 
- 
Functional domains of the C botulinum kinase proteins 0336 and 0340, 
as analysed on the SMART website (http: //smart. embl-heidelberg. de/). The position of 
the intron insertion is indicated by the blue arrow. In CB00336 the intron inserts into 
the HisKA (histidine kinase) domain. In CB00340 the intron inserts into the PAS 
domain. Green triangles indicate histidine kinase-like ATPase domains. Small pink 
regions indicate segments of low compositional complexity. 
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Figure 5.16 
- 
Schematic diagram depicting the insertion site of the group 11 intron in the 
C. botulinum agrD mutants, along with the possible transcriptional fusions which may 
occur. In the agrDI mutant, a transcriptional fusion may occur between part of the 
intron and the 3' segment of the agrDI gene. Transcription may be driven from the 
strong thiolase promoter of the RAM. A methionine start codon found within the fusion 
may result in translation of the fusion, incorporating the AIP region. This should not 
occur in the agrD2 mutant as there is a stop codon downstream of the thiolase promoter 
which would prevent translation of the truncated agrD2 sequence. 
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There are also other issues which should be borne in mind when using the ClosTron 
system. When an intron is inserted into a target gene in the antisense orientation (as with 
the agrD mutants in this study), it is unable to splice out from the sense transcript of the 
target gene. However, if the intron inserts in a sense orientation (as with the 336 and 
340 mutants in this study), it is possible that it could splice out from the transcript, 
allowing reversion to the wild type. This would be dependent on the presence of the 
LtrA protein, which is required for the re-targeting process (Heap, 2006). It is therefore 
imperative that the cell is cured of the pMTL007 plasmid as soon as possible, as this 
ensures the absence of the LtrA protein, preventing any further, unwanted, mobilisation 
of the intron. This would be a potential problem when introducing a second plasmid 
containing the LtrA protein during the production of a double mutant. However, this 
problem is prevented by rapid curing of the first plasmid, as once the intron has inserted 
into the chromosomal DNA, it cannot be spliced out. It would also be avoided by the 
use of a removable ErmRAM as in plasmid pMTLO07C-E2. 
Another potential limitation of the system is the possible polar effects caused by the 
insertion of a RAM (Heap 2006). The ErmRAM possesses its own, strong, promoter 
which may have polar effects on the transcription of genes flanking the target gene. If 
the intron has inserted in a sense orientation, the RAM's promoter may cause antisense 
transcription of upstream genes, which may have potential negative effects on the sense 
transcription of these genes. If the intron inserts in the antisense orientation, the RAM's 
promoter may drive over-expression of downstream genes. These potential problems 
can also be avoided by the use of removable markers in the ClosTron delivery vectors. 
Polar effects on the agr regions would potentially be avoided in the kinase mutants, as it 
has been shown in Chapter 3 that these genes are not transcriptionally linked to the agr 
region genes. There may therefore be transcriptional terminator sequences between the 
kinase genes and the agr genes. Again, in the agrD2 mutant, downstream polar effects 
may also be avoided by the fact that the gene immediately downstream of agrD2 is 
kinase 0340, which is not transcriptionally linked and hopefully separated by a 
terminator sequence. However, polar effects may possibly occur in the agrDI mutant, 
as the gene immediately downstream (0333) is transcriptionally linked, and may suffer 
over-expression due to the strong thiolase promoter of the ErmRAM. 
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In summary, clearly this method of gene inactivation is not perfect, and several factors 
must be considered when choosing a target site, and interpreting results of phenotypic 
analyses. The data obtained in this study would indicate that the agrD genes are 
involved in the control of sporulation in C botulinum, but the magnitude of the effect of 
agrDl cannot be fully assessed due to the possible transcriptional fusion which may 
result in the production of low levels of AIP in this mutant. It would also appear that the 
0336 kinase protein is not involved in the initiation of sporulation in C botulium and C 
sporogenes. However, it is difficult to draw any definite conclusions on the role of the 
0340 gene. It would appear that it is involved to a certain degree in sporulation, 
according to the C botulinum results, but this gene may not have been completely 
inactivated in either species, leading to difficulties when interpreting the two sets of 
spore assay results. 
Despite these drawbacks, ClosTron technology is in its infancy, and has proved to be of 
ground-breaking importance as a clostridial knockout tool. It has enabled the relatively 
straight-forward generation of four directed insertional knockout mutants in C. 
botulinum, which has never before been achieved. The technique will also enable a 
wealth of knowledge to be obtained on the molecular mechanisms of gene expression in 
clostridia, which has for so long eluded the clostridial scientific community. 
5.3.1 Future Work 
Future developments in ClosTron technology will enable the inactivation of multiple 
target genes, and will avoid the problems of polar effects discussed earlier. This 
methodology was first documented in E coli by Zhong et al. (2003), who created an E. 
coli lacZlargF double mutant by removing the first RAM using the Flp recombinase 
enzyme. The pMTLO07C-E2 plasmid has been constructed for this purpose (J. T. Heap, 
unpublished work) but, to date, attempts at multiple gene knockout using this system 
have been unsuccessful. The only clostridial species in which the RAM has been 
successfully removed is C. acetobutylicum. Jamie Scott (personal communication) at the 
University of Nottingham has removed the RAM from mutants created using the 
ClosTron. Saint-Prix et al. (2006) also removed a marker from a mutant constructed 
using an unstable plasmid. In both cases, the plasmid used to express the Flp protein 
was one constructed by the group of Philippe Soucaille (Saint-Prix et al., 2006). This 
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would indicate that it is indeed possible to remove the RAM from a ClosTron mutant, 
and the problem encountered in this study lies with the Flp expression vector. 
Although the Flp recombinase enzyme has been successfully used for marker removal 
in C acetobutylicum, an attempt to use this method to construct aC botulinum 
agrDlID2 double mutant in this study was unsuccessful. This was due to the inability to 
remove the RAM from the agrDl mutant. The modified ErmRAM in the pMTLO07C- 
E2 plasmid was flanked by FRT sites, which should be recognised by the Flp 
recombinase enzyme. However, on introduction of plasmid pMTL5402F-FLP, and 
subsequent induction of flp expression, the RAM remained in situ. A factor affecting 
this result may be the thermolability of the Flp protein. It has been shown to function 
maximally at 35"C, and not at all at temperatures exceeding 39"C (Buchholz et al., 
1996). Indeed the successful removal of the RAM by Jamie Scott (personal 
communication) was carried out at 300C. 
Buchholz el al., (1996) also concluded that the Flp: substrate ratio played a major role in 
the efficiency of the enzyme, as did levels of its expression. Neither of these factors was 
tightly regulated in the attempts to remove the ErmRAM in this study. An alternative 
may be to use a different recombinase protein such as Cre from bacteriophage P 1. This 
protein was shown to function most efficiently at and above 37*C and is therefore 
suitable for use in hosts which grow at these temperatures (Buchholz et al., 1996). The 
same group proposed that Cre may function more efficiently than Flp in E. coli at low 
expression levels. 
Clearly further developmental research must be carried out in order to create an efficient 
marker removal system to be used in conjunction with the ClosTron. The efficiency of 
marker removal may possibly be improved by using a plasmid which expresses the Flp 
protein constitutively, which would avoid any problems encountered with induction 
times and IPTG concentrations. 
An alternative gene knockout technique has recently been developed, which may be of 
relevance to this study. Suzuki et al. (2005) developed a system for gene knockout in 
Corynebacterium glutamicum which combined the marker removal principle using a 
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recombinase enzyme, with a method of DNA removal from the chromosome using the 
meganuclease I-SceI. Bacterial genomes do not naturally contain I-SceI sites and this 
nuclease has also been successfully used in E. coli to produce knockout mutants induced 
by homologous recombination (Posfai et aL, 1999). 
Suzuki et aL (2005) utilised this system to knock out a region of DNA totalling 67 Kb. 
A plasmid containing two Cre recombinase recognition sites and two I-Scel recognition 
sites was first introduced into the chromosome by homologous recombination. On 
introduction of a plasmid expressing Cre and I-Scel, a large segment of chromosomal 
DNA was first excised by recombination of the Cre sites. This left the remaining 
segment of target DNA flanked by I-Scel sites, which was then cut by the I-Scel 
enzyme, resulting in the excision of a large portion of DNA. The fact that all 
recognition sites were removed during the process meant that the method could be used 
repeatedly to remove subsequent portions of DNA. This principal could ideally be used 
to produce knockout mutants in clostridia, where the target gene was not merely 
interrupted, but entirely removed. This would circumvent problems encountered with 
polar effects and incomplete inactivation of the target gene, and would also allow the 
investigation into the ability of the 0340 kinase mutants to initiate sporulation. The 
whole kinase gene should ideally be removed using the above method, and the 
downstream portion containing only the histidine kinase domain inserted in its place. 
Subsequent spore assays would confirm whether that portion of the protein is in fact 
able to initiate sporulation, and would ascertain whether the 0340 mutants constructed 
in this study were 'true' mutants. This is clearly a technology for the future of clostridial 
gene knockout. 
Finally, it would be of great interest to investigate the ability of the C botulinum 
mutants to produce neurotoxin. Along with sporulation, this is a major virulence factor 
of this organism. Toxin is produced temporally throughout growth, but reaches maximal 
levels towards late exponential growth (Rao et al., 2007). Considering the agr system in 
S. aureus is involved in the control of toxin production, it is a distinct possibility that 
this is also the case in C. botulinum. Indeed Sebaihia et al. (2007) postulated that, since 
maximal neurotoxin production takes place in late exponential and early stationary 
growth, 'it seems likely that neurotoxin gene expression may be subject to quorum 
sensing'. 
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Another area of investigation should centre round the relationship between toxin 
production and sporulation. In some clostridial species, for example C perfiringens, 
toxins are produced in association with sporulation (Mitchell, 2001). However, it has 
been proposed that, in C botulinum, the highest levels of toxin production were 
generally found in cells undergoing rapid autolysis, which did not sporulate (Davis et 
al., 2000; Schantz & Johnson, 1992). Furthermore, Roa et al. (2007) also demonstrated 
that, although type A toxin production was maximal towards late exponential growth, 
cells were yet to sporulate at that time point. This suggests that in C botulinum, 
sporulation is not a prerequisite for toxin production, and there is a possibility that the 
cells either carry out one of these processes or the other. Indeed, in B. anthracis it has 
been demonstrated that when cells were cultured in toxin-inducing conditions, 
sporulation efficiency was significantly reduced in comparison to B. subtilis under the 
same conditions (Hadjifrangiskou et al., 2007). In addition, Takumi et al. (1980) 
isolated non-toxic variants of type AC botulinum and demonstrated that these 
exhibited enhanced sporulation. It would therefore be interesting to observe whether the 
C botulinum mutants in this study, which displayed a reduced ability to sporulate, 
produced toxin at higher levels than the wild type. This remains to be investigated, as 
facilities for a neurotoxin assay were not available at the University of Nottingham 
during this project. 
Currently, methods employed to assess toxin production are Real Time RT-PCR and the 
mouse bioassay, both of which are time-consuming and expensive. The Clostridial 
Research Group at the University of Nottingham is currently establishing an ELISA 
assay which will give a rapid and quantitative measure of neurotoxin production. 
173 
Chapter 6.0 
General Discussion 
Chapter 6- General Discussion 
6.1 Introduction 
The role of quorum sensing in the control of virulence factor production in C botulinum 
clearly needs to be elucidated. Due to the serious nature of the disease caused by this 
organism, it is imperative to understand how its virulence is controlled, in order to 
develop suitable preventative measures. The aims of this study were to establish that a 
functional agr system exists in C botulinum and to investigate the nature of its 
mechanism of action. In order to determine which processes the system controlled, an 
effective gene inactivation tool was sought. 
6.2 A functional agr system in C. botulinum and C. sporogenes 
Before the commencement of this study, there was no published evidence to suggest 
that C botulinum possessed a functional agr system. The genome sequence clearly 
confirmed the presence of two agr regions but it was unknown whether they were 
actually expressed, and what their mechanism of action was. 
Sequencing of the C sporogenes agr regions, along with subsequent analysis revealed 
that the genes of the agr systems were well conserved in the clostridia included in the 
analysis, particularly between C botulinum, C sporogenes and C perfringens. Some 
similarities also existed with the staphylococcal agr genes, particularly agrB and agrD. 
Alignments of AgrD proteins from S. aureus and various clostridial species revealed 
that a putative AIP was present in the clostridia, which showed some degree of 
similarity to the AIPs produced by the four S. aureus groups. Most importantly, all of 
the clostridial proteins included in the alignment showed the presence of the conserved 
cysteine residue, known to be essential for formation of a functional AIP in S. aureus 
(Zhang et al., 2002). There is also some evidence to suggest that putative processing 
sites are present on either side of the clostridial AIP sequences. This was the first line of 
evidence to suggest that C botulinum and C sporogenes do indeed possess agrD genes 
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which could potentially produce a functional AIP. However, since the AgrD and AgrB 
proteins in the two agr regions of C botulinum and C sporogenes were quite different 
(possessing approximately 40% protein identity) this suggested that the two agr systems 
could function independently, and may have evolved separately. The fact that there are 
two separate systems present renders the elucidation of their function more complex. 
Although comprehensive sequence alignments and BLAST searches were carried out, a 
definitive identification of agrA and agrC genes in C. botulinum and C sporogenes was 
not achieved. This could be because the agr systems do not directly utilise a two 
component system, but it is also possible that signal transduction takes place via a 
slightly different mechanism to that observed in S. aureus. Indeed, there are several 
genes, whose allocated function was related to signal transduction, found in close 
proximity to the agr genes. However, their involvement in the C botulinum agr system 
was not elucidated in this study. 
The second line of evidence to support the theory of a functional agr system in C 
botulinum and C sporogenes was obtained from transcriptional studies of the C 
sporogenes agr systems. RT-PCR experiments indicated that the genes of the agr 
system were indeed expressed. This had not been previously confirmed and added 
evidence to the theory that this system is indeed functional. The genes of agr region I 
were shown to be transcribed together as an operon. This corresponds to what has been 
previously demonstrated in S. aureus, where the agr genes are transcribed together from 
the P2 promoter (Novick et al., 1995). However, the agr genes in region 2 of C 
sporogenes were not found to be transcribed together. The two orphan kinase genes 
flanking the region appeared to be transcribed separately from the agr genes. This 
would suggest that these kinase genes are not involved in the agr response, and indeed, 
later studies (see Chapters 4 and 5) suggested that these genes could in fact be involved 
in the control of sporulation, and might be implicated in the equivalent of the 
phosphorelay system of Bacillus species. 
Finally, Real Time RT-PCR was used to demonstrate that the agrD genes were 
maximally expressed towards late exponential growth. This also corresponds with what 
has been previously demonstrated in S. aureus, where the agr system is maximally 
expressed towards late exponential to early stationary growth phase (Yarwood & 
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Schlievert, 2003). Problems were, however, encountered with the Real-Time PCR 
experiments, which were likely due to the high AT content of clostridial DNA. This 
necessitated the use of the Absolute Quantification method, rather than the Relative 
Quantification method, but this has also been used by other groups attempting Real 
Time PCR on clostridial DNA (Couesnon et al., 2006; Kouguchi et al., 2006). 
The data obtained from this study gave clear evidence for functional agr systems in C 
botulinum and C sporogenes. This evidence then needed to be taken fiu-ther in order to 
ascertain which functions these agr systems controlled. 
6.3 Gene modulation techniques for determining agr function 
In order to assess the function of the agr genes, it was necessary to inactivate some of 
them, allowing the appropriate phenotypic tests to be carried out. Historically, the 
inactivation of genes in the clostridia has been extremely problematic, with only the 
occasional report of such an achievement. Alternative strategies were therefore sought. 
The first of these was the construction of an integrative vector, which would introduce a 
mutant copy of a target gene in the form of an unstable single stranded DNA species. 
This would potentially integrate into the host chromosome by homologous 
recombination. 
Several problems were encountered with this methodology. Firstly, it proved impossible 
to conjugate the plasmid into the target organism 
-C sporogenes. This was possibly 
because of the highly unstable nature of the plasmid. Eventually, conjugation into an 
uncharacterised mutant of C sporogenes proved successful, but was not ideal, as the 
mutant strain appeared to stabilise the plasmid, which conflicted with the overall 
strategy of using an unstable plasmid. After introducing a knockout cassette into the 
integrative vector and attempting to induce recombination with the chromosome, the 
nature of the recombination event which had occurred could not be determined. This 
confirms that the use of these types of vectors for gene inactivation is not ideal, as it is 
almost impossible to predict the recombination events which may occur. It has been 
previously shown that the occurrence of recombination events is highly unpredictable 
(Gruss & Ehrlich, 1989). The fact that the mutant strain of C sporogenes used was 
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uncharacterised also contributed to the complexity of the methodology, as it is possible 
that some unknown mutation in the strain was responsible for the unsuccessful 
recombination. Few groups using unstable plasmids for the purpose of gene knockout 
have induced predictable recombination events. In summary, this method of gene 
inactivation is not the method of choice and in this instance was unsuccessful. 
Another method of gene modulation employed was the use of antisense RNA. This 
method has its advantages in that it does not give absolute inactivation of the target 
gene; protein production is merely down-regulated. This is ideal for the study of 
essential genes. Another advantage to its use was exploited in this study, where an 
inducible expression vector was used for antisense delivery. This means that the time at 
which antisense production is induced can be controlled to a certain degree, although it 
was shown that some antisense expression was still allowed to occur in the absence of 
induction, due to the use of a 'leaky' promoter in the vector. 
Disadvantages of this technique include the difficulty in interpreting phenotypic assay 
data. The fact that the target gene is only partially inactivated means that the full 
magnitude of its inactivation cannot be assessed. An absolutely quantitative result 
cannot be gained, as there is still some target gene expression occurring. In order to 
obtain a quantitative result from phenotypic tests, the gene would need to be knocked 
out. A further disadvantage to the technique is that it cannot be confirmed whether an 
antisense fragment is only acting on the intended target gene. Indeed, in this study, 
genes were targeted which show significant regions of homology with other genes in the 
agr region. For example the antisense fragment designed to target the agrBI gene in C 
sporogenes could also have been acting on agrB2. This could also be the case with the 
two orphan kinase genes (0336 and 0340). Again, this should be borne in mind when 
interpreting phenotypic assay results, and ideally, a targeted knockout mutant should be 
obtained. 
Nevertheless, the construction of antisense 'mutants' gave extremely important 
preliminary data, which suggested that both the agrB genes and the 0340 orphan kinase 
gene were involved in the control of sporulation in C sporogenes. Previously there had 
been no evidence to suggest a link between the agr system and sporulation in clostridia. 
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6.4 Construction of targeted knockout mutants for determining function of the agr 
genes 
This study has produced the first ever documented targeted knockout mutants in C 
botulinum using the newly-developed ClosTron system. This technology has 
revolutionised clostridial gene manipulation methodology and has the potential to be 
used in any clostridial species. 
As the agr system in S. aureus has been shown to control the expression of a number of 
secreted virulence factors, such as haemolysins, toxic shock syndrome toxin (Otto et aL, 
1998) and coagulase (Novick, 2003), it would seem appropriate to assay for secreted 
proteins in the C botulinum and C sporogenes mutants constructed. Collagenase assays 
carried out on the C sporogenes antisense mutants failed to yield any definitive 
conclusions. Furthermore, the facilities to assay botulinum. neurotoxin were not 
available during this project. It was therefore decided, as an alternative, to investigate 
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sporulation. Although this was not the ideal phenotype to test for, considering it was not 
connected with a secreted virulence factor, the assays did in fact provide some hugely 
important data on the control of sporulation in C botulinum and C. sporogenes. The 
knockout mutants produced have allowed a link between the agr system and sporulation 
to be established for the first time, and have indicated that both of the agrD genes in C 
botulinum are involved in this process. 
However, this study has also highlighted that the ClosTron system is not perfect, and 
that the nature of any target genes should be fully assessed before attempting to 
inactivate them using this methodology. The orphan kinase proteins targeted in this 
study exhibit a number of different functional domains. It became apparent, after mutant 
generation, that the position of these domains in relation to the intron insertion site may 
have an effect on the efficiency of inactivation of the gene. It is possible that some of 
the domains of the protein may still be synthsised and hence be functional. In the future 
generation of such mutants, this must be investigated before commencement of the 
procedure. 
This issue is also relevant to proteins which are post-translationally processed, which is 
the case with many signalling molecules utilised by Gram-positive bacteria (Fuqua & 
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Greenberg, 1998). In the construction of the WDI mutant, the group II intron was 
inserted upstream of the AIP sequence, which allowed the possibility of some low 
levels of transcription of the AIP sequence, resulting in incomplete inactivation of the 
agrDl gene. 
Despite these drawbacks, the data obtained from the mutants generated in this study has 
indicated that the agr system is involved in the control of sporulation. in C botulinum, 
which has not previously been described. 
Data obtained from the kinase mutants has indicated that the 0336 kinase is not 
involved in the control of sporulation in C botulinum or C sporogenes. It would appear 
that the 0340 kinase gene may be involved, but the degree of involvement could not be 
determined for certain, as it could not be confirmed that the complete inactivation of 
these genes was in fact achieved in the generation of the insertion mutants. 
6.5 Summary and future work 
This study has allowed the characterisation of an agr system in C botulinum and C. 
sporogenes, of which very little was previously known. It has indicated that one of the 
cellular functions controlled by this system is sporulation 
- 
an essential survival 
mechanism in this organism. This may contribute to the future development of control 
measures against foodborne botulism. 
Results obtained in this study also indicate high similarities between the agr systems in 
C botulinum, C sporogenes and S. aureus, including the timing of the expression of 
their genes. This may suggest that virulence factor production is controlled in a similar 
manner in all three organisms, although a two-component system has yet to be 
identified in C botulinum and C sporogenes. 
There is huge potential for future work on this project. It has yet to be confirmed that a 
diffusible signal molecule is utilised by these agr systems. In order to confirm this, the 
peptide should be purified and further characterised to compare it to those produced in 
S. aureus and other Gram-positive bacteria. This has recently been undertaken in 
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Streptococcus thermophilus by Ibrahim et al. (2007). This group have begun the 
characterisation of a novel quorum sensing system and subjected S. thennophilus 
culture supernatant to HPLC analysis in order to search for signalling molecules. 
Sequencing and mass spectrometry was used to further identify these peptides. They 
focussed their study on a new modified peptide termed Pep1357C and found that the 
production of this signalling molecule required the activity of both a transcriptional 
regulator and an oligopeptide transport system. This is clearly the next stage in the 
investigation into the agr system in C botulinum. Either natural or synthetic peptides 
would ideally then be used in complementation experiments to demonstrate the 
restoration of sporulation to wild type levels in the knockout mutants. 
The addition of wild type supernatant to the agrB antisense 'mutants' failed to restore 
sporulation in these strains, but as discussed previously, antisense mutants are not 
simple mutants and a much cleaner picture would probably be obtained using knockout 
mutants. 
Since a link between the agr system and sporulation has been demonstrated, it seems 
likely that other late exponential phase processes may also be under the control of this 
system. In order to confirm this, microarray analysis should be carried out. This may 
also indicate how toxin gene expression is affected by knocking out the agr system. 
Along with sporulation, toxin production is an important virulence factor in C 
botulinum, and the inhibition of its production could also lead to the development of 
effective control measures for use in the food industry. Toxin production in many 
clostridia is maximal during late exponential to early stationary growth (Dupuy & 
Sonenshein, 1998; McClane & Rood, 2001). Since the agr system has been shown to be 
maximally expressed during this phase, it is possible that it is involved in the control of 
C botulinum toxin production. Microarray data would also indicate whether expression 
of the botR gene is affected by knocking out the agr system. This sigma factor has been 
previously shown to up-regulate toxin expression in C botulinum (Marvaud et aL, 
1998b). 
It is not known what effect inactivation of the agr system may have on toxin production 
in C botulinum. It has been shown in some clostridia that toxin expression is 
sporulation-dependent (Durre & Hollergschwandner, 2004) indicating that a reduction 
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in sporulation in the agrD mutants may result in a reduction in toxin production. 
However, in B. anthracis, it has recently been demonstrated that, when this organism is 
cultured in toxin-inducing conditions, a reduction in sporulation is observed compared 
to B. subtilis under the same conditions (Hadjifrangiskou et al., 2007). This would 
indicate that this organism makes the decision to either sporulate or produce toxin. The 
explanation offered was that the bacterium may maximise toxin production when 
needed (i. e. during infection in the case of B. anthracis), whilst maintaining the ability 
to sporulate if a change in environmental conditions necessitates it (Hadjifrangiskou et 
al., 2007). It can therefore not be predicted which would be the case in C botulinum. 
To confirm for certain whether inactivating the agr system resulted in a change in 
neurotoxin expression in C botulinum, toxin assays should be carried out on the agrD 
mutants. Unfortunately, facilities for carrying out such an assay were not available at 
the University, of Nottingham until after the completion of this project. 
Another obvious area of this project to be continued is the construction of an agrD 
double mutant in C botulinum. This would indicate whether the agr system is essential 
to the cell, and would provide interesting information on whether the complete 
knockout of both systems resulted in the total abolition of sporulation and/or toxin 
production. Complementation vectors could also be introduced into all mutants 
constructed in an attempt to restore a wild type phenotype. 
Finally, there is huge scope for the investigation of the mechanism of sporulation 
initiation in C botulinum. Initial experiments in this study have indicated that kinase 
0340 may be involved in this process in C botulinum and C. sporogenes, but the nature 
of the mutants produced needs to be confirmed, in order to ascertain whether this target 
gene was truly inactivated. As discussed in Chapter 5, I-Scel technology could be 
employed to completely remove this gene, giving a clearer picture of its function. 
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Protein alignment of C botulinum and C sporogenes 0330 
MLFLVVEFVARA12FAFLLIFAVY7FSNT FMN-, (FNYLLS Ma"Ori*. y 
10 20 40 
:MLF1, 
-VV 
ý' T, V"PA 
-1 
L, EAF1,1,1 FAVYTFSNT LTI M t! Y. :KNYLLc. spor0331p. PRO 
VEFVA-, AI YLK1,1 [P EAFLIFAVY5NTKMNKKN1,1, oct 0331. PRO 
SFLM. L 
.1MIFSL El ISYS1HTILS1MV1.1 LLS; Y11ND Majority 
50 60 70 80 
5T"T'- 41 I-S F 1,1 I. T. MIF pý$yG7L ýS ý V. VLIJT LL3YIý ý' ýa_l DI C. spor033! p. PRO 
41 1ý 14 LTMIFIS 
_'PTSYG_-'Tr LSIKV"rLLSyI 
-IT _N 
D 0331. PRO j bot 
VIFAVKSTIVT II LQL ICEGTN I Fl IQY 1 LKEDIXNH 1 FKD Majority 
90 100 11 120 
81[VIMtAV 11, ýý TT 
III 
TI ILFý. ý LtC, F, ' rTNI L' ýI 'ý Y1 'ý X-E 0M t4 9ý F' KrN C. spor0331p. PRO 
-J 1LQ, LIGTNIFIIýYIL Fl, KNL. M Bi BI FFR.! ý bot 033 1. PRO LR4, VTIVTT 
PALKTIYG. PSLIIFACIIVLRYIR 1- LFREELQYD- 
130 
Yu-. PSLI I FAI- 
FAY 
Protein alignment of C botulinum and C sporogenes 0331 
Majority 
C. spor0331p. PRO 
bot 0331. PRO 
201 
Protein alignment of C botulinum and C sporogenes AgrB I 
MKKLSKKVLMLVATFTTLLASVVASSACVWCVYQPEEPKC MaDor, ty 
IIIr 
i0 20 30 40 
41 
-Lý 7777-ý-iF I, vmT, FTT1, LASII ýv A 'I "! A Cý -Y-w fl. vYQ, qLlr, P F, bot agrDI. PRO ý' Pý M LVATFTTL: T-A S'-" C. s porAgrDIp. PRO IMFFLv.. v T, vwc V-Y c KI 
LRE Majority 
41 ý! IR Z ýý' 
. 
bot agrDI. PRO 
41 [ý- REEC. so orAgrDIp. PRO 
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MSDVGDDKRNQIKDIVSVVKLSSLLFSAIAIFKRFFSGNSSALIYSNNYSH. j. -ty 
10 20 3 40 50 
I IN SIK MQDD KI 
---INDIV SIT IV KL $JMJ1, Lr3A III F; F KR-F Fly YN Nit Y SI- -LYJY C. spox 0333 
1 LDýN ýNN LK RNQINN 
-I 
VSVVRL CS LL_r -. NND 
Uic 
K ýN ME hot 0333 
__" 
IA j'F K C', F Far 
AL 
_* 
IVSTVVLLFLLIYGIWAFLTTNKrSGRYIKRVYI. IENLVLILLILVV majority 
100 
46 
E; 
ýýýV V L, LFLLrYGIWA L" PKN NJ R LI S! DýR y F. N! I rji i 
Er, C.. por OD! 
F9r r[vLý6 b., 0333 S I. I YJ`CýT W 
'r FLTTN Ký F R'G R YrNJIK R] LLY IT NJ I 
[V L 
yT"! V 
YýF 
M 
VLGSGTYASEYKFLFLFIIIITTIQIC, MKQC, IIIACT. A5LIILIM I) ýVcA majority 
110 120 130 140 150 
411 
96 T 
_H -T 
lýS 01 CJY ASIYKFLFLF11rITTI OA_G MK-0GIIIACLA 
11TAKF 0L 
_J 
TLG 
__ _ 
Jt 
, 
-Z 
T Yý G Yý s_FQ 
_Y 
KFLF ? 
I. 
"k jjIQ,. --K YlG IIIACLA 
*NLVVNEYFEQDLILAGVFIL:: AWPLGFYVKVESEHiRKESLVNKDGLT majority 
T, 
160 170 180 190 200 
146 QDLrL, AGVFILTAWPLGlryvxvz SER ILKIK La5LVXKDGtTC. pr 0331 
151 LAGVrI LTAWPLGFYVKV SWBUIRILES LVMKD0LT bo: 0333 
*VYNHRFFHDALSKEVIECEEKNEAL5MIF1 1) 1 1) YFXHYNDLYG 11 0KGDQ Majority 
210 220 
-1 
3n ý40 250 
19' VYN21, F"HDAL5K BL_, ý. ... LS. i,, 01DYFIHYNDLYGRC.. p- 03JJ 
201 rD VYNRRPFHDALSKRVIaC3x9x2AL IS KIPIDI DYFRRYN DLYGRQKG 1ý QJ hot 0333 
VLKTIGEILKNNTR9EDIVARYGG9RFAVLLPSTS9EDAINTAF. KTRKKI Majority 
2tD 2 
;0 
280 290 300 
246 LKTIGEILKNNTR' It 9DIVARYGG It 9F A[111, LFSTS9 X", ýJA rWIAEKI FLI RJKJ_T C.. p.. 0333 
R 13 JL 251 V, 
LL 
KLt DIv NLT SB; AINIA It KIK 1IJ ! 
-LI), _u 
LT 
_Rý 
it- YGG9 
_S 
1r AVLL W1 
__BfQ 
I hot 0333 
EYTYFEGEENQPNGNLTVSMGISVYPYKATSDMZLIKSADDA1, YRAKFTN Majority 
310 3U 330 34L, 35) 
jL 
296 Fs YTYFFGZRN0PNGN1, TVSMa13vYrYKAX5 1) MRL195ADDALYRAKFF N' C-poi 03ýU 
301 JE TYFa. 9 EN 0 PR GNLTVSMGISVYPYKAK5DMFLTKSADDA LIHAKFFNý: b- 0333 
XNRVEAYTSILDELKKDIDEEHIDLVTSIK1LISVINAKDRYTYGHVERV Majority 
360 370 360 390 400 
3461K NRV9AYTSILDKLKNDID 'E, LIKJ HIDLVT31KTI. ISVINAK. 
Al 
C. 3p. 9 03n 
351 LK NRVEAY T-A L09LXNDID9 Is RIDLVTSI hot 0333 
V 1. Y 
.5RLLADKLKLSAEDKXIFIYGAYM IT DIGXINISR91LNKKMPLAK93 majority 
4.0 420 430 440 450 
A 
.4 396 7L Y3RI, LADKX, KL3ACDKKIFIYGAYKH31 LNK KNp 111: K Cal c. spor 0333 01KI15R 
401 I: V T. Y_g 1ý L 
_L 
ADK ]i 1ý LS]EII-B DK K]NIP-1 Y 
ýG 
A Y-M HDIG R-1 
:_ 
ISR IILNKXMPLA It E 81 hot 0333 
WEI I. KQF. pvNGVEIIKpVSST. ýQNTsDLI LHHF. ERYDCKCYFDNI KGUN IP majority 
40 470 460 ; 90 500 
1, cL, p 
446 31L9QHFVNGV9119PVS51, QN15E, LILHH8aRYDGKGYP D[N LXGDNI 1ý1 C. spor 0333 
451 
ýw 
IaHVNGV Is IIXFVSSLQNISDLILHHHZRY 1) GKGYPD KIL KGDNIh., 
rtARALTVV DS FDANTS NRP YNR RKTYE: EAT 98 LK R CSC. TQFLISY I AZKF Majority 
510 5; 0 5 4'0 550 
496 FF LARAL7VVDSFDAMTSNR 
IP 
YNRRKTY9ZA19ELK"C8G10F08YIA8KIa pr 0331 
50 1ALTVVD5FDA pt NRPYHRRK7YaaP, IFaLFR5b. 033 3 
_T5 
___A_ 
CA GT Or D sK 1 .1 11 
IEVI: ENKDsFEnL. SLL Majority 
560 
.1 
rL 
146 11 RVIIRNXD 
.1DDLS L' C.. p.. 0331 ýL 
551'1 Zvi I EKK_DS D-D LLL hot 0313 
]L 
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MFKLSILEFFLIAIPESFIFT-IGI YFLS KRFFDKKRL I-IM Majority 
I r- II 
10 20 30 40 
1---------- 
-- 
------------ 
_IMI 
C. 5por 0335i 
i rNFK. 151 Z. EFFLI AI PES FI FTI G IYELS KRF FDKKRL 1 IMI bot 0335 
ALLSAVEIYWVRMLPIHFGVH LGINI IFLILVSVNIGKI S Majority 
50 60 70 ýO 
2 JA L LIFJAýI. EýSýYr,! v RMLPIHF G[I]H LIA! I NII FLS 
_IILI 
JV, S VNIGKI Sl C. spoz 0335ý 
41 S IL L3AVBIYWVRMLPIHF., G v- 
J. 
I IG INI I-F-L ILL ýS VNIS bot 0335 J 
IKDAISYNMVMIIILSISEFVGIFVLINVFKINRSLL3LT Majority 
II --T- 1 
90 100 110 120 
42 11 Ll C [I SEFVFVL IIKJV FKINRSL, L SL TI C. spoz 0335 JS]l 
- -IS LJI - 81 MIJ IL S]T'S E FJ I ýG IFV L[Y LN ILF KI NFM KPR bot 0335 
SLIKVINFIPSFILFAFSVFLINKFIDREEQCNNI- Majority 
I11 
130 140 150 
1 
"1 1 -77 82 PI N]K VINFI PJYIF ILF ; ýT[7NJV FLINK FIMýD WR K[Q CNNIC. spor 0335 
I --L -LF LF --- 
--L 12 1 fS LI KI I FY F_l PS 
-EFT 
 11 
_JVIF 
SV F[T MIN KFINREE bot 0335 
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Y. 
- 
fl', LDKIEI KNWSHCF1NSM-IVKFIILLFCCGA 
-- 
YLM. jority 
10 11 46 
9 a: MLIVk, vIII. L b. cl v 4' A 1: ýY_ Ll C.. p. r0336p. PRO L 
M, I NSMLI VýK. F 114G 0336. PRD 
-)L. 
LJ bot 
YNFFALLA: IIIC1, V Z; VYLIWHFISI Majority 
50 60 0 90 
39 Llij FYFDA1. K 1. ATTT7CL! Tll Y"TK fl FISI C-p-033EP. PRO Y 
-IJ 
EF Lt- K LDC 
41YAEFN, N: K ý'q S"Q! N F Yý - K'A 
7 L jll ICIv3V yf. 'Jý 6' MtI bct 0336. PRO 
KAFF 
-' 
E F. IKvvLNi111TVIM3 :ýSY<E Mýjcýity 
90 loc ilo '20 
79 ýF A? KI. JK, F IKIQVENIt [F T ", 11MSGn? Pt SiKp L4 C-p-0336p. PRO 
-7 =, I Tý- IsS1FL LLL 3336. PRO KK 81 LF ý7f, FIQV-ENVIF- ý-fmý! q G 
FLATITATQL-, XF41AT. V rý I-V A-t 11 APKAP Majority 
130 140 160 
119 .11 TtTJT 19 To, C, V. xly'. ýý TJ T A1_1W Z : ýL-Jý VLATp:, ILAPKAC. spor0336p. PRO LL: 
II TJ SVSIIIA111P, Y, 
11 1LsL r) L. bot 0336. PRO 121 111TATI 0-k, P. 
-M 
K -H, PA1? FK 
-L, 
-1 -] 
VNVYFETDLILVGVF1 11 TAWPLGYYVNTQK -1 r. T, RQKEEEV Majority 
110 180 19D 200 
-. 
t* g-t± 1). C. sporO336p. PRO 159 V,. x10; Ký5: -L R091E EVI 6 1M14 A- it 11 Zý'G-Y. Y: v HIKEbLR2KEF.. E v] bot 0336. PRO 
N 
-- 
LATELDQKEMQKTYMEQLLIKNENCYLLIKNSKDAL Ma]ority 
2-0 22D 230 240 
199 NI Li f i, V0KZMQXT It H k' 
,0LL1KNFNZINLLIKNsKrAC. sporO336p. PRC 
201 N-i LýA NK LLD ýKEMJ RON EM ýJK Fcýý F0 L- L 1, ýý NFNCYNL LlfR,, N SKDA Lý být 0336. PRO 
VHRFGKIIFANLRAKQMLGYKEEYNFErT 1) 1KST. IPKGEY Majority 
23 26) 270 2eC 
239 VAR T1 D11, I! FA. 14 EAA90MLGYKEN ýy N. F E oLrJD 
, 
. 
(LL IPK Cý EYC. ýp-C336p. PRO GKft 
LL 241 IV i RfY :. 
-F 
ANE RFL K 
_Jk 
MLGK KýK Y wf, )Li-yj bt 03--6. PRO 
8TVFKK1, FD1, YYGSENVVNFQHGV1FNKEXKTIQNTSTYV maorlty 
290 300 31C 320 
279 [4Z'--Z -1 1 l< R KI F 
_ýD. 
LY ! 
-L5LNJýý 
NLT rKHF, %" NK 'a ;<F. K9TTZ, NTr, TY V1 ý., p-0336p. FRO 
281 N T[V_K NE LE-IN LYY Qz ENNF 
-q 
liFN [Yýl t4 
. 
14 KE iý, - IT IV být 0336. PRO 
-ýT. ý-TAA 
Ii 'M ýTVLSLHDV-SQV rý K 14 TFNF5REr. ty Ma]o 
330 34C 31C 3EO 
llý 777- M. PTVLBIL 71, 
. 
ýJT sf0vrZ, eLvKNIEi I- NE!; R, ki C. spor0336p. PRO 
ý2C 
-, 
fi :ýt. 2TIF51LF. DV7SLK E) VKNIEL1. ljý fýi boý 0336. PRO 
YN 11, LT -- FL SN IShýLIFNVIiTAVQLLCYDVDYE Majority 
3-1c 380 390 400 
359 7X K F, T9fL$NISHELKTrL it VIAV91,4, G por3336p. PRO 
360 YNKIT9FL8NISHELVTPLNVIFTAV0L LF1712 ý 0336. PRO 
KEDKYLKL, KQNCYRLMKLINNLLDTTKLQ5GYLKLNLVNH. J. 
-ty 
41C 4, ' 0 430 440 
399 M ýK LIN tý 
I, L 1,15 SC It t KT. RLV tall C,. p.. 3336p:, PRO 
--L P 4001. 
F. 
111.1ý 
I., 
: 
'N 
I- 
ylý RýL 
LA N N-L LDT TAI: 1" DS4Y 1ý1ýR LNLV IN oot 0336. 
_J 
YNTVSTPFTTT, SVTSYA Tý SKr. INIIFr. ' TEVEEKVIAVDT Majority 
450 4Q 470 00 
439 1VSI, IFPTPVIPYAý. q kl-ýJ! NTTFr T'N 291rY, V DIP C-p. r0336p. PRC 
440 ý. )C -FF. T t, ýrl oot 0336. PRO N. IVEE17LF 
-'V 
'1 8YA8K 4ý 7NITFt, TE I- Iý V6 
F. IEPIL 14 1LS tý A1FN5GNIFVNV 11 CEENVYVHVK Majority 
493 51C 5; 0 
1 
.1 479 F. R11, LsN L"I FNQ, QFVNVýU8Et;, YV ýi Hv KI ý-pýr0336p. PRO 
R1 14 LL 
.3N. AIFF, N-2 N 'I FV4-WýSEE. ".. 
-V 
yvýJK b, t 0136. PRO 
-ý, G ,---- 
LIPLýf--E 
--l KTNKEII-. IC1. F :. VK YýJ-Ly 
ý30 40 550 560 
1 ýr '7 v C; IPE 
's 
17FRt. F01C; rC336p. rRC, 
:cTGv., G. I g. A 
-D-3ý L E_ 5- 1FERFF0Tc 
cllf-pRn 
FVFMHNGEVTINSELGKTLLF, LPAICEt; NIKSKNV Majority 
570 580 590 600 
559 5MvII,, K [N I F, SXW, 1 C. 
--pom0336p. PRO 
v Emiq IN bot 560 
!SFS 
Qý KSY, 11 V 0336. PRO 
VYFýNERINMSDITQ Majoýity 
6C 
iYEANRPINHFý01r0C.. por033bp. PRO 
60 
-3 TYF 
.4N7F. RF-; M P-. FIII bot 0336. PRO 
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MRLTPEAFLFI Fl 1 QAFSNSK INI(SKYV:. S SI LLAVI I YS Majority 
10 20 30 40 
M! 
-------------0AFS 
WRýg TNX9 ;(Y; ,L IET 12 1LLAI LM Y 21 C. spoý 0337. seq 
1VR-ýP ý- AFLFI-F1.1 QAFS 14 7KINYKYVLSS -- LF S[V 
.11YS bot 0333. PRO 
IRLLPIHYGVHTI LNIIAI ILICIFINEVAT I KAITYSLI Majority 
82 1LNTI 
-A ITTIKTý3 c-spor 0337. seq 
41 1RLLPRYG 'TI-NTA. -ý- I, I -, rTJ FIN! LV AFIKAYS ht 0337. PRO 
L'16 FLALSEALN 
-; YLIYKI FGEN IAN I LIJS F LKKCI YAMP Majority 
90 100 110 120 
-1 202 LALsz, LN1, YII, I lz Fýý rý K '41 T [A. NtLNIP Ll R :KCIVA P4 P1 C- spor 0337. seq 
81 
ilim 2 
'f F[1YF -ý ý' G- ýýI ,--- LVSýLAl,. 3---P, L, N- il II LfK [g PMP rF I_ 
_ý! 
FK I- YFL tot 0331. PRO 
SIAVLVIVVLLIFKINDRRVKDVFD Majority 
130 141) 
11 
322 ý5 1 Al I !, [Mjl VVL,, FIIFYINN: R RVKDV Fly C. spor 0337. seq 
12 1 
ý2 ý11 r bot 0337. PRO 
,V L7 IPY, 
-TJK 
D RE VKD; FD 
Protein alignment of C botulinum and C sporogenes 0337 
MFL1EKLSNKIGSEIASNLSL 1) K 1) TEEIIA 'ý GAFVVLQTL4.3-ty 
10 20 30 40 
I 1M F LFF', 1EKI: SNT, I C--s NL SýFJD 11. DT ILI Y ý' A iy V 1,0 TLC. sporAgrB2p. PRO 
I ýM FL ý_ ý--R ELTS N 
LS 
IIT-! - bot agrB2. pro 
-K 
IGN FT AN LK LýE [1ý D IN DTEE. 
L-A, 
Y JS-: L Fis 
IALLCVAILGMCr; VLVESVIALTAAAYR KYSGGIEANS Majority 
50 6c 70 80 
L71 ýýF LCVLr, MC 'ý vJ FvE5! IJ 1 LIS rS IA; IYRWYSC, 1ý IHAN Js C. sporAgrB2p. PRO 41 
.- 41 WFA LICVVLGAMCNVLVE 1z VIAT 11, : 1, AYYSCIH,, A NT bot agrR2. pro 
PNKCA1LGAIVFVGLALLVKNINIGVNLIFVLrGILVFIY Majority 
90 100 lio 120 
81 ýý N 1'ý cA FJ C- AI", c VIVIL ALLVKNTNI ýJý ýN IFI ýJ TLI IIFVFý ýf, C. sporAgrB2p. PRO 
81 ýp - I_C- IfFL, 7A IFI LI! TIF I YJ bot agrB2. pro 
-L, 
-v-(-; 
7-F V-F-- ly---4 ti- Jý ýký iS 
k6ýý- -Fi. 
SYYAVYKFVPV 1) TKAKP1LDVDEILKLKKY5FLI. 31LLM, I-ýty 
130 140 50 16D 
JýSj I 
's ILLC. sporAgrB2p. PRO 12PVDT KLSjK- PIE.. D. V L Jý LF, 'L R]L L'ýýJý 15 FrL 5y 
-ýý 
'k 
*-v 
-21 
----_E 
11 ilD EILK LfR R, Y 9F FIT, ISILFF bot agrB2. pro -YIv IJY K F-vp VDTKAKPI 
1EALL I- LLYLKY 14 NIALIYYCV: AGVLWQSFTLTPAAK Majority 
IT --"r 
170 i Ili J 190 200 
.111 161 11 EILL t-: 
-jl 
1, 
-1, 
YYNNTA-I, IYt-'CVIAGv LWQS, TPAA ý'K C. sporAgrB2p. PRO 
161 IT EA11. L--_IF, ý-pA, X LL'T. Y KJ C I, L,, -- agrB2. pro 
FVFANAME Ma)ority 
210 
2 01 WIF:, YNILMEC. sporAqrS2p. PRO 
201 RIV E. bot agrB,. pro 
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*TVSVRDMSEINQSREKN1YSITCIVKLASLLFSSIILYNYVSQNNCASK Majority 
10 20 30 40 50 
ISV RjY]m SEINSRKKNIYSITCIVK LIVIS LLFSSTILYN YJ 1, iS 0NNC A[!! JK C. Spor340 
S-- 
ýR 
I 
--N,! 
K LS A_ý_k_N IYS IT Cil, ýLy KLASLLF S-sl I LY NYV5QMNCA3K C500340 
*3Y YNVALA ILLSLITSAIYLIWSFFTVKTRMFXNILFIQRI It NIFiILI Majority 
"1 70 80 90 100 
iI 
'L 1 '1 51 Y YNýTNFLAT LLSL TIM T[A, T YL IWSFFTVK TRNFKNILPI (I RIEMIfFTL 11 C. spor340 
s V] L FL' 'L ' LIT YLIW3FFTVKTRNFKNfLP19NIF Ir Iý1 51 
ýN 
YY 
_N- 
IP MILSLITS 
-L' 
CB00340 
FTI LVIMSGKYNSQYKYLFLFI I ITTTTQRGLKSCMI ISI TS SVI ILTI D Majority 
110 1-10 130 140 ISO 
.I 'L 'I 1011F TILVIMSGKYKSQYKYLFLFIIITTTI Ik GLKSG MIF r911SSVIILTIC. spor340 
iW 
-Y 
LTL F-L 11 TTTIGLKSG 
_M 
IIS1.1 9 
_S 
VIILT CE00340 JMS 1o1 LF 
-T! 
L r- GKYX 
-5 
-ýýK 
1SMANYNC1NTYFEND1,1 LSGVFILTAVSLGYYVKLC. N F. S1K7. XN1Q1. ED malority 
160 170 180 191) 200 
151 ýL SXANYNCINTYF 19 N L' L1LSGVFILT A[ 1 ýS LGYYVXLGM8S1 RjulýK M10, --(,.. por340 
151 ;LSM AN YNC IN TYF EN DL1LSGVF1LTA VA_A G 
_X 
YV K_! t eN ES 1K lý KN 19LE Di CB00340 
LNKKLNEKDSQRKY I EELL FKNr)TCYNLL JENARDAI IIH RX DK 1 VFANK Majority 
211) 220 230 240 2 50 
201 KXLNEKDSQRKYIEELLFKNDT (' YNLLIENARDAIrIHRKD91VFA(., por340 
201 
ýL 
N9KLNEKD5QRKY19FLLFKNVTCYNLL19NARDAýK IV FAN Ký *KO0340 
SAAELLICSNNAELQNLNI NS F IVý2EEQK KT KNKLk: LVYKNK TDI VCVEQ Majority 
2,0 270 90 2 qO 300 
'L .1 251 EL 11 AELQN: I !NIN! K, F IVQ, E EQKKI, K, N KLZLVYK, N KITýD 
A- 
AELLNKQKK 
_L 
R J! KL -I]C 
v it 
-51 S A-S ELLI C'S N NJ JE LQ N-L'N IN S'F iLKPQ! 
C. spor340 L 14 
kV N K[ VCV 114 CB00340 
__ý 
RL 
VIQNNKREK1NVESISTYIIYNNKPA1LSILRVIT5QKQVEKLQKDVEKN Kajority 
310 320 330 340 350 
301 QNNKREKINVESI:: T YIIYNNKPAILSILRDITS0K0VEKLQ 
301 VIQN9K R[Kýx INVESTSTYIIYNN9PATLS 
_jLE_P_j 
TS9KQ V__ýK L9 
IELLNElREYNKLIT 1) FLANISH9LKTPLNVIFTAVQILD:. YKK 1) GL3YD Ka]ority 
3,0 370 3RO 3qc, 400 
351 LLNHSREYNKLIT 1) FLANISH9LKTPLNVIFTAV91LDLYKK DiqýNjg Y- C-. P.. 340 
351 1ELLN9S RE YNKLIT 13. FLAN IS H EL RT PLNVIFTAV ;jILDLYKK Dj A LE ýY 
__jD 
CRH340 
KKEQY1KVIKQNCYRLMRLINN1, LD7TKLDSGYLKLNLVNCNIVNLVZXI Ma]ority 
II11 
410 420 4 311 4; 0 450 
'I 401 GYLKLNLVNCNIVNL: IIZ IC poX340 
4 JIK 
KEQYIKVIKQNCYRLKRLINNLLDTTKLDS 
ýý 
C- 
- 
01K EQYIKVI KQ NC Y_F! L_M R_ LTNNý LD TTX 1ý DSG YL ý )L, ý! LVNC ýIVNLV92 CB. 0340 
TLSVVYYAESKDINIIFDT1, VEEKIMAVDPDKIF. RIVLN1, :, 5NAIKFTGS Majority 
460 470 480 4qO 500 
451 ýT L5VVYYAZ5KDrNIIFDTDvEzKrmAvDPDKIRR TI I IL N 11 LSNAIKFTG3C. spor340 
451 'T L_S V_V Y YAZ S K[NII NII F-D-T-D VEEK1 
-1.4 -A 
V-D 
-P-D 
I15RI 
-V 
L N- LLS 
-W 
AIR7TG. CDO0340 
GGNIYVTVK 1) FEDSIIISVX LITý, IGIP, ýDKIENIFVKFVýl V 11 KTLRRNK E Majority 
510 52`1 530 5411 
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Agr B alignment key (gi indicates the GenBank identification number) 
Cspor Clostridium sporogenes 
Cb1 Clostridium botulinum I 
Cb2 Clostridium botulinum 2 
CP Clostridium perfringens 
Ca Clostridium acetobutylicum 
Cd Clostridium difficile 
Cbe Clostridium beijerinckii 
Ct Clostridium thermocellum 
Sagtl2-cp5 gil46019607lembICAE92765.11 AgrB protein [Staphylococcus 
aureus] gtl2-cp5"isolate="i8I 
Sagt7l-cp5 gil46019603lembICAE92762.11 AgrB protein [Staphylococcus 
aureus] gt7l-cp5"isolate="m55 
S11 gil58025591gblAAD51708. IIAF173933_1 AgrB [Staphylococcus 
lugdunensis] strain="307; RN8160 
S12 giJ2951371gbIAAA71976.11 ORFD Staphylococcus lugdunensis 
db xref--"taxon: 28035 
Si gil454795821gblAAS66745.11 putative AIP processing/secretion 
protein [Staphylococcus intermedius] 
Se gil3320008lembICAA89193.11 agrB [Staphylococcus epidermidis] 
strain--"0869.12.80" 
SS gil5l490658lembICAG25888.11 Accessory gene regulator B 
[Staphylococcus saproph)Wcus] 
Bh gil I 56160371reflNP-244342.11 hypothetical protein BH3475 
[Bacillus halodurans C-125] 
Bc Bacillus cereus 
Ef gil488262561reflZP 
- 
00287478.11 COG4512: Membrane protein 
putatively involved in post-translational modification of the 
autoinducing quorum-sensing peptide [Enterococcusfaecium] 
Efa gil293438271gblAA081588.11 agrBfs protein [Enterococcusfaecalis 
V5831 
Lp gil28272732jernbICAD65661.11 accesory gene regulator protein B 
[Lactobacillusplantarum WCFSl] 
Lml giJ470193751gbJEALl 0 116.11 accessory gene regulator protein B, 
putative [Listeria monocytogenes str. 4b H7858] 
Lm2 giJ47016461 IgbJEAL073 82.11 accessory gene regulator protein B, 
putative [Listeria monocytogenes str. 1/2a F6854] 
Li gi116412462lembICAC95274.11 lin0041 [Listeria innocua] 
mti gil492372161reflZP 
- 
00331271.11 hypothetical protein 
MtherO2000212 [Moorella thermoacetica ATCC 39073] 
Mt2 gil492365101reflZP 00330569.11 COG4512: Membrane protein 
putatively involved7in post-translational modification of the 
autoinducing quorum-sensing peptide [Moorella thermoacetica 
ATCC 39073] 
Rc Ruminococcus 
Tt giJ205155531gbIAAM23839.11 hypothetical protein TTE0563 
[Thermoanaerobacter tengcongensis MB4] 
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X 150 AF. I.. VIVNEY F3QDLILAGVFrLTAWPLGFYVKVHNEH 
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-A-Jýl Rp 
XEYTYFEGEENQPNGNLTVSMGISVYPYKAKSDMELIKSADDALYRAKFF Majority 
310 320 330 340 350 
IY YT 
E 
.YT 
IRYT 
TEYT TV 
TEK TV 5JV)G 1JAJV'fffp 299 
7i Lll]KAK SIE LIE L 'L T ,TYFEG QIE NQP NIAJNJF T-- IV JX[C 1A DDALYRAKF Ff perf 1560 100 TvFEGEENQSD PNGNLTVSM ISVYPYKAKNELIKSADDALYRAKF ri tot 0333 
295  TY FEG&ENQPNGNLTVSKGISVYPYXAKS 
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N-VXYFASTF. RVI, M-E FADITSEýSSX Majority 
620 
597 N: 
- 
IIY SID I TJO 
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Appendix 3- Reaction Profiles and Standard Curves from Real Time 
RT-PCR 
SERIES OF 10-FOLD DILUTIONS 
A typical Real Time RT-PCR reaction profile. A standard curve has been run using 
serial 10-fold dilutions. The orange line shows the threshold level. Once fluorescence 
increases above this level, it is detected by the machine. The cycle number at which this 
occurs is known as the threshold cycle. 
pl 
2--- ý- 
-4 
A typical standard curve plot obtained during the Real Time RT-PCR experiments in 
this study. This graph is of C sporogenes agrDl (green line) and 16S (purple line) 
quantitation. A 100% efficient reaction would give a slope of 
-3.32. In this reaction, 
agrDl gave a slope of 
-4.428 and 16S gave a slope of -5.073, indicating an inefficient 
reaction. 
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Appendix 4- PCR Screen Results from Chapter 5 (5.2.2) 
PCR Screen 2 on four C hotulinum and two C sporogenes mutants 
88 
%" 3 2 Kb-->-... wo %.., 0 00 ý -4 %0 ýl-i wo 1.5 Kb 'OW %MW %Md 0ww 9-9 
123456789 10 11 12 13 14 15 16 17 18 19 20 
C bot agrDI C bot agrD2 C bot0336 C bot0340 
3 Kb 
2 Kb Nod 
2345 
C sporog 03 36 
789 10 
C sporog 0340 
C botulinum agrD mutant screen: I&6,2 log DNA ladder; 2&7, genomic DNA from 
putative agrDlIagrD2 mutant 1; 3&8, C botulinum wild type genomic DNA; 4&9, 
pMTL007 plasmid DNA, 5& 10, water negative control. 
C botulinum 0336 and 0340 mutant screen: II& 16,2 log DNA ladder; 12 & 17, 
genomic DNA from putative 0336/0340 mutant 2; 13 & 18, C. botulinum wild type 
genomic DNA; 14 & 19, pMTL007 plasmid DNA, 15 & 20, water negative control. 
C sporogenes 0336 and 0340 mutant screen: I&6,2 log DNA ladder; 2&7, genomic 
DNA from putati, ýe 0336/0340 mutant 1; 3&8, C sporogenes wild type genomic 
DNA; 4&9, pMTLO07C-E2 plasmid DNA, 5& 10, water negative control. 
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PCR Screen 3 on four C botulinum and two C sporogenes mutants 
falo 4w 900 bp 
123456789 10 11 12 
C botulinum mutants 
8 
ýw 
* to 
900 bp 
234 
8 
1-4 
%W 
t9 w to b. 0 
6789 10 
sporogenes mutants 
C botulinum mutants: I&7,2 log DNA ladder; 2, genomic DNA from putative agrDl 
mutant 1; 3, genomic DNA from putative agrD2 mutant 1; 4& 10, C botulinum wild 
type genomic DNA; 5& 11, pMTL007 plasmid DNA; 6& 12, water negative control; 
8, genomic DNA from putative 0336 mutant 2; 9, genomic DNA from putative 0340 
mutant 2. 
C sporogenes mutants: I&6,2 log DNA ladder; 2, genomic DNA from putative 0336 
mutant 1; 3&8, C sporogenes wild type genomic DNA; 4&9, pMTLO07C-E2 
plasmid DNA ;5& 10, water negative control; 7, genomic DNA from putative 0340 
mutant 1. 
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Appendix 5- Presentations 
Oral Presentations 
Society for General Microbiology, 161" Meeting, Edinburgh, UK 
Gene Regulation and Quorum Sensing in Clostridium hotulinum 
Society for General Microbiology, 160'h Meeting, Manchester, UK 
Characterisation of a putative agr system in Clostridium botulinum and Clostridium 
sporogenes 
Poster Presentations 
4th Conference on Functional Genomics of Gram-Positive Micro-organisms, Green Park 
Resort, Tirrenia, Italy 
Clostpath 2006 
- 
5h International Meeting on the Molecular Biology and Pathogenesis 
of the Clostridia, University of Nottingham, UK 
Bacterial Conversations 
- 
Talking, Listening and Eavesdropping, Royal Society, 
London, UK 
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